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SUM M ARY
Endothelial dysfunction is a common pathophysiological feature which 
develops in the evolution o f  cardiovascular diseases, Strategies to maintain a healthy 
endothelium or to reverse endothelial dysfunction are crucial for the normal function 
o f the cardiovascular system and the maintenance o f cardiovascular health. 
Endothelial dysfunction is observed both in the coronary and peripheral vasculature.
Studies have demonstrated that surgical preparation o f  coronary artery bypass 
grafts can cause endothelial dysfunction and influence the viability and patency o f 
these grafts. An important consideration in the improvement o f  surgical techniques is 
to prevent damage to the endothelium during harvesting and implantation. The 
relative influence o f the Mayo stripper minimally invasive long saphenous vein (LSV) 
harvesting technique and the influence o f  internal mammary artery (IMA) pedicle 
width in preserving the integrity o f  endothelial function are uncertain.
Increased production o f reactive oxygen species, in particular, superoxide and 
radicals derived from superoxide, has been associated with endothelial dysfunction in 
animal models o f disease, and there is increasing evidence o f  a link between oxidative 
stress and endothelial dysfunction in humans. It has been reported that endothelial 
dysfunction and increased oxidative stress may predict future events in patients with 
coronary artery disease. However, concurrent and comparative data on endothelial 
function, direct m easures o f  superoxide in human vessels, and biomarkers o f  oxidative 
stress are not available simultaneously in patients with coronary artery disease nor in 
control subjects with no documented cardiovascular disease. Circulating biomarkers 
o f  oxidative stress have been investigated in patients with essential hypertension and 
in control subjects, but the relationship between these markers and endothelial 
function has not been examined. In addition, although the degree o f endothelial
XXI
function has been consistently linked to the number o f risk factors present in patients 
with coronary artery disease, the relative importance o f individual risk factors in 
determining levels o f oxidative stress and endothelial function remains uncertain.
To address these questions, this thesis studied the influence o f harvesting 
techniques and cardiovascular risk factors on endothelial function o f human blood 
vessels commonly used in coronary artery bypass grafting.
The aim o f the first study was to compare endothelium -dependent 
vasorelaxation in LSV harvested from patients undergoing coronary artery bypass 
grafting (CABG) by traditional open and Mayo stripper m inimally invasive 
techniques. The experim ental approach was to determine calcium ionophore A23187 
mediated relaxation and sodium nitroprusside mediated relaxation o f  LSV rings from 
patients undergoing CABG by traditional open and minimally invasive techniques. 
This study found no significant difference in calcium ionophore A23187 mediated 
vasorelaxation or sodium nitroprusside mediated vasorelaxation in LSV harvested by 
traditional open and m inimally invasive techniques. These results demonstrate no 
evidence that the increased manipulation o f  the LSV, consequent upon using the 
minimally invasive technique, affected functional trauma to both endothelial- 
dependent and -independent function any more than the traditional open harvest 
method.
The aim o f  the second study was to determine the effect o f  IM A pedicle width 
on endothelium -dependent vasorelaxation o f IMA harvested by monopolar 
electrocautery from patients undergoing CABG. The experimental approach was (1) 
to measure IM A pedicle width and IMA diameter post harvest, (2) to measure calcium 
ionophore A23187 m ediated relaxation and sodium nitroprusside mediated relaxation 
o f IMA rings from patients undergoing CABG and (3) to record cardiovascular risk
XXIÏ
factors and current drug therapy. This study demonstrated the predominant role of 
IMA pedicle width in determ ining calcium ionophore A23187 mediated relaxation of 
IMA harvested by monopolar electrocautery from patients undergoing CABG. This 
study dem onstrated that a wider IMA pedicle harvested with monopolar 
electrocautery better preserves IMA nitric oxide-dependent endothelial function. Total 
cholesterol level was also a significant determinant o f ealcium ionophore A23187 
mediated relaxation.
The aim o f the third study was (I) to study endothelium -dependent and - 
independent vasorelaxation o f  LSV in a group o f  patients with severe coronary artery 
disease eompared to eontrols, (2) to study superoxide production levels in LSV in a 
group o f patients with severe coronary artery disease compared to controls, and (3) to 
study circulating indicators o f  oxidative stress in a group o f patients with severe 
coronary artery disease compared to eontrols. The experimental approaeh was to 
measure relaxation o f  LSV rings to ealeium ionophore A 23Î87  (endothelium 
dependent vasodilatator), sodium nitroprusside (endothelium independent 
vasodilatator), allopurinol (inhibitor o f  xanthine oxidase) and apocynin (reduced 
nieotinamide adenine dinucleotide phosphate (NAD(P)H) oxidase inhibitor) from 
patients undergoing CABG and age- and sex-matched eontrol patients with no 
documented cardiovascular disease who were undergoing surgery for removal o f 
varicose veins, (2) to measure circulating indicators o f  oxidative stress: redueed to 
oxidized glutathione ratio and total antioxidant capacity from patients undergoing 
CABG and age- and sex-matched control patients with no doeum ented eardiovascular 
disease who were undergoing surgery for removal o f varicose veins and (3) to 
measure superoxide produetion using lucigenin chemilum ineseence and oxidative 
fluorescent m icrotopography with hydroethidine from patients undergoing CABG and
X X I I I
age- and sex-matched control patients with no documented CVD who were 
undergoing surgery for removal o f varicose veins. This study showed severe 
depression o f  relaxation to calcium ionophore A23187 in veins from patients with 
severe coronary artery disease despite normal responses to sodium nitroprusside, 
consistent with a specific defect in endothelium-dependent nitric oxide pathways. 
Superoxide levels, measured directly within the vessel wall using the 2 methods, were 
elevated in blood vessels from patients with severe coronary artery disease compared 
with control patients. In addition, in the organ bath studies, inhibition o f  xanthine 
oxidase and NAD(P)H oxidase with allopurinol and apocynin, respectively, caused 
significantly greater relaxation in vessels from patients with severe coronary artery 
disease compared with control patients. These findings indicate excess superoxide 
production as an important cause o f the attenuation o f endothelium -dependent 
relaxations in patients with severe coronary artery disease and suggest that both 
xanthine oxidase and NAD(P)H oxidase contribute to superoxide produetion in these 
patients.
The aim o f  the final study was to determine which cardiovascular risk factors 
influence calcium ionophore A23187 mediated relaxation o f LSV in patients with 
severe coronary artery disease. The experimental approach was (I) to measure 
relaxation o f LSV rings to calcium ionophore A 23I87, sodium nitroprusside, 
allopurinol and apocynin from patients undergoing CABG, (2) to m easure circulating 
indicators o f  oxidative stress (reduced to oxidized glutathione ratio and the total 
antioxidant capacity) from patients undergoing CABG, and (3) to record 
cardiovascular risk factors and current drug therapy from patients undergoing CABG. 
The study showed a significant relationship between low density lipoprotein (LDL) - 
cholesterol levels and calcium ionophore A23187 mediated relaxation. LDL-
XXIV
cholesterol level was also a significant determinant o f circulating indicators o f 
oxidative stress (reduced to oxidized glutathione ratio and total antioxidant capacity), 
but, here, other risk factors, including diastolic blood pressure, age, and smoking, also 
played a role. These data indicate that there is a significant relationship between LDL 
cholesterol and vascular oxidative stress across the entire range o f  LDL cholesterol 
concentrations. This provides a mechanistic explanation in support o f  intensive LDL 
cholesterol-lowering therapy as suggested by recent clinical trials
In conclusion, this thesis proposes that a multi factorial strategy aimed at 
prevention o f  endothelial dysfunction and graft failure should include improved 
surgical techniques and use o f specific pharmacologic agents, including statins, as a 
form o f  intervention. The successful application o f  this strategy may impact on long­
term graft patency.
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Chapter 1
Introduction
1.1 Cardiovascular disease
Cardiovascular disease (CVD) is a m ajor cause o f  morbidity and mortality in 
the world today and is set to be the leading cause o f  death worldwide by 2020 
(Levenson et al. 2002). A ccording to the W orld Health Organization, 16.7 million, or 
29.2%  o f  total global deaths result from CVD, o f these 7.2 m illion deaths are due to 
coronary artery disease (CAD) (Beaglehole 2004). The diseases constituting its range 
o f  fatal expression (end organ CVD) include myocardial infarction and acute coronary 
syndrome secondary to CAD. In the United Kingdom in 2000, the calculated annual 
direct costs o f  the care o f  patients w ith CAD were £1.8 billion, w ith the indirect costs 
o f  loss o f  productivity three to four times greater at £6.3 billion (Shearer et al. 2004). 
All forms o f  CVD are associated with some degree o f  endothelial dysfunction 
(Feletou and Vanhoutte 2006).
1.2 Coronary artery bypass grafting
Coronary artery bypass grafting (CABG) was developed in the 1960s and in 
the 1970s, utilizing the long saphenous vein (LSV) and internal m am m ary artery 
(IMA) grafts, and has dram atically changed the m anagem ent o f  patients with ischemic 
heart disease.
The goal o f  CABG is to provide long-term patent gi’afts in the native coronary 
arterial system (Ogus et al. 2007; Kleisli et al. 2005; Sirivella et al. 2005; Eagle et al. 
2004). The main reasons for CABG are: a) to relieve ischemia resistant to medical 
treatment, b) to prevent m yocardial infarction and c) to increase life expectancy (Ogus 
et al. 2007; Kleisli et al. 2005; Eagle et al. 2004; Barra et al. 2000; Canver 1995; Bell 
et al. 1992; M yers et al. 1989; Rahim toola et al. 1977). A lthough CABG has achieved 
these goals, the degeneration o f  grafts with time is a m ajor problem (Rosamond et al.
2006). There is increasing interest for the use o f  arterial conduits in CABG (Ferrari 
and von Segesser 2006). This is due to the well-docum ented long-term failure o f  vein 
conduits (Schachner 2006), which is the main cause o f  reoperation and is even more 
com m on than the progression o f  native CAD (Eagle et al. 2004; W eintrab et al. 1994; 
Salomon et ai. 1990). Despite the undoubted success and benefits o f  CABG with the 
use o f autologous LSV, the occlusion rate o f  LSV grafts in the first year is between 
15% and 26% and by 10 years up to 59% o f  LSV grafts are occluded (Cho et al. 2006; 
Eagle et al. 2004; Eagle et al. 1999; Favaloro 1998; Fitzgibbon et al. 1999; Mortwani
1998). The vein grafts that remain patent at 5 and 10 years frequently show 
angiographic luminal irregularity or narrowing (Cho et al. 2006; Eagle et al. 2004; 
Eagle et al. 1999; Grondin et al. 1984). However, the ready availability o f  LSV grafts 
still accounts for its use in over 70% o f  CABG (Hata et al. 2007; Eagle et al. 2004).
W ith 427,000 coronary bypass graft operations now perform ed annually in the 
United States in 2004 alone (Rosamond et al. 2007), the growing num ber o f  
degenerated grafts presents an increasing clinical dilemma. In spite o f  the fact that 
LSV graft failure remains a significant clinical and economic burden (Rosamond et al. 
2006), the m ajority o f  bypass procedures continue to use LSV (Rosamond et al. 
2006). Thus, for grafts to remain useful as stable and long-lasting coronary bypass 
conduits, the m ost important pathologic changes causing graft failure, which are graft 
throm bosis and atherosclerosis, m ust be delayed or prevented (Jeremy et al. 2007; 
Akowuah et al. 2003; Shuhaiber et al. 2002).
- Left main coronary artery
- Left anterior descending artery 
(also known as “the widowmaker”)
- 90% stenosis o f  left anterior 
descending artery
~  Left circumflex artery
-  Diagonal artery branch o f  
left anterior descending artery
Figure 1.1 Left anterior descending artery stenosis. (Courtesy o f  M edical 
Illustration Services, G lasgow  Royal Infirmary). A stenotic artery obstructs blood  
flow  from m oving through it normally. CABG  involves the palliative bypassing o f  
blockages or narrowings in the coronary vessels with a conduit from the aorta to a 
point on the coronary vessel beyond the major disease. The nature o f  C A D  lends itself 
to bypass surgery since it tends to be both proximal and focal as shown in the figure 
with 90% stenosis o f  the left anterior descending artery. The left main coronary artery 
arises from the posterior aortic sinus. It g ives o f f  the left anterior descending artery 
which descends to the apex o f  the heart in the anterior interventricular groove. The 
vessel provides diagonal branches to the left ventricular free wall. Both the anterior 
descending artery and its diagonal branches are important vessels to graft i f  diseased. 
The left main vessel passes posteriorly towards the diaphragmatic surface o f  the heart 
in the atrioventricular groove where it is known as the circum flex artery. The 
circum flex artery is another important vessel to graft i f  diseased.
A principal cause o f  early graft failure following CABG is surgical trauma 
during graft harvesting w hich can cause endothelial and smooth m uscle injury that has 
important im plications for conduit longevity (Poston et al. 2006; M anchio et al. 2005; 
Thatte and Khuri 2001). In fact, endothelial disruption in LSV used for CABG has 
been associated with the risk o f  developing early thrombosis (Poston et al. 2006; 
M anchio et al. 2005) and 70% o f  early graft occlusions in CABG are caused by 
thrombi overlying areas o f  endothelial loss (Alrawi 2001). Therefore modifications to 
surgical technique m ust be investigated to ensure endothelial damage is minimised to 
optimise graft survival and function or there will be significant m ortality and cost 
implications.
1.3 H istorical review o f  m yocardial revascularization
In the 1890s, as surgeons were discovering that blood vessels were lined with 
cells w ith a capacity for active repair, they hypothesized the possibility o f  performing 
vascular anastom osis (M orris 1935). In 1896, M athieu Jaboulay, introduced a 
technique o f  intima to intim a anastomosis o f  vessels using interrupted everting 
mattress sutures (Jabouley and Brian 1896). Morris suggested the possibility o f 
performing vascular anastom osis to the surgeon James M urphy and in 1897, James 
M urphy published the first report on vascular anastomosis in human patients (Murphy 
1897). In 1902, A lexis Carrel a student o f  Jabouley, moved to work with Charles 
Guthrie and further refined vessel anastomosis by the trifurcation technique (Carrel 
and Guthrie 1905). In 1905, Charles Guthrie, Jose Goyanes and Alexis Carrell 
reported the first experim ental use o f  autologous vein grafts (Carrel and Guthrie 
1905). Jose Goyanes, following Alejandro San M artin Y Sastrustigui’s advice.
perform ed the first successful vein autograft o f popliteal vein to bypass a popliteal 
aneurysm (Goyanes 1906).
Surgical treatm ent for CAD began in the early 1900s. Experim ental techniques 
by Alexis Carrel for directly anastom osing the aorta with the left anterior descending 
coronary artery failed (Carrel 1910) and indirect methods o f  myocardial 
revascularization by Claude Beck (Beck 1935; B eck and Leighninger 1954) and later 
by Arthur Vineberg (Vineberg and M iller 1951) only m arginally increased the blood 
supply to the myocardium. Development o f  the first selective coronary angiography 
by M ason Sones at The Cleveland Clinic led to the application o f  direct myocardial 
revascularization and dem onstrated the angiographic patency o f  the Vineberg 
procedure (Sones and Shirey 1962).
In 1962 D onald Bffler (Effler et al. 1964), was able to repair a tight narrowing 
o f  the left main trunk o f  the coronary artery (Figure 1.1) by using the patch graft 
technique developed by Ake Senning (Senning 1961). However, the m ortality when 
applying this technique was extrem ely high. In 1962 David Sabiston performed the 
first CABG on a beating heart, from the aorta to the right coronary artery using an 
autologous LSV as the conduit (Sabiston 1963). In 1965 Kolessov perform ed the first 
anastomosis betw een the left IM A and the left anterior descending through a left 
thoractomy (Kolessov 1967).
In 1967 Rene Favaloro successfully reconstructed the right coronary artery by 
interposing a segm ent o f LSV and later on he started using LSV graft direct from the 
aorta to the coronary arteries. Afterwards, significant progress occurred when 
Favaloro and his group were able to perform double bypass, emergency 
revascularisation and even combined operation (Favaloro 1970). The results o f  these 
efforts compiled by Sheldon et al. (Sheldon et al. 1969; Sheldon et al. 1970) were
immediately obvious to the m edical community. The same year, George Green and 
Bailey and Hirose separately published reports in which the IMA was used for CABG 
in patients (Green et al. 1968; Bailey and Hirose 1968).
In the 1980s studies dem onstrated that severe atherosclerotic deterioration o f 
LSV graft occurs between 6 and 11 years post CABG (Bourassa et al. 1984; Campeau 
et al. 1984; Grondin et al. 1984; Campeau et al. 1983). They proposed that 
aortocoronary surgery, w ith the use o f LSV grafts, should be reconsidered and 
suggested that modifications o f  harvesting techniques and pharmacological 
intervention m ight improve the patency o f  aortocoronaiy vein grafts. A t the same time 
Floyd Loop, in a great num ber o f  patients, showed a clear advantage o f  using IMA 
over the LSV (Loop et al. 1986). A few years later the benefit from expanded internal 
thoracic artery grafting techniques by using bilateral, free and sequential anastomoses 
was suggested (Loop et al. 1989). Until 1980, only 13% o f surgeons w ere using IMA 
grafts (M iller et al. 1981). Since the mid 1980s the num ber o f  surgeons has increased 
steadily and today m ost surgeons employ them (Eagle et al. 2004).
Due to the excellent results o f  the IM A grafts, surgeons looked for other 
sources o f  arterial conduits. In 1987, Pym et al. (1987), Suma et al. (1987) and Attum 
et al. (1987) reported the first studies on the use o f  the gastroepiploic artery for direct 
myocardial revascularization. In 1990, Puig et al. (1990) introduced the use o f  inferior 
epigastric artery. In 1971, C aipentier introduced the radial artery as an alternative 
conduit for CABG; however, the initial results were disappointing (Carpentier et al. 
1973). It was reintroduced after m odification o f  the harvesting technique and the use 
o f  preoperative calcium channel blockers, which significantly improved the mid-term 
angiographic results (Gardner 2007; A car et al. 1998; Acar et al. 1992; A car et al.
1991). Two randomised studies have provided no evidence o f its superiority to the
LSV. (Desai et al. 2004; Buxton et al. 2003) Therefore, the m ost prudent choice for a 
high proportion o f  patients continues to be the use o f  a single left IM A and multiple 
vein grafts (Souza et al. 2006).
Autologous IM A are the graft o f  choice as this conduit is the single m ost 
important factor in improved survival and freedom from angina (Hata et al. 2007; 
Ferrari and von Segesser 2006; Sirivella et al. 2005; Tatoulis et al. 1999; Acinapura et 
al. 1989). Despite the widespread use and superior patency o f  the IM A and other 
arterial conduits, the LSV continues to be the most commonly used conduit for CABG 
(Hata et al. 2007; Eagle et al. 2004). LSV graft failure after CABG surgery may be as 
high as 5% to 10% in the first postoperative week (M anchio et al. 2005). Up to 26% 
o f LSV grafts occlude within the first year after bypass surgery (Cho et al. 2006; 
Eagle et al. 2004; Fitzgibbon et al. 1999; Eagle et al. 1999; Favaloro 1998; M oitwani 
and Topol 1998; Fitzgibbon et al. 1996; Bourassa 1991; Campeau et al. 1984). 
Thereafter, for the next 5 years, the attrition rate is 1% to 2% per year, accelerating to 
up to 4% per annum as the graft ages further (Cho et al. 2006; Eagle et al. 2004; 
Fitzgibbon et al. 1999; Eagle et al. 1999; Favaloro 1998; M ortwani and Topol 1998; 
Fitzgibbon et al. 1996; Bourassa 1991; Cam peau et al. 1984). As a result, by 10 years 
after surgery, up to 59% o f  LSV grafts are occluded and the grafts that remain patent 
frequently show angiographic luminal irregularity or narrowing (Cho et al. 2006; 
Eagle et al. 2004; Fitzgibbon et al. 1999; Eagle et al. 1999; Favaloro 1998; Mortwani 
and Topol 1998; Fitzgibbon et al. 1996; Bourassa 1991; Campeau et al. 1984).
One end of the Wood vessel is attached to the aorta
A procedure to bypass a blocked section of a coronary artery and to deliver oxygen to the heart
Other end is attached to the coronary artery at a point Ijelov/ the blockage
Blockage in coronary artery
Figure 1.2 A picture o f  a coronary artery bypass graft: It involves a procedure to 
bypass a blocked section o f  coronary artery and deliver oxygen to the heart. One end 
o f  the blood vessel is attached to the aorta and the other end is attached to the 
coronary artery at a point below  the blockage thereby bypassing the blockage. (From: 
North G lasgow  University Hospitals N H S Trust Coronary Artery Bypass Grafting 
Patient Information Leaflet. Courtesy o f  M edical Illustration Services, G lasgow  Royal 
Infirmary).
The superior long-term patency rate o f  IMA grafts compared with LSV grafts 
is w ell documented (Ferrari and von Segesser 2006; Cho et al. 2006; Loop et al.
1986). Up to 5% o f  IMA grafts occlude within the first year and patency rates o f  the 
IMA implanted into the left anterior descending artery are as high as 83% at 10 years 
(Sirivella et al. 2005; Eagle et al. 2004; Schroeder et al. 2000; Lamm et al. 2000; 
Tatoulis et al. 1999; Mehta et al. 1997; Verrier et al. 1996; Izzat et al, 1994; Zilla et al. 
1993; Lytle et al. 1985) but again the grafts that remain patent frequently show  
angiographic luminal irregularity or narrowing. (Eagle et al. 2004; Eagle et al. 1999).
Reflecting this graft attrition and progression o f  native CAD, angina recurs in up to 
20% o f patients during the first year after LSV grafting and in 4%  o f  patients annually 
during the ensuing 5 years (Cameron et al. 1995). Indeed, further revascularization is 
required in 4% o f patients by 5 years, 19% o f  patients by 10 years, and 31% of 
patients by 12 years after initial bypass surgery (W eintrab et al. 1994).
With the exception o f  lipid lowering therapy (Campeau 2000; Datani et al. 
2000; The Post Coronary Artery Bypass Graft Trial Investigatiors 1997), no 
intervention has hitherto proved clinically effective in preventing late vein graft 
failure (Jeremy et al. 2007). Therefore, every effort should be made to optimise the 
patency rate o f  the grafts. Preparation o f  the graft is important since there is direct 
evidence that surgical injury during vessel preparation (Dashwood and Loesch 2007; 
Cunningham 1996) causes severe intimai loss as well as biochem ical and functional 
changes o f  the grafts (Dashwood et al. 2007; Poston et al. 2006; Schmid et al. 2006; 
M anchio et al. 2005; Dashwood et al. 2005; Deja et al. 2003; Thatte and Khuri 2001; 
M ills and Bringaze 1989; M ills and Everson 1995).
1.4 Pathophysiology o f graft failure associated with graft preparation
Bypass grafts undergo changes that are divided into two chronological phases. 
In post-CABG days 1-3, nondenuding endothelial injury, inflammation, limited fibrin 
deposition and platelet aggregation occur (Davies and Hagen 1995; Davies et al. 
1994; Davies et al. 1993). In post-CABG days 14-28, the inflam m atory infiltrate 
resolves, the functional integrity o f  the endothelium is restored, and vascular smooth 
muscle cell (VSM C) proliferation results in intimai hyperplasia (M itra et ai. 2006; 
Davies et al. 1994; Bulkley and Hutchins 1977).
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Figure 1.3 Haem atoxylin and eosin-stained sections o f  transected normal LSV  
graft (left) and LSV graft with intimai hyperplasia one month after implantation 
(right) (Courtesy o f  Dr MG D avies). Intimai hyperplasia is the universal response o f  a 
vessel to injury (Mitra et al. 2006). It involves the coordinated stimulation o f  smooth  
m uscle cells by mechanical, cellular and humoral factors to induce a program o f  
cellular activation that leads to proliferation, migration and extracellular matrix 
deposition (Mitra et al. 2006). A s intimai hyperplasia slow ly builds up significant 
restenosis may develop, as the neointima renders the graft susceptible to atherogenesis 
with macrophages infiltrating this layer to develop into foam cells and then plaque 
(Mitra et al. 2006), such that as many as 59% o f  grafts w ill occlude within a decade 
after the procedure.
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1.5 Early graft occlusion
There are multiple mechanisms underlying graft failure (Jerem y et al. 2007; 
Schachner 2006; Poston et al. 2006; Sarjeanta and Rabinovitch 2002; Shuhaiber et al. 
2002; Tsui and Dashwood 2002; Sessa et al. 2001; Davies et al. 1995; Angelini et al.
1992). This failure results from two processes (Schweiger et al. 1992; Campeau et al.
1983). First, acute throm bosis occurs early in the postoperative period in at least 5% 
o f  all vein grafts (Goldm an et al. 1989). Second, late graft failure occurs at a rate o f 
5% to 10% per year per vein graft due to a progressive atherosclerosis-like process. 
The substrate for the rapid developm ent o f atherosclerosis in venous bypass grafts is 
intimai hyperplasia resulting from VSM C m igration/proliferation, a characteristic 
feature o f  the accelerated atherosclerosis syndrome (Schwartz et al. 1996; Davies and 
Hagen 1995; Ip et al. 1990; Neitzel et al. 1986).
M aintaining structural and functional integrity o f  the endothelium  o f  the graft 
is an im portant feature o f  any procurem ent technique, as a principal cause o f  early 
graft failure following CABG is surgical traum a during graft harvesting which can 
cause endothelial and smooth m uscle injury that has im portant im plications for 
conduit longevity (Dashwood and Loesch 2007; Poston et al. 2006; M anchio et al. 
2005; Dashwood et al. 2004b; Thatte and Khuri 2001). In fact, endothelial disruption 
in LSV used for CABG has been directly correlated with the risk o f  developing early 
throm bosis (Poston et al. 2006; M anchio et al. 2005) and 70%  o f  early graft 
occlusions in CABG are caused by throm bi overlying areas o f  endothelial loss 
(Alrawi 2001).
It has been dem onstrated that early graft occlusion, throm bosis or stenosis 
(reduced graft patency) is related to the inevitable vascular trauma, especially a result 
o f  endothelial damage and/or dysfunction and/or loss that occurs during harvesting
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and surgical m anipulation for CABG (Dashwood and Loesch 2007; Dashwood et al. 
2007; Souza et al. 2006; Dashwood et al. 2005; O 'R egan et al. 1997; Soyombo et al. 
1993; D illey et al. 1988; Angelini et al. 1987b; Unni et al. 1974). Preparation 
techniques have dem onstrated the importance o f minimal m anipulation o f  the vein 
graft on the integrity o f  the endothelium, intima, and media (Dashwood and Loesch 
2007; Dashwood et al. 2007; Souza et al. 2006; Dashwood et al. 2005; Gundry et al.
1980). Studies have implicated harvest techniques, graft preparation and storage 
media as sources o f  endothelial traum a and dysfunction (Dashwood and Loesch 2007; 
Dashwood et al. 2007; Souza et al. 2006; Dashwood et al. 2005; Perrault et al. 2005; 
A lam anni et al. 2002; Soyombo et al. 1993; Liu et al. 2001) and intraoperative 
endothelial integrity relates directly to subsequent graft patency (Soyom bo et al. 1993; 
Dries et al. 1992; Angelini et al. 1987b; Lawrie et al. 1990; Roberts et al. 1984; 
Gundry et al. 1980). This traum a has been demonstrated to occur during (Dashwood 
et al. 2007; Dashwood and Loesch 2007; Souza et al. 2006; Dashwood et al. 2005; 
Angelini et al. 1989; Gundry et al. 1980) and after surgical preparation, when 
distending (Hasse et al. 1981; Bonchek et al. 1980) or stretching (Bush et al. 1986) the 
graft. It has been suggested that standardized vein harvest techniques may preserve 
LSV m orphology and reduce the incidence o f  graft failure (Souza et al. 2006; Dries et 
al. 1992). Furthermore, a relationship between early endothelial dam age and late graft 
atherosclerosis has also been postulated but not clearly established (Poston et al. 2006; 
M anchio et al. 2005; Thatte and Khuri 2001).
B iological endothelial integrity is required for NO production in the LSV and 
IM A (Dashwood et al. 2005; Lüscher et al. 1988), and inhibition o f  platelet deposition 
(Radomski et al. 1991; Radom ski et al. 1987). Few studies have assessed vascular 
reactivity and surgical techniques (Barker et al. 1994 Dhein et al. 1991), or compared
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different techniques (Chester et al. 1990), especially minim ally invasive techniques 
(Black et al. 2001; O ’Regan et al, 1997; O'Neil et al. 1993). The activity o f  
endothelium -dependent NO is sensitive to preparation techniques in hum an LSV 
segments (Lawrie et al. 1990).
Im pairm ent o f  biological endothelial integrity exposes sub-intimal tissue to 
circulating blood, enhances platelet and fibrin deposition (Baum gartner et al. 1976), 
initiates a chronic injury-repair process, and often may be followed by fibrous and 
myo-epithelial proliferation endothelial layer (Catinella et ai. 1982; Furchgott and 
Zawadzki 1980) which affects short- and long-term graft perform ance (Dhein et al. 
1991; He et al. 1989). However, damage to the tunica m edia and surrounding tissue o f 
the vessel also occurs and observations indicate that adventitial remodelling and 
subsequent effects on microvessels (vasa vasorum) and vascular nerves may also be 
important in the pathophysiology o f graft narrowing and occlusion (Dashwood et al. 
2007; Dashwood and Loesch 2007; Souza et al. 2006 D ashwood et al. 2004a; 
Gutterman 1999; Barker et al. 1994).
Dashw ood and Loesch (2007) state that “damage to segments o f  the LSV 
during harvesting as a graft is inevitable.” This damage to the LSV graft is aggravated 
by subsequent exposure to raised arterial pressure (Dobrin et al. 1989; Svendsen et al. 
1986; Brook 1975). One o f  the earliest findings is the insudation o f  blood constituents 
including fibrin, erythrocytes, and neutrophils into the graft intima. This is attributed 
to increased perm eability o f  the endothelium and is observed consistently in all grafts 
(Vlodaver and Edwards et al. 1971). In an animal study (W yatt and Taylor 1966), the 
autologous vein grafts used as arterial replacement have shown considerable damage 
to the endothelial cells during the process o f  grafting. The vessels w ere still partly 
denuded o f  endothelium  after four weeks. By 12 weeks and possibly as early as six
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weeks, a complete endothelial covering was present. Another study found that 
surgical preparation by perform ance o f the proximal venous anastom osis first, 
allowing the patient’s own blood pressure to distend the vein, preserved both 
endothelial and m edial function (Angelini et al. 1987a).
Graft failure is not only dependent on the quality o f  the conduit used and poor 
surgical technique but also poor distal run-off o f  the coronary arteries (Catinella et al. 
1982; Gundry et al. 1980).
1.6 Fibrointim al hyperplasia
Fibrointimal hyperplasia is the formation o f  scar tissue by smooth muscle 
proliferation and is believed to be a m ajor contributor to the occlusion o f  LSV bypass 
grafts following placem ent o f  vein grafts into the aortocoronary circulation (Schwartz 
et al. 1996; Davies and Hagen 1995; Neitzel et al. 1986). Fibrointim al hyperplasia is 
also caused by endothelial injury and invariably occurs to some degree (Schwartz et 
al. 1996; Davies and Hagen 1995; Soyombo et al. 1993; Cox et al. 1991; A dcock et al.
1984). Endothelial removal also results in the loss o f  vasculoprotective systems that 
prevent inflam m ation and thrombosis, these principally being nitric oxide (NO) and 
prostacyclin (PGU) system s (Wu and Thiagarajan 1996; Gryglewski et al. 1995; 
Angelini et al. 1989; Angelini et al. 1987c). Subsequent platelet activation may release 
platelet-derived growth factor and basic fibroblast growth factor, which stimulate the 
smooth-muscle cells o f  the m edia to migrate to the intima and to proliferate and 
synthesize fibrous tissue, including collagen and proteoglycans (LoGerfo et al. 1983). 
The latter process causes the intimai thickening or hyperplasia that generally results in 
a 25%  decrease in the luminal vessel diameter (Fuster and Chesebro 1986). Evidence 
shows that basic fibroblast growth factor released from injured endothelial cells
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(Nguyen et al. 1994) is important in fibrointimal hyperplasia. Recent data from a 
canine model showed that the density o f  receptors for this growth factor is increased 
when the vein graft is distended at 200 mmHg (M cNeil et al. 1989). The m ajority o f 
grafts that do not com pletely occlude exhibit some degree o f fibrointimal hyperplasia 
by one month (Angelini 1992). Intravascular ultrasonography has dem onstrated that 
significant fibrointimal hyperplasia occurs by 1 year (Hozumi et al. 1996).
1.7 Ischaem ic damage
It has been suggested that hypoxia may be important in m ediating LSV graft 
disease (Jeremy et al. 2004; Dashwood et al. 2004a; Jeremy et al. 1997a). Surgical 
harvest o f  the LSV will results in a loss o f  continuity o f  the vasa vasorum, a 
microvascular network responsible for the exchange o f  gases and supply o f  nutrients 
to the vessel wall, w hich in turn would result in hypoxia o f  the tissue (Jerem y et al. 
2007; Dashwood et al. 2004a), Interference o f  the vasa vasorum has been associated 
with CVD (Barker et al. 1993; M artin et al. 1991; Batson and Sottiurai 1985; 
M cGeachie et al. 1981). It has been suggested that damage to the vasa vasorum during 
LSV distension w ith resultant ischemia, may be an important m echanism  promoting 
the subendotheiial changes (Corson et al. 1985; Spray and Roberts 1977). There is 
evidence dem onstrating that medial fibrosis is induced when grafts are made 
ischaemic by interruption o f  vasa vasorum and this is independent o f  intraluminal 
pressure (Brody et al. 1972). Pig LSV becomes rapidly hypoxic after excision and 
remains so after im plantation for at least a month (Jeremy et al. 2007). As the LSV 
graft thickens rapidly, the graft is probably subject to an increase in oxygen demand 
which may also increase hypoxia (Jeremy et al. 2007). Hypoxia prom otes superoxide 
formation via activation o f  NAD (P)H oxidase, xanthine oxidase and mitochondrial
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respiratory chain (M uzaffar et al. 2005). This prolonged hypoxia upregulates the 
expression o f  m any proteins that prom ote LSV graft disease (Jerem y et al. 2004; 
Jeremy et al. 2002).
1.8 Altered local haem odynam ics
Following implantation, the vein graft, which has been subjected only to an 
internal pressure o f  10 mmHg, is immediately subjected to arterial pressure (100 
mmHg) (Dobrin et al. 1989). These pressures cause increased circumferential and 
radial stresses to the vein grafts) (Dobrin et al. 1989). Haem odynam ic forces, 
principally, excessive high wall shear stresses have been postulated as promoters o f 
intimai hyperplasia since studies have demonstrated that the ratio o f  luminal radius to 
wall thickness in grafts tends to adapt to the same value as that in the grafted artery, 
which suggests that wall thickening occurs to normalise tangential wall stress (Dobrin 
et al. 1989). Hydraulic distension was associated with mural thinning and endothelial 
dam age (Kennedy et al. 1989a), but the implications o f  these findings remain, unclear. 
Increased flow velocity is associated with reduced developm ent o f  fibrointimal 
hyperplasia and atherosclerosis, and m ay thereby be a factor o f  the higher long-term 
patency rate for IM A grafts (Fujiwara et al. 1988). There is evidence supporting a 
localized autoregulatory m echanism  that senses shear stress and transduces that 
information into a m essage to regulate luminal diameter (Zwolak et al. 1987). Further 
data suggests that this mechanism  is dependent on the presence o f  the endothelium 
that acts as the transducing elem ent (Langille and O'Donnell 1986). Since the LSV is 
m uch thinner than the artery and lacks connective tissue layers that characterizes 
arteries it adapts to arterial environm ent by thickening or remodelling. This 
effectively involves the proliferation o f  VSM Cs and a concomitant deposition o f
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matrix proteins (Berk 2001; Gibbons and Dzau 1994). The process o f  LSV graft 
rem odelling also intrinsically alters intra-graft haemodynamics. Both high and low 
shear stress are associated with enhanceed platelet adhesion (Kawano et al. 2002; 
Turitto et al. 1998; Kroll et al. 1996). The asymmetric growth o f  the LSV graft may 
also promote chaotic blood flow patterns (Caro et al. 2002) which prom ote platelet 
and leucocyte adhesion and thrombosis (Caro et al. 2002). This in turn would augment 
the initial triggering o f  neointim a formation and autoregulatory m alfunction which 
may conceivably lead to excessive fibrointimal hyperplasia w ith obstruction o f  the 
lumen (de Souza 2002).
1.9 Atherosclerosis
Initially vein grafts were thought to be resistant to the developm ent o f 
atherosclerosis (M anderson and Campbell 1986), but subsequent reports showed that 
atherosclerotic changes occur as early as three to six months postoperatively (Grondin 
1986; Barboriak et al. 1974). The incidence o f  these lesions increases w ith time and 
may be as high as 30% after three years (Sarjeant and Rabinovitch 2002; Fuchs et al. 
1978). A detailed m orphological study o f  vein grafts suggests that virtually all LSV 
grafts older than one year show atherosclerotic plaque formation (Kalan et al. 1990). 
The m ajority o f  LSV grafts that occlude in the late postoperative period, that is five 
years or m ore after grafting, develop a rapidly progressive form o f  atherosclerosis 
(Sarjeant and Rabinovitch 2002; R atliff and M yles 1989). There is evidence that 
endothelial damage stimulates migration and proliferation o f  VSM Cs into the intima, 
which is a key event for developm ent o f  atherosclerosis (Sarjeant and Rabinovitch 
2002; Ross 1973).
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1.10 Vasospasm
Reports o f  coronary bypass spasm have been published in the literature (Fukui 
et al. 2005; M yers et al. 2003; Reddy et al. 2001; Shapira et al. 2000; Taggart et al. 
2000; Caputo et al. 1999; M assa et al. 1991; Dye et al. 1984; W alinsky 1982; Singh et 
al. 1982; Singh et al. 1981; Baduini et al. 1981). It has been dem onstrated that LSV 
are capable o f  spasm (Zerkowski et ai. 1982; W addell et al. 1973). Spasm may be a 
clinically important m echanism  in the early and/or late occlusion o f  vein bypass grafts 
(M ann et al. 1987; Victor et al. 1981; Singh et al. 1981; Waters et al. 1980; Buxton et 
al. 1981). Spasm o f  arterial and venous graft conduits may occur both during 
harvesting and after the graft has been implanted (M ann et al. 1987). The cause o f 
spasm o f  a vein during harvesting is not well understood. The most likely cause is the 
response o f  smooth m uscle to m echanical stimulation during handling and dissection 
(Mann et al. 1987). Thus, unless specific pharmacologic measures are taken, the LSV 
is often in spasm after harvesting (Rosenfeldt et al. 1999; M ann et al. 1987). In 
general, spasm o f  vascular graft conduits is best managed by prevention by good 
harvest technique rather than treatm ent after spasm has occurred (Rosenfeldt et al. 
1999).
1.11 Potential role o f the adventitia in grafts
The tunica adventitia is the outermost layer o f  blood vessels and since it 
gradually m erges w ith the loose connective tissue surrounding the vessel, this region 
is usually removed during conventional harvesting o f  LSV and during IMA 
skeletonisation for use as bypass conduits (Dashwood and Loesch 2007; Boodhwani 
et al. 2006; M atsum oto et al. 2006; Deja et al. 2005; Ueda et al. 2003; Gaudino et al. 
1999). In m edium  sized vessels, such as the LSV and IMA, the adventitia consists o f
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longitudinally oriented bundles o f  VSM Cs, collagen fibres and networks o f  elastin 
fibres (W heater et al. 1987). Fibroblasts, macrophages and unm yelinated nerves are 
also found within the adventitia o f  medium and large sized vessels (W heater et al. 
1987).
The removal o f  the adventitia may play an important part in the subsequent 
processes involved in graft occlusion because the adventitia does not m erely provide 
structural support for the media, but contains the vasa vasorum (Dashwood and 
Loesch 2007). The vasa vasorum o f  veins penetrate much closer to the intim a than the 
vasa vasorum o f  arteries and this is particularly evident in the LSV (W heater et al.
1987). The vasa vasorum  has been shown to be associated with the long-term 
developm ent o f neointimal hyperplasia in vein grafts (M cGeachie et al. 1989), and 
also with tissue healing around LSV grafts (O 'Brien et al. 1997). Damage to vasa 
vasorum in LSV grafts may result in vessel wall hypoxia with subsequent neointima 
formation, similar to the observation in arteries where occlusion o f  vasa vasorum 
leads to neointim a formation and atherosclerosis (Barker et ai. 1993; M artin et al. 
1991). This may also occur when skeletonising the IMA.
Although the LSV graft is “disconnected” from its vascular bed, the supply o f 
blood to medial and adventitial structures will be m aintained by the retrograde blood 
flow observed through the vasa vasorum in “no-touch” vein grafts at implantation 
(Souza et al. 2006). Furthermore, the connective tissue surrounding the LSV graft 
when the “Souza no-touch” technique is used may act as a buffer against coronary 
arterial haemodynamics, “protecting” the graft in very much the sam e way that has 
been suggested with the use o f  experimental external stents (M ehta et al. 1997) and by 
retaining its surrounding connective tissue cushion during harvesting, perivascular 
sources o f  NO are maintained that contribute further to the improved patency rate in
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CABG patients receiving LSV prepared with minimal vascular damage (Dashwood et 
a l  2007).
The vascular nerves located within the tunica adventitia o f blood vessels are 
disrupted during bypass surgery (Dashwood et al. 1998a). The innervation o f  veins 
differs from that o f  arteries, so there will be m ajor differences between the LSV graft 
and the host artery w ith respect to neurogenic factors (Dashwood et al. 1998a). 
Arteries remain under a degree o f  vascular tone that is influenced by the autonomic 
nervous system. Apart from classical compounds, such as acetylcholine, 
noradrenaline and serotonin, there is an increasing list o f  vasoactive transmitters 
including NO, which affect vasom otor tone o f  arteries and veins. The autonomic 
vascular nerves within the adventitia penetrate the adventitia tunica m edia to release 
neurotransmitters that regulate vasom otor tone.
Adventitial fibroblasts have also been suggested to be involved in neointimal 
formation and vessel occlusion (Shi et al. 1996a; Shi et al. 1996b). There is evidence 
for adventitial remodelling following vascular damage, such as that caused during 
graft surgery. An increase in adventitial mass, due m ainly to the proliferation o f 
fibroblasts has been described. More recently, it has been suggested that fibroblasts 
from the adventitia are the progenitors o f  neointima (Shi et al. 1996a). The neointima 
may then progress, resulting in atherosclerotic changes in the vessel wall, causing the 
neointima to be called “soil for atherom a” (Schwartz et al. 1995).
1,12 Storage solution for graft preservation
Several solutions have been used as a storage medium for the preservation o f 
grafts after harvesting (Alamanni et al. 2002). The important role o f  the temperature 
and the type o f  solution used for graft preservation is well recognized (Karnsz et al.
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1981). However, there is no ideal solution for rinsing, distending and storing the 
grafts prior to their im plantation (Alamanni et al. 2002). Although, as there is yet no 
universal agreem ent on this subject, the superiority o f  blood over crystalloid solutions 
for the preservation o f  endothelial and medial VSMC morphology has been suggested 
(Gundry et al. 1980; Sottiurai et al. 1983). It has been dem onstrated that the 
preservation o f  endothelium  was better in autologous heparinised blood than in 
heparinised saline solution (Schaeffer et al. 1997). However, the best preservation o f 
the endothelium was observed with Bret Schneider’s solution com pared to all other 
solutions tested (Schaeffer et al. 1997). Plasma-Lyte solution at 37°C has been 
recom m ended as a venodilating storage solution during coronary bypass operations to 
optimise vein graft relaxation before implantation (Sanchez 1994). A study showed 
that vessel storage in heparinised blood m aintained good contractility the first 24 
hours and NO dependent vasodilation was effective for a period o f  up to 12 hours. 
University o f  W isconsin solution and Perfadex gave good preservation for 24 hours 
but Euro-Collins solution was not a suitable solution for long-term preservation o f 
blood vessels (Ingem ansson 1995). Vessels stored in Krebs solution, the only solution 
containing calcium, m anifested no reduction in contractility throughout the 36 hour 
test period (Ingem ansson 1995). Considering the excellent results obtained with Krebs 
solution regarding contractility, it was suggested that the addition o f calcium to 
University o f  W isconsin solution and Perfadex would improve their ability to preserve 
VSMC function during prolonged storage (Ingemansson 1995). However, another 
study has shown specific potentially detrim ental effects o f  U niversity o f  W isconsin 
solution on the endothelium  and smooth m uscle function o f isolated LSV (Anastasiou 
et al. 1997). A  more recent study demonstrated that incubation w ith Celsior and 
University o f  W isconsin solutions substantially preserved endothelial viability and
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proliferative capability (Alamanni et al. 2002). Conversely, a prolonged incubation in 
either Euro-Collins or St. Thom as solutions caused severe and potentially irreversible 
damage referable to the induction of, respectively, apoptotic or necrotic changes 
(Alamanni et al. 2002).
1.13 M ethods o f reducing graft failure
Various methods have been attem pted to reduce graft occlusion (Schachner 
2006; Shuhaiber et al. 2002). In addition to established adjuvant therapy, 
modifications o f the surgical technique for the preparation o f  grafts and emerging 
strategies are currently being used. All these m ethods are aim ed to maintain 
endothelial integrity, reduce early platelet activation, prevent excessive neointimal 
proliferation and avoid lipid deposition.
1.14 Vasoactive substances
The use o f  arterial rather than venous grafts guarantees better long-term results 
after CABG (Ferrari and von Segesser 2006), mainly because these conduits show a 
well-preserved endothelial layer, w hich leads to an enhanced adaptability to acute and 
chronic flow changes, and to a preserved antithrom botic state (Yang and Luscher
1993). Preferential N O-m ediated relaxation (Hamilton et al. 1999; Luscher et al. 
1990) and PGL (Sala et al. 1994) release appear have been proposed to contribute to 
the better patency rate o f  arterial grafts as compared with venous grafts as they resist 
vasoconstriction, developm ent o f intimai thickening and thrombus formation (Pearson 
et al. 1992). The wall o f  the IM A is more resistant to arteriosclerosis than the wall o f 
the venous conduit, because o f  differences in muscular layers and in the lamina 
elastica interna (Del Campo 2003). Surgical preparation o f  the LSV graft itself results
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in a significant reduction in NO as compared with the freshly isolated vein and is 
associated with m arked denudation o f  the endothelium (Angelini et al. 1989). In free 
harvested vein grafts, endothelium  lost to sloughing (in both hum an beings and 
experimental animals) requires up to 3 months to be re-populated by blood elements 
(LeM aitre 1989). Preservation o f  endogenous NO levels, by m inim ising endothelial 
damage during harvesting, may prevent spasm when using atraum atic techniques 
(Dashwood et al. 2005). This “protective” mechanism may also be maintained during 
the early postoperative period, counteracting any effects o f  endogenous 
vasoconstrictors to which the graft is highly sensitive (Tsui and Dashwood 2002; 
Chester et al. 1998). As long as 1 week after CABG, surgical preparation that results 
in endothelial injury causes platelet aggregation at the exposed intimai surface and 
throm botic occlusion (Shuhaiber et al. 2002; Tsui and Dashw ood 2002). As an 
inhibitor o f platelet adhesion and activation (M oncada and Higgs 2006), NO is 
beneficial in reducing early graft failure (Dashwood et al. 2005). In addition, NO 
promotes endothelial cell m igration and proliferation (M urohara et al. 1999), which 
may lead to a more rapid re-endothelialization o f the graft, thus reducing the period 
during which it is vulnerable to throm boses (Tsui et al. 2002).
1,15 Surgical techniques
The normal healthy vascular endothelium o f  autologous grafts is 
antithrom bogenic (Sim ionescu 2007) and its preservation will m inim ise early graft 
thrombosis (Dashwood et al. 2005). Platelet aggregation, coagulation, vasospasm, 
occlusive intimai hyperplasia, and accelerated arteriosclerosis occur as a result o f  
endothelial denudation (Hinokiyam a et al. 2006; Shuhaiber et al, 2002; Tsui and 
Dashwood 2002; Thatte and Khuri 2001; H ickethier et al. 1999). Light and scanning
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electron m icroscopy have shown com plete loss o f  endothelium with electrocautery 
(Lehtola et ah 1989; Yoshida et al. 1995; Sparmann et al. 1992; Gaudino et al. 2000; 
Noera et al. 1993). M odifications to surgical technique which minim ise endothelial 
damage should improve graft survival and function will have significant mortality and 
cost implications.
Routinely, vein graft preparation includes dissection o f  the vein from its bed, 
ligation o f  side branches, flushing and distension o f  the lumen to overcom e spasm and 
to identify leaks (Gundry et al. 1980; Hofer et al. 1981). A recent paper demonstrated 
that standard surgical handling o f  vein grafts induces inflammation in the vessel wall 
and impairs vascular function and suggested that this may potentially contribute to 
both early and late graft occlusion (Hinokiyama et al. 2006).
Endothelial injury results from direct mechanical traum a (Catinella et al. 1982) 
and stretching as a result o f  luminal distension (Adcock et al. 1984; Haudenschild et 
al. 1981). Impaired fibrinolytic activity, caused by uncontrolled distension o f LSV 
prior to its use as a vascular conduit, may contribute to early vein graft thrombosis, 
and can be avoided by using controlled distension to <120 mmHg (Underwood 1993).
The technique o f  harvesting the IM A for CABG influences the fate o f  artery 
grafts. Skeletonisation o f  the IM A (Keeley et al. 1987) has been advocated to provide 
greater length, probable reduction in sternal wound and pulm onary complications 
(Cunningham et al. 1992; M atsum oto et al. 1997), and superior free flow (Choi and 
Lee 1996; Gaudino 1999; Takami and Ina 2002; W endler et al. 1999; Deja et al.
1999), but its effect on vascular function has not been studied. Cunningham (1996) 
and Yacoub (1996) state that avoiding the use o f  electrocautery near the IM A can (at 
least in theory) prevent or minim ize endothelial function. A m ore friendly surgical 
handling also plays a determ inant role in favour o f  arterial grafts, especially when
25
managed in situ, as free grafts can undergo significant endothelial damage, due to 
preparation and storage (Lehmann et al. 1989).
In 1977, an endothelium preserving technique w ithout touching the vein 
during the anastom osis was described (Gottlob 1977). In 1980 it was recommended 
that the vein should be harvested by a "no touch" technique to minim ize manipulation, 
side branch ties should be placed away from the LSV wall, veins should be immersed 
in cold blood and distension above lOOmmHg was to be avoided (Gundry 1980). 
Prevention o f endothelial dam age in veins was dem onstrated by applying 
pharmacologic relaxation o f  the vessel that allows a gentle dilatation with low, 
controlled pressure (Haudenschild et al. 1981). Based on this principle, it was 
suggested that the LSV preparation should incorporate subcutaneous and perivenous 
infiltration with papaverine, atraum atic dissection, controlled gradual distension, and 
storage o f  the vein in cold heparinised blood (Adcock et al. 1984). The use o f  glyceryl 
trinitrate-verapam il solution both topically and intraluminally was introduced in 1993 
as a very effective and safe combination to promote relaxation o f  the vein during 
preparation (He et al. 1993).
The no-touch technique o f  LSV harvesting provides high short- and long-term 
patency rates for vein grafts and is comparable to the patency rate o f  the IM A graft 
(Souza et al. 2006). This technique provides better structural, functional, and 
mechanical protection o f  the vein wall, thereby resulting in a nonthrom bogenic graft 
immediately after surgery and long-term improvement due to reduced late intimai and 
medial hyperplasia (Souza et al. 2006). Dashwood et al. (2007) demonstrated a 
reduction in endothelial nitric oxide synthase (eNOS) and N O  release in LSV 
harvested by conventional surgical methods com pared with those prepared 
atraum atically by the no-touch technique. An improvement in LSV graft surgery may
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have a significant impact on graft usage, reduced graft pathology, improved graft 
patency leading to improved patient care and survival.
1.16 Established adjuvant medical therapy
Adjuvant pharmacological interventions have been introduced in an attempt to 
improve graft patency (Schachner 2006). Post-CABG, anti-platelet agents and lipid- 
lowering agents are the established strategies for reducing graft occlusion (Schachner 
2006). A multicentre study showed that aspirin improved graft patency at one year 
post CABG surgery, and the m ajor benefit occurred in LSV grafts placed to smaller 
vessels (Goldman et al. 1989). The same authors (Goldman et al. 1990) found in a 
prospective, randomised double-blind, placebo study that both IM A grafts and LSV 
grafts had excellent patency rates at one year. Aspirin did not alter this at one year, 
and there were no differences in patency between IM A grafts and LSV grafts when 
they were anastom osed to the left anterior descending artery. Consistent beneficial 
effects o f  other anti-throm botic agents have yet to be established (Stein 1995). In 
1997, The Post Coronary Artery Bypass Graft Trial Investigators dem onstrated that 
aggressive reduction o f  LDL (low density lipoprotein) -cholesterol with lovastatin 
significantly reduces the rate o f  vein graft ocelusion assessed by angiographic follow- 
up (The Post Coronary Artery Bypass Graft Trial Investigators 1997).
1.17 Em erging strategies: pharm acological agents
There is evidence that NO synthesis is impaired at sites o f  vascular injury and 
that the NO system is involved in graft failure (Tsui et al. 2002; Tsui et al. 2001; 
Jeremy et al. 1998). Particularly, early vasospasm  and throm botic occlusion may be 
due to reduced endothelial N O  activity in vein grafts. NO donors, such as S-
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nitrosoglutathione have been investigated in vein grafts and were found to cause 
vasodilation (Sogo et a l  2000) and inhibit platelet deposition. A  recent study 
dem onstrated that N O -releasing aspirins induced vasodilation o f  LSV grafts (Lorusso 
et al 2006).
Therapies that reduce neointimal hyperplasia are also being investigated as 
potential pharmacological approaches for preventing vein graft occlusion. 
Thapsigargin is a substance that increases cytosolic calcium^^ (Ca^"^) by its action as 
an irreversible inhibitor o f  Ca^^-adenine triphosphatase. Intracellular calcium pools 
are important in regulating vascular smooth m uscle migration, a prerequisite for 
neointimal hyperplasia. Pre-treatm ent with thapsigargin ex vivo reduces neointima 
formation in cultured LSV (George et al. 1997a) although the effects o f  exposing LSV 
to thapsigargin prior to im plantation have not been studied in vivo. Oral and 
intramuscular administration o f  rapamycin, a m acrolide antibiotic w ith anti-mitotic 
properties, has also been found to reduce neointimal formation after balloon-induced 
vascular injury in porcine m odels (Burke et al. 1999; Gallo R et al. 1999).
There is evidence from animal studies, that endothelin-A (ETa) receptor 
antagonists reduce neointimal formation (Dashwood et al. 1998b), therefore these 
agents may possess therapeutic potential in patients undergoing bypass surgery. I f  so, 
the tim ing o f  antagonist administration may be an important consideration. Used as an 
adjunct to CABG ETa antagonists may be effective at reducing early stages o f graft 
occlusion (which norm ally occurs in the first month) by reducing subintimal VSMC 
proliferation caused by intraluminal distension and surgical traum a (Dashwood et al. 
2004b).
W hilst these approaches have been shown to reduce neointim a formation in 
experimental models, their clinical potential has yet to be demonstrated.
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1.18 Em erging strategies: gene transfer
Vascular gene therapy is a new area o f investigation and the use o f  gene 
transfer to reduce intimai hyperplasia and subsequent graft failure is receiving 
considerable attention (George et al. 2006; Baker et al. 2006; Conti et al. 2005). The 
use o f  gene transfer is attractive since it may potentially produce long-term 
therapeutic benefit without systemic side effects (George et al. 2006; Baker et al. 
2006; Conti et al. 2005. Prom ising genes currently being evaluated include genes for 
NOS (nitric oxide synthase) and vascular endothelial growth factor (VEGF) (George 
et al. 2006; Baker et al. 2006; Conti et al. 2005; M iller et al. 2005; Dom iniezak et al. 
2005; M cBride et al. 2005). NOS gene transfer may prevent vein graft failure by 
locally increasing N O  synthesis in grafts.
Several animal studies using liposomal, adenoviral or retroviral delivery o f 
eNOS to injured arteries have demonstrated a reduction in intimai hyperplasia (Chen 
et al. 1998; Janssens et al. 1998). iNOS (inducible NOS) gene transfer also inhibits 
intimai hyperplasia in rat and pig models (Shears et al. 1998), and since iNOS 
produces greater levels o f  NO  compared to eNOS, the viral load required w ith iNOS 
gene transfer to achieve the same levels o f  NO should be reduced, which may be 
advantageous in clinical settings.
VEGF is a potent angiogenic factor, which promotes endothelial cell regrowth 
following vascular injury via a NO dependent mechanism. Early vascular gene 
transfer studies using VEGF have focused on its potential in therapeutic angiogenesis 
in both m yocardial and lower limb ischemia (Chen et al. 1998; Janssens et al. 1998). 
In a rabbit model o f  arterial injury, VEGF reduced intimai thickening and macrophage 
influx into the vessel wall (Rutanen et al. 2005) but in another rabbit m odel o f  arterial
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injury local transfer o f  the VEGF gene did not inhibit neointim a formation (Dulak et 
al. 2005).
D irect intravascular delivery o f  target genes to vein grafts is possible when 
using endovascular techniques (Yla-Herttuala and M artin 2000). It is not clear if 
intravascular delivery o f  genes to the intima or extravascular targeting o f the 
adventitia will be more effective. For example, an animal model using LSV grafts 
interposed in femoral artery has shown that ex vivo adventitial liposomal transfection 
o f the eNOS gene is m ore effective at inducing NOS activity than transfection o f  the 
intimai surface (Kalra et al. 2000). M iller et al. highlighted the importance o f  vector 
targeting to achieve therapeutic gain and presented the first such study in 
cardiovascular gene therapy (M iller et al. 2005).
W hilst new developm ents are being m ade in this area, results are mainly 
limited to data from animal studies and there is little information from controlled 
trials, and long-term effects remain unknown.
1.19 Em erging strategies: external stenting
External stenting procedures have been introduced as a strategy to prevent late 
graft failure. P lacem ent o f  a non-restrictive external stent around a porcine vein graft 
prevents early neointim a formation and m edial thickening (M ehta et al. 1998; Violaria 
et al. 1993). The m echanisms underlying this effect are not elear and are under 
investigation. Initially, it was believed that the external stent reduces the pulsatile 
stretch and shear forces to which the arterialised LSV graft is exposed. 
Circumferential stretch rather than pressure itself may provide a partial explanation 
for the beneficial effect derived from external stents (Okon et al. 2004; M ehta et al.
1998). Protection o f  veins against overstretching is perhaps an im portant reason for
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long-term patency seen in LSV grafts where the LSV is harvested with the 
surrounding tissue (Souza et al, 2002). This would reduce the generation o f 
endothelium - and tissue-derived vasoactive factors with prothrom botic and 
proliferative properties. Placem ent o f  an external stent also promotes angiogenesis in 
the adventitial region o f  the graft (M ehta et al. 1997) and this m ay improve 
oxygenation to otherwise hypoxic regions o f  the graft. Effects on the levels o f  the 
adventitial vasoactive factors, such as NO, PGL and ET-1 may also be potential 
m echanisms (Dashwood et al. 1998b; Jeremy et al. 1998; Jeremy et al. 1997b). There 
is evidence that PG L and cGM P are conserved at intimai and medial regions o f 
stented LSV grafts and that adventitial formation o f  these compounds is increased 
(Jeremy et al. 1998). NOS content and activity within the adventitia o f  stented grafts 
is also higher than in unstented grafts (Jeremy et al. 1998).
1.20 The vascular endothelium
M ore than a trillion endothelial cells line the inner surface o f the 
cardiovascular system, thereby representing a critical strategic interface between 
blood and tissue (Félétou and Vanhoutte 2006; M oncada and Higgs 2006; Yetik- 
Anacak and Catravas 2006; Cockcroft 2005). The endothelium o f  an average-sized 
adult hum an contains 6x10*^ cells, constitutes a mass o f  alm ost 1 kg and covers an 
area approxim ately 7000 m^ (Simionescu 2007). It is the largest regulatory organ 
present in the hum an body (Sim ionescu 2007; M oncada and Higgs 2006; Yetik- 
Anacak and Catravas 2006; Cockcroft 2005). The location and the enormous surface 
area enable the endothelium  to interact very effectively with blood com ponents and 
also with adjacent vascular smooth m uscle cells (VSMCs) (M oncada and Higgs 2006; 
Yetik-Anacak and Catravas 2006; Cockcroft 2005). Endothelial cells, strategically
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located in the interface between the blood and vascular smooth muscle cells, release a 
num ber o f  vasoactive substances and play a major role in the control o f  vascular 
structure and function and platelet aggregation (M oncado and Hicks 2006; Yetik- 
Anacak and Catravas 2006; Félétou and Vanhoutte 2006; Vane et al. 1990). Under 
physiological conditions, the predominant effeet o f  substances released by the 
endothelium  is vasodilator, antiproliferative and antiaggregant, lim iting the raise in 
blood pressure, regulating tissue blood flow and maintaining blood fluidit (M oncada 
and Higgs 2006; Y etik-A nacak and Catravas 2006; Félétou and Vanhoutte 2006). 
Endothelial-derived substances with vasodilator and antiproliferative effects include 
NO, PGI2 and endothelium -derived hyperpolarising factors (EDHF), and substances 
with vasoconstrictor and m itogenic effects include endothelin-1 and prostaglandin H2 
(PGH2).
1.21 Endothelial dysfunction
The equilibrium between vasodilator and vasoconstrictors is shifted in CVD, 
where vasoconstrictor and proliferative effects predominate, leading to hypertension, 
atherosclerosis, platelet aggregation and ischemia (Simionescu 2006; M oncada and 
Higgs 2006; Yetik-A nacak and Catravas 2006; Cockcroft 2005). Endothelial 
dysfunction has been defined as an imbalance between endothelial relaxing and 
contracting factors, but also between anti- and pro-coagulant factors, and between 
growth inhibiting and growth promoting factors (Feletou and Vanhoutte 2006; 
Endemann and Schiffrin 2004). W ith respect to the functional investigation the term 
endothelial dysfunction is generally used for an impaired maximal dilative response 
and/or an impaired sensitivity to endothelium dependent vasodilators such as calcium 
ionophore A23187, under conditions o f a preserved response to endothelium-
32
independent dilators such as sodium nitroprusside (Feletou and V anhoutte 2006; 
Endem ann and Schiffrin 2004). Endothelial dysfunction is an early and independent 
predictor o f  poor prognosis in m ost forms o f CVD (Endemann and Schiffrin 2004; 
Schachinger et al. 2000; W idlansky et al. 2003; Heitzer et al. 2001). Thus, alterations 
in endothelial function have been consistently found in hypertension, atherosclerosis, 
coronary heart disease, diabetes, sepsis, obesity and aging (Endem ann and Schiffrin 
2004; Kawashim a and Yokoyam a 2004; W idlansky et al, 2003; Fleitzer et al. 2001; 
Schachinger et al. 2000).
1.22 Nitric oxide
NO is a freely diffusible m olecule formed from L-arginine by the endothelial 
isoforms o f  NOS which requires Ca^Vcalmodulin, flavin adenine dinucleotide, flavin 
m ononucleotide and tetrahydrobiopterin as cofactors (M oncada and Higgs 2006; 
Libby 2006). eNOS is activated upon increases in cytosolic Ca^^ which occurs in 
response to m ultiple stimuli such as shear stress, hormones, platelet derived 
substances and several drugs (M oncada and Higgs 2006). NO diffuses to the adjacent 
smooth muscle cells where it activates soluble guanylyl cyclase and induces 
vasodilatation (Simionescu 2007; M oncada and Higgs 2006; W arner et al. 1994). The 
vascular endothelium  and NO play important roles in vascular homeostasis 
(Simionescu 2007; M oncada and Higgs 2006).
NO causes vasodilation, prevents throm bus formation, suppresses smooth 
muscle proliferation and decreases leucocyte attachment to the vascular wall 
(M oncada and Higgs 2006; Yetik-Anacak and Catravas 2006; Cockcroft 2005; 
Shimosawa et al. 2002). All these events have been implicated in the initiation and 
progression o f  atherosclerosis, therefore NO is considered an anti-atherosclerostic
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agent (Sim ionescu 2007; M oncada and Higgs 2006; Libby et al. 2006; Stary et al.
1995).
NO plays a fundamental role in controlling blood pressure, tissue flow and 
blood fluidity (M oncada and Higgs 2006). Loss o f  endothelial N O  bioavailability is 
therefore a m aladaptive event and is one common m anifestation o f  “endothelial 
dysfunction” (Lahera et al. 2007; Yetik-A nacak and Catravas 2006). The most 
characteristic pathophysiological feature o f  endothelial dysfunction is this diminished 
bioactivity o f  endothelium -derived NO resulting in impaired vascular homeostasis 
(Endemann and Schiffrin 2004; Kawashim a and Yokoyama 2004; W idlansky et al. 
2003; Heitzer et al. 2001; Schachinger et al. 2000) and is an early event in the 
atherosclerotic process that predicts future cardiovascular events (Papaharalambus 
and Griendling 2007).
Endothelial NO bioavailability can be assessed in animals and humans by the 
measurem ent o f  endothelial-dependent relaxation (Halcox and Deanfield 2004; 
W idlansky et al. 2003; V erm a et al. 2003). The classical approach to analyse 
endothelial function, both in vitro and in vivo, is to stimulate endothelial NO release 
with agonists such as acetylcholine (Verma et al. 2003).
Decreased endothelial-dependent relaxation is an early, yet reversible feature 
o f  atherosclerosis that strongly predicts the risk o f  future cardiovascular events 
(Endemann and Schiffrin 2004; W idlansky et al. 2003; Gokce et al. 2002; Heitzer et 
al. 2001; Al Suwaidi et al. 2000; Schachinger et al. 2000). These findings have 
prompted speculation that endothelial dysfunction plays a causal role in the 
progression from stable to unstable atherosclerosis (Lahera 2007; Cockcroft 2005). 
The im portant role o f  NO in both the development and clinical expression o f 
atherosclerosis is supported by m any experimental and clinical studies which have
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found decreased NO bioavailability in the setting o f  pre-atherothesclerotic factors 
such as diabetes m ellitus (Guzik et ai. 2002), hypertension (Rajagopalan et al. 1996a), 
hypercholesterolaem ia (W arnholtz et al. 1999), and smoking (Zeiher et al. 1995).
The mechanisms involved in the decreased endothelial-derived NO responses 
have been extensively studied and include (M oncada and Higgs 2006; Félétou and 
Vanhoutte 2006; Endem ann and Schiffrin 2004; Heitzer et al. 2001; Cai and Harrison 
2000; M iw ae ta l. 1997):
(1) inhibition o f  the signal transduction from receptor activation to eNOS activation,
(2) changes in the activity and/or expression o f  eNOS,
(3) changes in the vascular levels o f  superoxide and, thus, superoxide driven NO 
inactivation and,
(4) changes in the sensitivity to the NO-cyclic guanosine m onophosphate (cGMP) 
pathway in vascular smooth m uscle cells.
Derivatives o f  oxygen [reactive oxygen species (ROS)] decrease NO  bioactivity and 
interfere with NO signalling processes and thus represent a potential target for the 
treatment o f  atherosclerotic vascular disease (Valko et al. 2007; Yung et al. 2006). 
Reduced N O  synthesis associated to endothelial dysfunction may be caused by 
reduced expression o f  eNOS, postransductional m odification o f  the enzyme (e.g. 
phosphorylation or fatty acid m odifications), interactions with calm odulin or caveolin, 
suboptimal concentrations o f  the substrate L-arginine or the cofactor 
tetrahydrobiopterin, or the presence o f  endogenous NOS inhibitors such as 
asymmetric dimethylarginine and N-m onometylarginine (Endemann and Schiffrin 
2004). The isoprenoid geranylgeranyl pyrophosphate, an intermediate factor in the 
cholesterol synthesis pathway, also inhibits the activity o f  eNOS. In addition, 
hyperhomocysteinemia, which is associated with increased risk o f  stroke, ischemic
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heart disease, peripheral vascular disease and venous thrombosis, leads to reduced 
eNOS activity (Lentz et al. 2003).
L23 C yclooxygenase
Activation o f  endothelial cyclooxygenase leads to the transform ation o f 
arachidonic acid into PGH 2 which is metabolized by several enzymes into different 
products (Terlain et al. 1995). In endothelial cells, under physiological conditions, the 
m ajor metabolite is PG I2 (M oncada and Vane 1978). The vasodilator activity o f  PGI2 
is determined by the expression o f  specific receptors on vascular smooth muscle cells 
that are coupled to adenylyl cyclase (Narumiya et al. 1999). Cyclooxygenases exist in 
two isoforms, COX-1 (cyclooxygenase-1) and COX-2 (cyclooxygenase-2), which are 
constitutively expressed or inducible, respeetively (M itchell and W arner 1999; 
Fitzgerald 2002). Some o f  the cyclooxygenase by-products are endothelium-derived 
contracting factors (M atz et al. 2000; Taddei et al. 1997; Koga et al. 1988). The use o f 
inhibitors o f  cyclooxygenase, like indomethacin, pointed out an increased 
participation o f  endothelial cyclooxygenase-derived vasoconstrictor metabolites in 
conductance and resistance arteries in animal m odels o f  CVD and in humans (M atz et 
al. 2000; Taddei et al. 1997; Koga et al. 1988). The cyclooxygenase metabolite(s) 
involved in the increased endothelium -dependent vasoconstriction are those who can 
activate the throm boxane A 2 (TXA 2) / endoperoxide reeeptor such as PG H 2 , TXA2 or 
prostaglandin F2« (M atz et al. 2000; Heymes et al. 2000; Taddei et al. 1997; Kung and 
Luscher 1995; Koga et al. 1988). Hence, the use o f  an antagonist o f  the 
TXA 2/endoperoxide receptor improves endothelial dysfunction in certain 
circumstances (M atz et al. 2000; Heymes et al. 2000; Taddei et al. 1997; Kung and 
Luscher 1995; Koga et al. 1988). The increased participation o f  vasoconstrictor
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factors derived from cyclooxygenase has been associated with an increased 
expression o f  COX-1 and COX-2 proteins in the vessel wall (M atz et al. 2000). 
Regarding the cyclooxygenase isoform responsible for the release o f  vasoconstrictor 
prostanoids, no consensus can yet be established. The change in the pattern o f 
products released by cyclooxygenase might be related to an alteration in the lipid 
substrates. Indeed, an increase in lipid peroxidation was associated with an increased 
participation o f  cyclooxygenase-derived vasoconstrictors in endothelium -dependent 
relaxation in the rat. This m ay be a consequence o f  an increased oxidative stress on 
the cyclooxygenase-dependent response for example in the course o f  aging. Finally, it 
should be noted that N O  can chemically interact with PGH 2 and decrease the 
availability o f  NO (Auch-Schwelk et al. 1992; Ito et al. 1991).
1.24 Endothelium -derived hyperpolarising factor
Another im portant endothelium -derived relaxing factor, especially in 
resistance arteries, is EDHF. The nature o f  EDHF, depending on the type o f  artery 
considered, has been proposed to be epoxyeicosatrienoic acid, potassium  ions (K^), 
anandamide and hydrogen peroxide (H2O2) (Busse et al. 2002; Dora and Garland 
2001; Cam pbell and Harder 1999). The responses mediated by EDHF are resistant to 
NO synthase and cyclooxygenase inhibitors but are sensitive to the combination o f  the 
SKCa and IKCa channel inhibitors apamin plus charibdotoxin. EDHF-mediated 
responses are initiated by the activation o f  endothelial SKCa and IKCa channels which 
leads to the hyperpolarisation o f  endothelial cells (Busse et al. 2002). The consecutive 
hyperpolarisation o f  smooth m uscle cells involves the spread o f  an electric current 
through m yo-endothelial gap junctions (Busse et al. 2002). Endothelial dysfunction is 
associated in some cases with a reduced EDHF-component o f  the relaxation.
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independently or in addition to NO. Possible reasons to explain the differences 
observed in the m agnitude o f  the alteration in EDHF-m ediated relaxation could be 
species or anatom ical heterogeneity o f  vasomotor regulation conductance vs. 
resistance arteries (M arijic et al. 2001). Also changes might occur downstream of 
EDHF release such as a decreased expression o f voltage- and Ca^”*" -activated 
channels (M arijic et al. 2001). Under physiological conditions, these channels serve as 
a hyperpolarising force that oppose contraction. Thus, their reduced expression could 
lead to a decreased vasodilatory capacity. However, this change is not uniform among 
different vascular beds and species.
1.25 Endothelin-1
An increased participation o f the potent vasoconstrictor endothelin-1 (Jeremy 
et al. 2005) could also explain reduction o f  endothelium -dependent vasodilatation. 
Indeed, endothelial dysfunction is associated with an upregulation o f  mRNA 
expression o f  the precursor o f  endothelin-1, preproendothelin-1 and endothelin-1 
protein (Brunner et al. 2006; Barton 2000). Num erous conditions characterized by an 
impaired availability o f  N O  have been found to be associated with enhanced synthesis 
o f  endothelin-1 and vice-versa, thereby suggesting that these two factors have a 
reciprocal regulation (Rossi et al. 2001). Endothelin-1 has been described to exert a 
bidirectional effect by either enhancing NO production via endothelin-B receptors 
located in endothelial cells or blunting its effect via endothelin-A  receptors 
prevalently located in the vascular smooth m uscle cells (Brunner et al. 2006). 
Conversely, NO was found to inhibit endothelin-1 synthesis in different cell types 
(Brunner et al. 2006). Several factors affect in opposite direction the transcription o f 
prepro-endothelin-1 and NOS genes, peroxisome proliferator-activated receptors
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playing a key role in these regulatory mechanisms (Rossi et al. 2001). A ll these data 
suggest that endothelial dysfunction is also characterized by this dual effect on the NO 
and endothelin-1 pathways.
1.26 Free radicals, reactive oxygen species, oxidative stress and antioxidants
A free radical is any species that contains one or more unpaired electrons, that 
is, electrons singly occupying an atomic or m olecular orbital (Halliwell and 
W hiteman 2004). ROS is a collective term that includes both oxygen radicals and 
certain nonradicals that are oxidizing agents and/or are easily converted into radicals 
(Halliwell and W hitem an 2004).
Oxidative stress is a condition in which cells are exposed to excess levels o f 
oxygen or ROS, principal among which is 'O 2" (Seifried 2007; Young and Woodside 
2001; Betteridge 2000; Sies 1999; Kodja and Harrison 1999). Protective systems that 
remove 'O 2'in c lu d e  superoxide dismutase (SOD; breaks down 'O 2" to H 2O2) and 
catalase [breaks down water (H 2O)] (Young and W oodside 2001; Betteridge
2000; Kodja and Harrison 1999). Thus, oxidative stress can be considered to be the 
up-regulation o f  *0 2 ’-generating systems coupled with down-regulation o f  protective 
systems leading to potential damage (Griendling and FitzGerald 2003).
Halliwell and Gutteridge (1999) defined an antioxidant as “any substance that, 
when present at low concentrations compared with those o f  an oxidizable substrate, 
significantly delays or prevents oxidation o f  that substrate.” The term “oxidizable 
substrate” includes every type o f  m olecule found in vivo (Halliwell and Gutteridge
1999). This definition emphasizes the importance o f  the damage target studied and the 
source o f  reactive species used when antioxidant actions are examined.
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1.27 Reactive oxygen species in the vasculature
Atherosclerosis and its risk factors such as diabetes, hypertension and 
hypereholesterolaem ia are characterised by excess vascular production o f  ROS 
(Harrison et al. 2003; Cai and Harrison 2000). Over the last two decades considerable 
effort has been devoted to identify sources o f ROS in vascular disease. All layers o f  
the vascular wall have enzyme systems that produce ROS (Yung et al. 2006), In 
general, ROS are formed by one or two electron reduction o f  m olecular oxygen, 
yielding either the 'O 2" or H 2O2 , respectively (Halliwell and Gutteridge 1999). Among 
the important ROS sources in the vasculature are NAD(P)H oxidases, mitochondria, 
xanthine oxidase and eNOS (Landmesser et al. 2007; Yung et al. 2006).
1.28 NAD(P)H  oxidases
Considerable investigation indicates that a m ajor source o f  "O2" is an 
NAD(P)H dependent oxidase (Griendling 2004; Lassegue and Clempus 2003). 
Originally, NAD (P)H  oxidases were deseribed and characterised in phagocytic 
immune cells (Babior et al. 2002). Neutrophils and other phagocytic cells produce 
ROS during phagocytosis through activation an a NAD(P)H oxidase, also called the 
respiratory burst oxidase, which catalyses the production o f  'O 2" (Babior et al. 2002). 
Then 'O 2' can dism utate to form H 2O2 , that supports the production o f  hypochlorous 
acid (Babior et al. 2002). Together, these oxygen-derived species are largely 
responsible for the bactericidal activity o f  neutrophils (Babior et al. 2002).
The phagocytic NAD (P)H  oxidase is a m ulticom ponent enzyme, consisting o f 
two main components, cystolic and membranous (Bedard and Krause 2007). The 
cystolic com ponent is com posed o f  p40^ '^^ °^ , p47*’^ ° ,^ p67*^ '^ ™ and the small G protein 
Rac (phox stands for phagocyte oxidase) (M oldovan et al. 2006). Together gp9U^°''
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and form an integrative m embrane complex, termed cytochrom e b^^g, whose
catalytic subunit is gp9H^’°  ^ (Bedard and Krause 2007). Upon activation o f  the
enzyme, the GDP on the G-protein Rac is exchanged for GTP, and gp47^’’°  ^ is 
phosphorylated by protein kinase C (M oldovan et al. 2006; Sauzeau et al. 2000). 
These two events trigger a conformational change in cytosolic components, which 
facilitates the association o f  the cystolic components with cytochrom e bsss in the 
membrane, forming a functional enzyme. NAD(P)H, the reduced substrate o f the
enzyme, binds to the catalytic subunit, gp9F'^°^, on the cytoplasm ic side o f the
membrane and releases two electrons, which are passed subsequently to two 
successive m olecules o f  oxygen on the opposite side o f  the m em brane to produce 
molecules o f  'O 2 '  (Griendling et al. 2000) Once activated, phagocytes produce large 
quantities o f "O2" during the oxidative burst (Bedard and Krause 2007; ).
Recently it has become evident that the expression o f  the m ajor phox units is 
not restricted to phagocytic cells, but m any vascular cell types exhibit oxidases similar 
to the neutrophil enzyme. Since the enzyme activity requires gp9U^’°^ p22*’*^°’‘,p47‘’’°’^ , 
pgyphox  ^ and the G-protein Rac, considerable effort has been devoted to determining 
the vascular distribution o f  these NAD(P)H oxidase components (M oldovan et al. 
2006; Griendling et al. 2000). The p22^ ^^ °% p47‘’'^ “  and p67’’’’°’' com ponents o f the 
NAD (P)H oxidase were found to be ubiquitously distributed am ong the m ajor cell 
types o f  the vascular wall (Bedard and Krause 2007; Cai et al. 2003; Griendling et al. 
2000; Jones et al. 1996). In contrast, the catalytic subunit gp9P'^°'^ was not 
ubiquitously distributed, suggesting that other isoforms o f  gp9F'^°’^  m ight exist in 
these cells. Indeed, we now know that there is a family o f  gp9U'^°^ isoforms found in 
all cells and this family is term ed the NOX family (NAD(P)H oxidase) (Bedard and 
Krause 2007; Sorescu et al. 2002). Thus far, the NOX  family includes 5 members.
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named NO X 1-5 (Bedard and Krause 2007). They are thought to transfer electrons 
from the reduced and the small G protein Rac (phox stands for phagocyte oxidase) 
(M oldovan et al. 2006). They are thought to transfer electrons from the reduced 
NAD(P)H substrate to molecular oxygen in a way similar to the gp91phox (named as 
NOX2) (Bedard and Krause 2007; Lam beth 2004: Lambeth et al. 2000).
Expression o f  the N O X  isoforms varies among different vascular cells. 
Endothelial cells have been shown to express all the essential subunits o f  the enzyme 
(Jones et al. 1996). These results were confirmed by cloning o f  endothelial 
com plem entary deoxyribonucleic acids almost identical to the corresponding 
phagocytic sequences and dem onstration o f  the proteins by W estern blotting and 
im munocytochem istry (Zeiher et al. 1995). M oreover, it has now been shown that 
endothelial cells express m ostly the NOX4 isoform and a lesser am ount o f  the N 0X 2 
(Sorescu et al. 2002). The situation in vascular smooth muscle eells (VSM C) appears 
to be more complicated. In aortic VSMC, N 0 X 2  levels are veiy low or undetectable. 
The absence o f  functional N 0 X 2  was supported by experiments showing that basal 
and growth factor-induced oxidase activity o f  aortic vascular smooth muscle cells 
were unaffected by disruption o f  this gene (Barry-Lane et al. 2001; Souza et al. 2001). 
Recently it was discovered that VSM C derived from large vessels, like aortic VSMC, 
mostly express NOX4 and to a lesser extent N O X l with negligible amounts o f  N 0X 2, 
while small resistance vessels predominatly express N 0 X 2  (Touyz et al. 2002).
Since the products o f  the vascular NAD(P)H oxidase are potentially cytotoxic 
(Griendling 2004; Cai et al. 2003; Li and Shah 2004; Touyz and Schiffrin 2004; 
Brandes 2003), one would expect the expression o f  the vascular oxidases to be more 
tightly regulated. M oreover, if  one considers ROS as m ediators o f  vascular cell 
signaling, one must account for both the physiological and pathophysiological role(s)
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o f these species. In particular, any normal response can be rendered 
pathophysiological simply by removing normal control mechanism(s). The regulatory 
role o f  NAD (P)H oxidase has been investigated by exposing cultured cells to various 
stimuli known to increase ROS generation. Endothelial cells exposed to angiotensin II 
exhibited elevated expression o f  p67'’*’°  ^ and NOX 2 (Lassegue and
Clempus 2003; Patterson et al. 1999). Conversely treatments that decrease ROS 
production (e.g. activators o f  peroxisone proliferators-activated receptor and statins) 
downregulate mRNA o f these subunits (Du et al. 2001; M atthews et al. 1999). 
Exposure o f  VSM C to stimuli such as platelet-derived growth factor and tumour 
necrosis factor a  also increase the expression o f  p22’’’’®^,p47’’'^ ™ p67’’’'®  ^ and N O X l, 
the latter representing an abundant NAD(P)H oxidase catalytic subunit found in 
smooth muscle cells (DeKeulenaer et al. 1998). In summary, there seems to be a 
relationship between ROS production in the vascular wall and expression o f 
NAD (P)H oxidase subunits, suggesting that cells in the vascular wall express 
functional NAD(P)Hoxidase(s).
Apocynin is a methoxy-catechol (4-hydroxy-3-methoxyacetophenone), 
originally extracted from the root o f  the medicinal herb Picrorhiza kurroa, from the 
Himalayas, and has shown to possess anti-inflam m atory properties (Ximenes et al. 
2007; Engels et al. 1992). Apocynin has been used as an efficient inhibitor o f 
NAD(P)H oxidase in many experimental models involving phagocytic and non- 
phagocytic cells (Ximenes et al. 2007; Zhang et al. 2005; Lafeber et al. 1999). The use 
o f  apocynin as an inhibitor o f  the activation o f  the NAD(P)H oxidase complex is 
based on the inhibition o f  the assembly process, as the migration o f  the p47phox 
com ponent to the m em brane is impeded in its presence (Ximenes et al. 2007; Barbieri 
et al. 2004). The vasodilator effect o f  apocynin is endothelium m ediated as it can be
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reversed by the NOS inhibitor A^-nitro-L-arginine-methyl ester (Hamilton et ai. 
2002).
1.29 Regulation o f NAD (P)H  oxidase in atherosclerosis
NAD(P)H oxidase is relevant to human atherosclerosis (Griendling and 
FitzGerald 2003). For example, early atherosclerosic lesions exhibit upregulation o f 
the p22^’’°^ p /^yphox y phox Qf the vascular NAD(P)H oxidase compare to
non-atherosclerotic vessels (Barry-Lane et al. 2001; Szocs et al. 2002; Shi et al. 2001). 
Upregulation o f  NAD (P)H  oxidase appears to be o f importance as a loss o f  in
hyperlipidaemic ApoE'^‘ m ice results in a dramatic reduction in aortic lesion 
formation (Barry-Lane et al. 2001). This effect was mainly observed in early lesions 
o f  the descending aorta, rather than advanced lesions in the aortic sinus, suggesting a 
greater role for ROS-m ediated events at that site. Furthermore, disruption o f  the 
p4 '7Phox results in decreased superoxide production in the vessel wall (Hsich et al.
2000). These results establish the signifieance o f  NAD(P)H oxidase and p47'’'’°’^ in 
particular, in the developm ent o f  atherosclerotic lesions.
The expression o f  gp9P '^^°^, however, appears elevated only in established 
lesions, not in early stages o f atherosclerosis. The latter is characterized by the 
proliferation o f  VSM C, w hich express N O X l rather that gp9F*^°’‘ (Szocs et al. 2002). 
The data do not suggest a role for gp9U ’^ ^^  in developing atherosclerosis and are 
consistent w ith data in gp9P''°^ knockout mice that have not dem onstrated a 
significant effect o f  this gene product on m urine models o f  atherosclerosis (Kirk et al. 
2000).
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The role o f  N 0 X 4 , the most abundant isoforms in vascular cells, is not clear at 
the moment, although it is upregulated in the neointima after balloon injury and in 
advanced atherosclerotic lesions (Szocs et al. 2002).
1.30 Regulation o f NAD (P)H  oxidase in diabetes mellitus
It is well established that diabetes mellitus is associated with accelerated rate 
o f  atherosclerosis and disproportionately increased risk o f  cardiovascular events. 
Several in vitro studies have demonstrated that high glucose levels and advanced 
glycalation end products increase NAD(P)H oxidase-induced superoxide production 
in the vascular wall (W eidig et al. 2004; Ülker et al. 2004). Furthermore, the 
expression o f  p22 '^^°^ is also increased in diabetes (Christ et al. 2002). In blood vessels 
from genetically diabetic rats (a model o f  type 2 diabetes mellitus), streptozotocin- 
treated rats, and patients with type 2 diabetes mellitus, there is an increase in 
NAD (P)H  oxidase activity (Kanie et al. 2002; Kim et al. 2002). This increased 
superoxide production in diabetic vessels correlates with reduced vascular NO 
bioactivity (Guzik et al. 2002). The specific reasons for increased N AD (P)H  oxidase 
activity are not yet clear, although several putative mechanisms exist. For example, 
hyperglycaem ia increases protein kinase C activity, a well known stimulus for 
NAD(P)H oxidase activation (Lee et al. 1989). In addition, the m RNAs o f  the major 
phagocytic NAD(P)H oxidase subunits p22P’’°’^ , gp91’’^’°’^ , p47 '^^ '^  ^ and p67'^’^ °’' were 
upregulated in vessels from diabetic animals (Kanie et al. 2002; Kim  et al. 2002; Flink 
et ai. 2001). Therefore, these data indicate an association between vascular NAD(P)H 
oxidase activity and diabetes mellitus.
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1.31 Xanthine oxidase
Xanthine oxidoreductase exists in two different forms in m am m als (Parks and 
Granger 1986). In vivo, the m ost abundant form is xanthine dehydrogenase, whereas 
the xanthine oxidase form constitutes only a minor fraction (Frederiks and Bosch 
1996). Xanthine dehydrogenase can be reversibly transform ed into xanthine oxidase 
by sulfhydryl compounds or it can be irreversibly converted by protelytic cleavage. 
Both forms o f  xanthine oxidoreductase catalyse the reaction o f the purine metabolite 
xanthine to hypoxanthine and urate. However, only xanthine dehydrogenase employs 
nicotinamide adenine dinueleotide as an electron acceptor (Harrison 2002). In contrast 
xanthine oxidase transfers electrons to m olecular oxygen, yielding significant 
amounts o f  superoxide and H 2O2 that may contribute to vascular disease (M eneshian 
and Bulkley 2002).
The subcellular location o f  xanthine oxidase in vascular cells is still a matter 
o f  controversy. Initial reports found the enzyme in an exclusively cytosolic location in 
endothelial eells (Jarasch et al. 1981), whereas other publications showed xanthine 
oxidase can bind to the outer surface o f endothelial cells (W hite et al. 1996). Xanthine 
oxidase can also be released into the circulating blood, thereby increasing the amount 
o f  xanthine oxidase in plasma, another com partment with xanthine oxidase activity. 
Since serum proteases can cleave xanthine oxidoreductase, it is noteworthy that most 
o f  the enzyme in the circulation is in the oxidase form. Information about the location 
o f  xanthine oxidase is o f  particular importance, as low substrate availability may limit 
xanthine oxidase activity in the tissues.
Xanthine oxidase has been identified as a m ajor endothelial source o f 
superoxide (Landm esser et al. 2007; Berry and Hare 2004; Spiekermann et al. 2003; 
W hite et al. 1996; Ohara et al. 1993) that is activated in experimental atherosclerosis
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(W hite et al. 1996; Ohara et al. 1993). Initial studies that suggested a role for xanthine 
oxidase in vascular disease found that ROS produced by xanthine oxidase contribute 
to ischaem ia/reperfusion associated vascular injury (Zweier et al. 1988; Korthuis et al. 
1985). Activation o f  xanthine oxidase was also linked to early stages o f 
atherosclerotic disease, as superoxide generation and endothelial dysfunction in 
hypercholesterolaem ic rabbits is abolished by the xanthine oxidase inhibitor, 
oxypurinol (Ohara et al. 1993). Several subsequent studies have demonstrated 
increased xanthine oxidase activity in heart failure (Landmesser et al. 2002) and 
atherosclerosis (Speikermann et al. 2003). Moreover, it has been dem onstrated that 
endothelial xanthine oxidase activity and protein levels are substantially increased in 
patients with coronary disease or carotid stenosis, (Guzik et al. 2006; Spiekermann et 
al. 2003; Patetsios et al. 2001) and inversely related to endothelium  dependent 
vasodilation (Spiekermann et al. 2003). In addition, serum levels o f  uric acid, the 
product o f  xanthine oxidase, have been suggested as a predictor o f  CVD mortality 
(Niskanen et al. 2004; Fang et al. 2000). The mechanisms, however, leading to 
increased endothelial xanthine oxidase activation in atherosclerosis remain to be 
determined (Landm esser et al. 2007).
1,32 M itochondria
M itochondrial respiration is an essential energy producing organelle in 
eukaryotic cells (Chandel and Budinger 2007; M cFarland et al. 2007; Saks et al.
2006). Enzymes o f  the inner mitochondrial matrix space use the electron transfer 
chain to generate a proton gradient that is used by adenine triphosphate (ATP) 
synthetases to generate ATP (Chandel and Budinger 2007; M cFarland et al. 2007; 
Saks et al. 2006). However, even under normal conditions, up to 1-2%  o f the
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:electrons may react w ith m olecular oxygen to form superoxide and H 2O2 (Chandel 
and Budinger 2007; M cFarland et al. 2007; Saks et al. 2006). This “leakage” is 
exacerbated by very high mitochondrial m embrane potentials (Chandel and Budinger 
2007; M cFarland et al. 2007; Saks et al. 2006). Eukaryotic cells have two major 
means to limit electron loss and mitochondrial ROS production Chandel and Budinger
2007). First, several uncoupling proteins at the mitochondrial m embrane reduce 
mitochondrial ROS production (Casteilla et al. 2001). These proteins protect against 
excess electron loss while they decrease the inner m itochondrial m embrane potential. 
M oreover, a mitochondrial form o f  SOD (manganese SOD) elim inates superoxide 
which has been produced in this cellular compartment (Casteilla et al. 2001).
M itochondrial ROS production in vascular cells is particularly important in 
hypoxia (Chandel and Budinger 2007; Chandel et al. 2000) and diabetes mellitus 
(Nishikawa et al. 2000). During hypoxia, ubisemiquinone, a part o f  complex III, 
contributes to vascular ROS production and thereby causes increased endothelial cell 
permeability and interleukin-6 release (Pearlstein et al. 2002). In diabetes mellitus, 
m itochondrial-derived ROS have been implicated in other processes known to 
promote oxidative stress such as protein kinase-C activation, advanced glycation end 
product formation and increased aldose reductase activity (Pearlstein et al. 2002). 
Thus, m itochondrial ROS generation in diabetes mellitus appears to be an early event 
involved in oxidant injury.
1.33 eNOS Uncoupling
Pritchard et al. (1995) discovered that eNOS can switch from a N O  producing 
to a superoxide producing enzyme and this phenomenon has been term ed eNOS 
uncoupling. In this setting, electron flux through the enzyme results in reduction o f
48
molecular oxygen rather than production o f  NO (Stuehr et al. 2004). Several 
m echanisms have been identified that are able to initiate NOS-derived ROS 
production (Stuehr et al. 2004). Decreased availability o f  the NOS substrate L- 
arginine has been shown to account for ROS production in the neuronal isoforms o f 
the enzyme (Pou et al. 1992; Heinzel et al. 1992). As proper eNOS activity requires 
cofactors, their limited availability may also cause eNOS derived ROS production. 
Indeed, oxidation o f  the eNOS cofactor tetrahydrobiopterin is a w ell established 
mechanism that leads eNOS uncoupling (Laursen et al. 2001; Landm esser et al. 
2003). Recent data implicates post-translational protein modification in eNOS 
uncoupling (Sampaio et al. 2007). For a catalytically active enzyme, eNOS must be a 
homodimer, linked by a zinc thiolate cluster. Oxidation o f  the zinc thiolate cluster 
results in zinc release and eNOS m onomerization, which leads to uncoupling o f  the 
enzyme (Zou et al. 2002). W ith either tetrahydrobiopterin or zinc thiolate oxidation, a 
strong oxidant is necessary and current evidence implicates peroxynitrite in this 
process, an oxidant that is formed by the reaction o f  NO with superoxide (Laursen et 
al. 2001; Zou et al. 2002). Several animal studies have confirmed that eNOS-derived 
ROS occur in vivo. In particular, this ROS source has been shown to contribute to 
endothelial dysfunction observed during hypercholesterolaem ia (Laursen et al. 2001), 
nitrate tolerance (M unzel et al.2000), diabetes mellitus (Guzik et al. 2002; Hink et al.
2001) and hypertension (Landmesser et al. 2003; M ollnau et al. 2002).
1.34 H ow do ROS affect vascular homeostasis?
Oxidative stress plays a major role in the developm ent o f  endothelial 
dysfunction by direct and indirect m echanisms (Lahera et al. 2007; Cal and Harrison
2000). An im portant m echanism  o f endothelial dysfunction is inactivation o f
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endothelial-derived NO by form superoxide. NO reacts w ith form superoxide with a 
biom olecular rate that approaches the diffusion limit (k = 1.9 x 10^ ® M'^s'^) to form 
peroxynitrite (K issner et al. 1997). The reaction o f  superoxide + NO ->  peroxynitrite 
is axiomatic in CVD since this effectively diminishes NO levels which in turn is 
associated with angina, atherogenesis, hypertension, diabetic angiopathy and vein 
graft disease (Jeremy et al. 2004; Napoli et al. 2001; Napoli et al. 2001; Cal and 
Harrison 2000; Jerem y et al. 1997b). Unlike NO, that readily activates guanylyl 
cyclase and increases cyclic GM P formation in vascular smooth muscle, peroxynitrite 
is a much weaker agonist for guanylyl cyclase (Tarpey et al. 1995). Thus, any reaction 
o f  NO with superoxide will im pair NO-induced relaxation. Peroxynitrite may also 
alter other enzyme systems that are important in vascular hom eostasis (Zou et al,
1996). For example, peroxynitrite causes tyrosine nitration o f  the prostacyclin 
synthase leading to inactivation o f  this enzyme (Zou et al. 1996). Since endothelial 
PGI2 release causes vascular relaxation, loss o f  PGI2 will contribute to endothelial 
dysfunction under increased conditions o f oxidative stress (Klumpp et al. 2005). 
There is evidence that prostacyclin synthase tyrosine nitration is particularly 
important in diabetes mellitus, as peroxynitrite formation is induced in endothelial 
cells by hyperglycaem ia and this is responsible for inactivation o f the enzyme (Zou et 
al. 2002). Another detrimental action o f  peroxynitrite relates to its potent oxidant 
properties. Peroxynitrite oxidizes tetrahydrobiopterin (M ilstein et al. 1999) or the zinc 
thiolate cluster o f  eNOS (Zou et al. 2002), processes that may cause eNOS 
uncoupling, which further limits eNOS derived NO production (Landmesser et al. 
2003; Laursen et al. 2001). Thus, an increased superoxide flux not only inactivates 
endothelial-derived NO, but also decreases production o f  PGI2 via peroxynitrite
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formation and both m echanisms contribute to endothelial dysfunction in the setting o f 
increased oxidative stress.
In addition, increased ROS production may affect vascular hom eostasis by 
indirect mechanisms (Clempus and Griendling 2006). A large body o f  evidence shows 
that increased oxidative stress may prom ote atherosclerotic disease through the 
oxidation o f  LDL. This phenom enon is germane for endothelial dysfunction as 
consequences o f  LDL oxidation include endothelial cell toxicity (Negre-Salvayre 
1993), adhesion o f  leucocytes to the endothelium and m igration o f  leucocytes into the 
subendothelial space (Navab et al. 1991). Components o f  oxidised LDL also 
inactivate NO (Chin et al. 1992) and impair receptor induced endothelial NO 
production (Kugiyama et al. 1990). Thus, ROS produced in the vasculature have a 
num ber o f  effects on both atherosclerosis and vascular homeostasis.
1.35 Antioxidants in the prevention o f endothelial dysfunction and CVD
As discussed above, ROS may cause endothelial dysfunction by a number o f 
mechanisms. Since antioxidants have been implicated in both atherosclerosis and 
endothelial dysfunction, it is not surprising that a num ber o f  antioxidant compounds 
have been tested as agents to restore endothelial function and treat atherosclerosis 
(W assm ann et al. 2006).
1.36 Lipid-soluble aiitioxidants: Vitamin E
Vitam in E is a potent lipid-soluble anti oxidant compound that inhibits LDL 
oxidation, thus, it has drawn considerable attention as a potential treatment for 
vascular disease. In accordance with this concept, vitamin E has shown beneficial 
effects on endothelial function in various animal models. For example, vitamin E was
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able to reverse endothelial dysfunction caused by hypercholesterolaem ia (Keaney et 
al. 1993), diabetes mellitus (Cinar et al. 2001), and heart failure (Bauersachs et al.
2001). H owever it is noteworthy that these positive effects in experim ental studies 
might depend on the chosen vitamin E concentration. In hypercholesterolaem ic 
rabbits, high concentrations o f  vitam in E worsened endothelial function w hile a lower 
dose improved endothelial function (Keaney et al. 1994). This observation may 
explain why the results o f  vitam in E treatm ent in patients with endothelial dysfunction 
were mixed. Studies that have investigated the effect o f vitam in E on endothelial 
function in patients with hypercholesterolaemia, diabetes mellitus, smoking, advanced 
age, previous m yocardial infarction or vasospastic angina, have dem onstrated a partial 
benefit (Fang et al. 2002; Skyrme-Jones et al, 2000; Heitzer et al. 1999; M otoyam a et 
al. 1998; Green et al. 1998), whereas others showed no benefit for vitamin E in these 
settings (Gazis et al. 1999; Simons et al. 1999; Chowienczyk et al. 1998; Elliott et al. 
1995; Gilligan et al. 1994). These mixed results on endothelial function parallel larger 
clinical studies that examined the effect o f  vitamin E on atherosclerotic progression 
and cardiovascular events. Two smaller clinical trials have shown a benefit for 
vitam in E supplem entation in patients with prevalent CVD. The “Secondary 
prevention with antioxidants o f  CVD in endstage renal disease trial showed that 
vitamin E in haemodialysis patients with known vascular disease, decreased the risk 
for myocardial infarction (Boaz et al. 2000). The “Cambridge Heart Antioxidant 
Study” (CHAOS) showed sim ilar results in patients with CAD (Stephens et al. 1996). 
In the CHAOS study, patients had a lower risk o f  myocardial infarction if  they were 
treated for one year with vitam in E (Stephens et al. 1996). Despite these two positive 
results, the m ajority o f  larger prospective clinical trials failed to show any benefit for 
vitamin E intake in preventing CVD, in particular three large scale trials, the “Heart
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Outcomes Prevention Evaluation” Study (Y usuf et al. 2000), the “Heart Protection 
Study” (Heart Protection Study Collaborative Group 2002) which used an antioxidant 
vitam in “cocktail” that also included vitam in E and the “Heart Outcom es Prevention 
Evaluation - The Ongoing O utcom es” (Lonn et al. 2005).
Thus, although experim ental data from animal studies suggest that vitamin E 
improves endothelial function in different pathophysiological setting, vitamin E 
treatm ent in patients has yielded equivocal results. In accordance w ith these results on 
endothelial function, trials w ith vitamin E to reduce atherosclerotic complications 
have not been uniform ly successful. There are several potential explanations for these 
discrepant results. First, vitam in E potently protects against lipid peroxidation in vitro, 
but the relevance o f  LDL oxidation for atherosclerotic progression in vivo is much 
less clear (Thomas and Stocker 2000). Second, vitam in E is not a strong scavenger o f  
superoxide, and superoxide and its reaction product with NO, peroxynitrite accounts 
for many deleterious effects o f  ROS on endothelial function. Thus, vitam in E does not 
seen to be the antioxidant o f  choice to prevent endothelial dysfunction. Since 
endothelial dysfunction is a predictor o f  future cardiovascular events (Endemann and 
Schiffrin 2004; W idlansky et al. 2003; Gokce et al. 2002; Heitzer et al. 2001; Al 
Suwaidi et al. 2000; Schachinger et al. 2000), one m ight speculate that this failure o f 
vitamin E to improve endothelial function m ight explain its inability to prevent 
clinical m anifestations o f  atherosclerosis.
1.37 Lipid-soluble aiitioxidants: Probucol
Probucol is a synthetic antioxidant that effectively inhibits LDL oxidation 
(Kita et al. 1987) and limits atherosclerosis in animal m odels (Kita et al. 1987; 
Taw ara et al. 1986; W issler and Vesselinovitch 1983). Since decreased NO
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bioavailability is a feature o f  atherosclerosis and oxidative stress, the effects o f 
probucol on NO bioavailability have been studied. In animal models o f 
hypercholesterolaem ia (Simon et al. 1993; Keaney et al. 1995) and hyperglycaem ia 
(Tesfamariam and Cohen 1992), probucol restored NO bioavailability. The 
mechanism for this effect is related to vascular ROS levels as probucol treatment 
reduces the ROS flux in hypercholesterolaem ic rabbits (Keaney et al. 1995; Inoue et 
al. 1998). Since probucol is only a weak superoxide scavenger, these two studies 
suggest that probucol interferes with signals involved in stimulating the superoxide 
flux within the arterial w all (Keaney et al. 1995; Inoue et al. 1998), perhaps by 
reventing aecum ulation o f  lysophosphatidylcholine (Keaney et al. 1995). In patients, 
probucol seems to have sim ilar protective effects regarding endothelial function when 
combined with lipid lowering (Anderson et al. 1995).
1.38 Lipid-soluble aiitioxidants: |3-Carotene
(3-Carotene is another lipid soluble antioxidant that has been tested with regard 
to endothelial function (Constans et al. 1998). Rabbits that were fed with a high 
cholesterol diet showed a m arked degree o f  endothelial dysfunction, and concomitant 
treatm ent with (3-Carotene was able to improve endothelial function, although the 
responsible mechanism remains obscure, as (3-Carotene did not affect LDL resistance 
to ex vivo oxidation (Keaney et al. 1993). A similar study dem onstrated a reduction in 
atherosclerosis in cholesterol-fed rabbits treated with (3-Carotene (Shaish et al. 1995). 
However, human trials w ith p-Carotene have failed to dem onstrate a benefit with 
regard to clinical CVD (The Alpha-Tocopherol, Beta Carotene Cancer Prevention 
Study Group 1994).
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1.39 W ater soluble antioxidaiits: Vitam in C
Lipid peroxidation is not the only important feature o f  oxidative stress in 
vascular disease. W ith regard to water-soluble antioxidant protection, vitam in C is the 
most effective water-soluble antioxidant in human blood plasm a (Frei et al. 1989). 
and it is able to scavenge a variety o f  ROS including superoxide, hydroxyl radical 
COH') and H 2O2 (Frei et al. 1989; Nishikimi 1975; Bodannes and Chan 1979). Its 
antioxidant activity has prom pted its investigation as an agent to improve endothelial 
function. There is evidence from animal as well as human studies that vitamin C can 
improve endothelial function in a num ber o f  settings characterised by excess oxidative 
stress such as CAD (Levine et al. 1996; Gokce et al. 1999), diabetes mellitus (Ting et 
al. 1996), hypercholesterolaem ia (Ting et al. 1997), hypertension (Taddei et al. 1998; 
Duffy et al. 2001), heart failure (Hornig et al. 1998), and in smokers (Heitzer et al. 
1996; Fennessy et al. 2003).
The specific m echanisms responsible for the effect o f  vitam in C on endothelial 
function are not straightforward. Originally, it was speculated that superoxide 
scavenging was the principal means o f  improving NO bioactivity by preventing the 
formation o f  peroxynitrite. However the reaction o f  NO with superoxide proceeds at 
the diffusion limit (k = 1.9 x 10^° M "'s‘‘), whereas the reaction o f  vitam in C with 
superoxide occurs at a  much lower rate o f  ~10^ M'^s"' (Sherman et al. 2000; Kissner 
et al. 1997). As a consequence, direct superoxide scavenging by vitam in C can only 
occur at concentrations o f  the antioxidant that are higher than Im m ol/L, and data to 
support this direct effect in hum ans is available (Sherman et al. 2000). However, 
several other factors o f  vitam in C have been discovered that may contribute to the 
im provem ent o f  endothelial dysfunction at lower concentrations o f  the compound. For 
example, vitamin C can enhance eNOS derived NO production by increasing and
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stabilizing cellular tetrahydrobipterin levels (d’Uscio et al. 2003; H eller et al. 2001; 
Huang et al. 2000) and it m ight also decrease ROS production by inhibiting NAD(P)H 
oxidases (Ulker et al. 2003).
1.40 W ater soluble antioxidants: Glutathione
Glutathione (GSH) is an important intracellular antioxidant and some studies 
have investigated its effects on endothelial cell NO bioactivity (Ford et al. 2006). 
GSH (L-y-glutamyl-L-cysteinylglycine) is a naturally occuring ubiquitous tripeptide 
present in virtually all anim al cells, whose nucleophilic and reducing properties play a 
central role in m etabolic pathways, as well as in the antioxidant system o f  most 
aerobic cells (Sies 1999; Fahey and Sundquist 1991; Dolphin 1989; M eister et al. 
1983). It is usually the m ost abundant intracellular small m olecular weight thiol, 
present in the 1-10 m illim olar range in m ammalian cells (Sies 1999; A nderson 1997). 
The peptidic y-linkage between glutamic acid and cysteine is thought to protect the 
tripeptide from degradation by am inopeptidases (Sies 1999). GSH is also less prone to 
oxidation than eysteine, m aking it an ideal compound for m aintaining intracellular 
redox potential (Sies 1999). GSH exists either in reduced (thiol, GSH) or oxidized 
(disulfide, GSSG) form (Chakravarthi et al. 2006; Sies 1999). GSH is the predominant 
form, and GSSG content is usually less than 1% o f  GSH (Sies 1999). In the cell, 
almost 90% o f  GSH is in the cytosol, 10% in the m itochondria and a small percentage 
in the endoplasmic reticulum and in the nucleus (Sies 1999; M eister 1991). 
M itochondria appear to have a distinct pool o f  GSH that is resistant to GSH depletion 
(M eister 1991). M itochondria do not synthesize GSH them selves but import it 
through an, as yet unidentified, ATP-dependent mechanism (Fernandez-Checa et al.
1998). As m itochondria do not contain catalase, GSH-dependent reactions are thought
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to be the main mechanism by which m itochondria dispose o f  H 2O2 (M eister 1991), 
although the recent characterization o f  the thioredoxin-redox system im plies that these 
could be involved as well (Pedrajas et al. 1999).
Studies in endothelial cells that m anipulated intracellular GSH levels yielded 
some contradictory results regarding NO bioactivity. For example, a study addressing 
the association generation was impaired after intracellular depletion o f  GSH in bovine 
endothelial cells (H ecker et al. 1992). However, one o f  the agents used, 2,2’- 
dithiodipyridine, had no significant effect on intracellular GSH levels making an 
interpretation o f  the results problematic. Another study found no effect on endothelial 
NO production, after intracellular GSH levels were decreased by 90% with butathione 
sulfoximine (M ugge et al. 1991).
The effects o f  GSH manipulation on eNOS have been examined in detail, and 
there seems to be no association despite the finding that thiol modulating agents have 
GSH-independent effects on endothelial NO bioactivity (Huang et al. 2001). In 
contrast, a deficiency o f  glutathione peroxidase, an important cellular defence against 
oxidative stress by utilising GSH, elicits endothelial dysfunction in mice (Forgione et 
al. 2002). Consistent w ith these experimental data, GSH showed an improvement o f 
endothelial function in hum an studies. Treatm ent with oxo-4-thiazolidine, an agent 
that selectively increases intracellular GSH levels, improved endothelial function in 
patients with CAD (Vita et al. 1998). Other clinical studies showed similar effects o f 
GSH on endothelial function in patients with atherosclerotic risk factors (Prasad et al.
1999) or vasospastic angina (Kugiyama et al. 1998). A recent paper dem onstrated that 
glutathione depletion in vivo enhances contraction and attenuates endothelium- 
dependent relaxation o f  isolated rat aorta (Ford et al. 2006). This functional effect was 
associated with elevations in aortic ROS release and elevated H 2O 2 levels and with a
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slight compensatory upregulation o f the components o f the signaling pathways 
controlling NO bioavailability in the aorta (Ford et al. 2006).
The m echanisms leading to some o f  the observed beneficial effects o f 
increasing intracellular GSH are not entirely understood. A lthough thiol groups are 
essential for eNOS activity (Patel et al. 1996; Hofmann and Schmidt 1995), some of 
the beneficial effects o f  GSH m ight be unique to this molecule, as other thiol 
containing com pounds such as cysteine have much less impact on NO bioactivity 
(Komori et al. 1995). One potential explanation for these data is the fact that GSH is a 
cofactor for GSH peroxidase, whereas cysteine is not.
1.41 Angiotensin converting enzym e inhibitors and angiotensin receptor
blockers
Activation o f  the renin angiotensin system is known to play a deleterious role 
in the initiation and progression o f  atherosclerosis (M azzolai and Hayoz 2006). 
Initially designed as antihypertensive drugs, angiotensin converting enzyme (ACE) 
inhibitors and angiotensin receptor blockers (ARB) are today com m only used in the 
therapy o f  heart failure and CAD. A large body o f  evidence shows that these drugs 
strongly reduce cardiovascular m orbidity and m ortality in patients with hypertension 
(D ahlof et al. 2002), heart failure (The SOLVD Investigators 1991; The Acute 
Infarction Ramipril Efficacy (AIRE) Study Investigators 1993), and CAD (The Heart 
Outcomes Prevention Evaluation Study Investigators 2000). Experim ental data from 
recent years suggests these effects may be due to reduced oxidative stress. ACE 
inhibitors block angiotensin II formation from its precursor angiotensin I. This results 
in stimulation o f  several angiotensin II receptor subtypes, the best characterised being 
the angiotensin II type I receptor (AT-1 receptor). Angiotensin receptor blockers
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inhibit the effects o f  angiotensin through direct interaction with this receptor. The AT- 
1 receptor m ediates classical angiotensin II effects such as vascular contraction, 
smooth muscle cell hypertrophy (Geisterfer et al. 1988), extracellular m atrix synthesis 
(Kato et al. 1991), increased platelet aggregation (Feener et al. 1995), monocyte 
adhesion (Hernandez-Presa et al. 1998) and activation (Hahn et al. 1994), and release 
o f inflammatory cytokines (Kranzhofer et al. 1999). All o f  these events are crucial 
steps in both atherosclerosis and the control o f vascular homeostasis. M ore recent data 
suggests that many effects o f  angiotensin II are m ediated by ROS. For example, rats 
rendered hypertensive with angiotensin II infusion show a marked elevation in 
vascular ROS production, whereas norepinephrine infusion in these rats causes a 
similar degree o f  hypertension, but no change in ROS generation (Rajagopalan et al. 
1996a). A ngiotensin II, but not norepinephrine, causes endothelial dysfunction in this 
model, a condition that is known to increase the chance for future cardiovascular 
events (Endemann and Schiffrin 2004; W idlansky et al. 2003; Gokce et al. 2002; 
Heitzer et al. 2001; Al Suwaidi et al. 2000; Schachinger et al. 2000). NAD(P)H 
oxidases are a particularly im portant ROS source in the vasculature, and it is now 
known that angiotensin II is a potent stimulus for the activation o f  N A D (P)H  oxidases 
(Griendling et al. 2004; Griendling and FitzGerald 2003).
Given all the deleterious effects o f angiotensin II discussed above, inhibition 
o f  renin angiotensin system would be expected to reduce vascular ROS generation 
and prevent m any o f  its consequences. In fact, treatm ent o f  hypercholesterolaem ic 
rabbits with angiotensin receptor blockers reduced vascular ROS generation, 
improved endothelial function, and slowed progression o f  atherosclerotic plaque 
formation (W arnholtz et al. 1999). In addition, an increase in SOD expression 
observed after treatm ent with ACE inhibitors as well as angiotensin receptor blockers
59
æ:
m ight also improve N O  bioactivity (Hornig et al. 2001). ACE inhibitors exert their 
beneficial effects mostly by inhibiting angiotensin II action, but other mechanisms 
may contribute. For example, ACE inhibitors inhibit bradykinin breakdown via 
inhibition o f  kinase II (Linz 1992; Busse and Lamontagne 1991; Clozel 1991). 
Increased bradykinin levels cause vasorelaxation and N O  release. As NO may 
scavenge some o f  the superoxide being produced, this effect may lower the ambient 
ROS levels in the vasculature. Since angiotensin receptor blockers do not affect 
kinase II activity, their effects are independent o f bradykinin mediated NO release.
The well described beneficial actions o f  ACE inhibitors in experimental 
studies are consistent w ith clinical studies that compared the effects o f  ACE inhibitors 
to other antihypertensive drugs. Despite similar blood pressure lowering effects o f  13- 
blockers, diuretics or calcium channel anagonists, only ACE inhibitors improved 
vascular com pliance and reduced intima/media ratio in patients (London et al. 1994; 
Thybo et al. 1995; Breithaupt-Grogler et al. 1996; Chen et al. 1995; Schiffrin and 
Deng 1995). Furtherm ore, the ACE inhibitor quinapril improved endothelial function 
in normotensive patients w ith CAD (M ancini et al. 1996) and the ACE inhibitor, 
enalaprilat, enhanced N O-m ediated endothelial function in type I diabetic patients 
(O'Driscoll et ak. 1997a). Angiotensin receptor blockers showed sim ilar effects in 
hypercholesterolaem ic patients (W assmann et al. 2002). As endothelial dysfunction 
predicts the prognosis for patients with CVD (Endemann and Schiffrin 2004; 
W idlansky et al. 2003; Heitzer et al. 2001; Schachinger et al. 2000), the improvement 
o f  this param eter by ACE inhibitors m ay account for their beneficial effects observed 
in secondary prevention trials (M acM ahon et al. 2000).
A recent study suggested that angiotensin II induced endothelial xanthine 
oxidase activation and therefore angiotensin II blockade in patients w ith CAD could
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reduce endothelium -bound xanthine oxidase activity which would contribute to 
improved endothelial function (Landmesser et al. 2007). A  small clinical study 
attempted to link the beneficial effects o f  angiotensin II blockade to a decrease in 
oxidative stress (W assm ann et al. 2002). The angiotensin II receptor blocker 
candesartan improved endothelial function in hypercholesterolaem ic individuals and 
concominantly decreased levels o f  oxidative stress, m onitored by serum 
concentrations o f  8 -isoprostane (W assmann et al. 2002). In contrast, the calcium 
antagonist felodipine did not affect endothelial dysfunction or 8 -isoprostane levels 
(W assm ann et al. 2002).
Taken together, ROS generation by the renin angiotensin system  plays a role 
in the developm ent o f  endothelial dysfunction (Lonn 2002). Both ACE inhibitors and 
angiotensin receptor antagonists decrease NAD(P)H oxidase activity (Cai et al. 2003; 
Griendling et al. 2003), a m ajor vascular ROS source in experimental studies. 
Therefore, the lim itation o f  oxidative stress by these compounds may contribute to the 
improved prognosis for patients with CVD, although data from large clinical trials to 
support this link are not yet available.
1.42 Statins
Among the more im portant findings in the last century has been the link 
between circulating cholesterol and atherosclerosis. This link is also supported by data 
dem onstrating that 3-hydroxy-3-m ethylglutaiyl coenzyme A reductase inhibitors, or 
“statins”, which inhibit the rate limiting step o f  cholesterol biosynthesis, have a 
profound effect on atherosclerosis (Lahera et al. 2007; Shepherd et al. 1995; The 
Scandinavian Simvastatin Survival Study (4S) Investigators 1994; Sacks et al. 1996; 
The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study
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Group 1998; Downs et al. 1998). A  post-CABG trial has shown that aggressive 
lowering o f  LDL is effective in reducing the progression o f  atherosclerosis in LSV 
grafts; low-dose warfarin, on the other hand, had no effect (The Post Coronary Artery 
Bypass Graft Trial Investigatiors 1997). Statins are known to have m any properties 
that are independent o f  cholesterol lowering (Lahera et al. 2007; Duffy et al, 2001). 
This has prompted speculation that other mechanisms might contribute to the overall 
effect o f  statins (Lahera et al. 2007). Support for this hypothesis is derived from 
experimental studies revealing that statins exert antioxidant effects in the vascular 
wall by increasing eNOS activity (Kureishi et al. 2000; Laufs et al. 1998) and 
decreasing ROS production (W assmann et al. 2001a; W agner et al. 2000). In 
particular, statins are able to prevent lipid oxidation (Suzumura et al. 1999; Giroux et 
al. 1994; Aviram et al. 1998) and they decrease AT-1 receptor dependent ROS 
generation (W assm ann et al. 2001b). Statins inhibit NAD(P)H oxidase expression 
(M ason et al. 2004; W assmann et al. 2001a), activity (Christ et al. 2002), and 
assembly by preventing isoprenylation o f  the small p21 rac protein (M oldovan et al. 
2006; W agner et al. 2000). In accordance with these data, statin withdrawal increase 
oxidative stress and elicits endothelial dysfunction in mice (Vecchione and Brandes 
2002). Interestingly, these effects are absent in gp9U ’’°  ^ knockout mice, suggesting 
that NAD(P)H oxidase dependent ROS production is the causal event (Vecchione and 
Brandes 2002).
All the aforem entioned effects will increase NO bioavailability by preventing 
its reaction with superoxide, but there is evidence that statins also directly increase 
eNOS activity (Lahera et al. 2007). For example, statins increase levels o f  the eNOS 
cofactor tetrahydrobiopterin (Hattori et al. 2002) and also stabilize eNOS mRNA 
(Laufs and Liao 1998) that m ay lead to enhanced expression o f  eNOS protein. Statins
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may also prom ote NO production by preventing LDL or oxidized LDL mediated 
downregulation eNOS protein expression (Lahera et al. 2007; M artinez-Gonzalez et 
al. 2001; Laufs et al. 1998; Hernandez-Perera et al. 1998). Another mechanism o f 
eNOS activation by statins involves a decrease in caveolin abundance, the latter can 
bind to eNOS and directly inhibit its activity (Feron et al. 2001). Statins are also able 
to increase Akt phosphorylation and aetivity, which is an important pathway o f  eNOS 
activation via phosphorylation, that may play a role in NO dependent angiogenesis 
(Kureishi et al. 2000).
In summary, statins strongly prevent ROS generation, either by directly 
decreasing cholesterol levels or due to their well-established pleiotropic effects. 
M oreover, they also directly increase eNOS activity. As a consequence, statins have 
been shown to improve endothelial function (Fichtlscherer et al. 2006; Tsunekawa et 
al. 2001; Anderson et al. 1995; John et al. 2001; John et al. 1998; O ’Driscoll et al. 
1997b). Given the im portant prognostic significance o f endothelial dysfunction, part 
o f the beneficial statin effects m ay be explained by their antioxidant and NO elevating 
properties, although direct evidence for this hypothesis is not yet available.
1.43 Sum m ary I: Surgical dam age o f the IM A and LSV  and endothelial
dysfunction
The long-term success o f  CABG depends on continued patency o f  the bypass 
conduits (Dashwood et al. 2007; Souza et al. 2006; Eagle et al. 2004). M any strategies 
have been used to improve the short- and long-term graft patency rates. Apart from 
established adjuvant medical therapy (Goldman S, et al. 2004.; Goldm an et al. 1990; 
Goldman et al. 1989; FitzGibbon et al. 1987; Voors et al. 1996), new pharmacologic 
agents (Schachner 2006; Shukla et al. 2003), gene therapy (George et al. 2006; Baker
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et al. 2006; Conti et al. 2005; Tanner et al. 2004) and the use o f  m echanical devices 
(Jeremy et al. 2007) are presently undergoing evaluation. M any o f  these strategies 
show promise in experimental bypass models, but few have successfully been 
transferred into clinical practice. An important consideration in the im provement o f 
surgical techniques is to prevent damage to the endothelium during harvesting and 
implantation (Dashwood et al. 2007; Dashwood and Loesch 2007; Souza et al. 2006; 
Cunningham 2006; D eja et al. 2005; Cunningham 1996; Cunningham  et al. 1992). 
Damage to the bypass conduits during conventional CABG is a m ajor contribution to 
graft failure and improved patency may be achieved simply by reducing endothelial 
damage with the use o f less traum atic harvesting techniques (Dashwood and Loesch 
2007; Cunningham  2006; Cunningham 1996).
1.44 Sum m ary II: CVD and endothelial dysfunction
Endothelial dysfunction occurs in conjunction with CVD (Feletou and 
Vanhoutte 2006). It is observed both in the coronary and peripheral vasculature 
(Takiuchi et al. 2004; D rexler 1997; Anderson et al. 1995). M oreover, risk factors for 
CVD have been almost universally associated with a degree o f  endothelial 
dysfunction in humans (Landmesser et al. 2004; Drexler 1999). Increased production 
o f  reactive oxygen species, in particular, superoxide and radicals derived from 
superoxide, has been associated with endothelial dysfunction in animal models o f 
disease, and there is increasing evidence o f  a link between oxidative stress and 
endothelial dysfunction in humans (Touyz et al. 2004; Taniyam a et al. 2003; Harrison 
et al. 2003; Ham ilton et al. 2002; Alexander et al. 2000). It has been reported that 
endothelial dysfunction and increased oxidative stress may predict future 
cardiovascular events in patients w ith CVD (Heitzer et al. 2004; Al Suwaidi et al.
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2000). However, concurrent and comparative data on endothelial function, direct 
measures o f  superoxide in human vessels, and circulating indicators o f oxidative 
stress are not simultaneously available in patients with CVD and in control subjects 
w ith no documented CVD. Circulating indicators o f  oxidative stress have been 
investigated in patients w ith essential hypertension and in control subjects (Simic et 
al. 2006; Redon et al. 2003), but the relationship between these indicators and 
endothelial function has not been examined. In addition, although the degree o f 
endothelial function has been consistently linked to the number o f  risk factors present 
in patients with CVD, the relative importance o f  individual risk factors in determining 
levels o f  oxidative stress and endothelial function remains uncertain (Guzik et al. 
2000; Huraux et al. 1999).
1.45 Hypotheses
1 LSV harvested from patients undergoing CABG by traditional open vein
harvesting (TOVH) have better calcium ionophore A 23187 mediated 
relaxation than LSV harvested by minim ally invasive vein harvesting (MIVH).
2 The width o f  pedicles harvested by m onopolar electrocautery influences
calcium ionophore A 23Î87  mediated relaxation o f  IM A harvested from 
patients undergoing CABG.
3 Patients with severe CAD have endothelial dysfunction and increased levels o f 
oxidative stress compared to healthy control subjects w ith no documented 
CVD.
4 Cardiovascular risk factors modify endothelial function.
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1.46 Aim s
1 To compare calcium  ionophore A23187 mediated relaxation in LSV harvested
from patients undergoing CABG by TOVH and MIVH.
2 To determ ine the effect o f  pedicle width on calcium ionophore A23187
mediated relaxation o f  IM A harvested by m onopolar electrocautery from 
patients undergoing CABG.
3.1 To study endothelium -dependent and -independent relaxation o f  LSV in a
group o f  patients w ith severe CAD compared to controls.
3.2. To study superoxide production levels in blood vessels in a group o f  patients 
with severe CAD compared to controls.
3.3. To study circulating indicators o f oxidative stress in a group o f  patients with 
severe CAD com pared to controls.
4 To determ ine which cardiovascular risk factors influence calcium ionophore
A23187 mediated relaxation o f  LSV in patients with severe CAD.
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Methods
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2.1 Sum m ary
This chapter provides a detailed description o f  how and from whom blood and 
blood vessels were obtained, and secondly the laboratory and clinical techniques used 
in the studies described in this thesis. Chapters 3, 4, 5 and 6  detail the studies. Within 
each individual chapter, a description particular to that study will be given. In this 
present chapter are described the materials, apparatus, experimental technique and 
physiological basis behind each o f  the main techniques used in the studies.
Laboratory studies were undertaken within the British H eart Foundation 
Glasgow Cardiovascular Research Centre, Division o f  Cardiovascular and Medical 
Sciences, University o f  Glasgow.
2.2 Ethics Com m ittee Approval
All the studies contained within this thesis were fully approved by the West 
Ethics Com mittee o f  the W estern Infirmary [Reference 01/67(2)] and the East Ethics 
Committee o f  the Glasgow Royal Infirmary (Reference 01SC006), on behalf o f  the 
North Glasgow Hospitals University NHS Trust (ethical approvals letters appended in 
chapter 9). All subjects gave written informed consent, the forms being approved by 
the Ethics committee.
2.3 M aterials used in Experim ental Procedures
2.3.1 Chem icals
The following chemicals (all purchased from Sigma Com pany Limited, Poole, 
United Kingdom) were used for the studies in this thesis:
• 4 ’,6-diam idino-2-phenylindole dihydrochloride (DAPI);
• Allopurinol;
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• Apocynin;
Calcium chloride (CaCE);
Calcium ionophore A 23187;
Carbachol;
Lucigenin;
Dimethyl sulfoxide solution (DMSO);
Ethylenediam inetetraacetic acid disodium salt solution (EDTA);
Glucose;
Hepes;
Hydroethidine;
Indomethacin;
M agnesium  sulphate (M gSO ^;
Phenylephrine;
Potassium chloride (KCl);
Potassium dihydrogenphosphate (KH2PO 4);
Sodium bicarbonate (NaHCOs);
Sodium chloride (NaCl);
Sodium nitroprusside.
The following chemical was purchased from Dow Corning (Midland, 
Michigan, United States o f  Am erica) for the studies in this thesis:
•  Sylgard 3140RTV (clear silicone).
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2.3.2 Buffers
The following buffer solutions which were prepared fresh each day were used 
for the studies in this thesis:
• Krebs buffer solution (composition in mmol/L: NaCl 118.4, KCl 4.7, M gS0 4  ' 
H2O 1.2, KH 2PO 4 1.2, NaHCO ] 24.9, C aC b 2.5, glucose 11.1, EDTA 0.023 
and indomethacin 0.02, dissolved in DMSO, which gives a pH o f  7.4 ± 0.22);
• Krebs / Hepes buffer solution (composition in mmol/L: N aCl 118.4, KCl 4.7, 
M gS0 4  • LI2O 1.2, K H 2PO4 1.2, NaHCOs 24.9, CaClg 2.5, glucose 11.1, 
EDTA 0.023, indom ethacin 0.02, dissolved in DM SO and Hepes 10, which 
gives a pH o f  7.4 + 0.22).
2.3.3 Instrum ents
The following instruments were used for the studies in this thesis:
• M ercian Basic M icro Instrum ent Set BMS-1 (M ercian Surgical Supply Co 
Ltd, Birmingham, United Kingdom);
• Swann-M orton surgical steel disposable scalpel (LIG Supplies Ltd., 
Cambridge, United Kingdom);
• Fixed position, through-the-lens surgical telescopes (3.5X; Designs for Vision, 
Ronkonkoma, N ew  York, United States o f  America);
• Grass force-displacem ent transducer FT03 (Grass Instruments, Quincy, 
M assachusetts, United States o f  America);
• ETH-400 am plifiers (CB Sciences, Dover, New Hampshire, United States o f 
America);
• M acLab 8/s data acquisition system (Apple Computer, Cupertino, California, 
United States o f America);
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Power M acintosh 7200/90 (Apple Computer, Cupertino, California, United 
States o f  America);
Chart recording software version 4/s (ADInstruments, M ilford, M assachusetts, 
United States o f  America);
Pye U nicom  SP8-500 UV/VIS spectrophotom eter (Spectronic Unicam, 
Cambridge, Cambridgeshire, United Kingdom);
Tricarb 2100TR liquid scintillation counter (Hewlett Packard, Meriden, 
Connecticut, United States o f  America);
SPECTRAm ax Plus 384 M icroplate Reader (M olecular Devices Corporation; 
Sunnyvale, California, United States o f America);
MRC 1024 laser scanning confocal microscope (Bio-Rad Laboratories; 
Hercules, California, United States o f  America);
Scion Image software version 4.0 (Scion Corporation Inc., Frederick, 
M aryland, United States o f  America);
Hettich Rotofix 32A centrifuge (Hettich-Zentrifugen G m bH & Co., 
Tuttlingen, Germany);
Caliper ruler (Vicarey, Davidson & Company Limited, Glasgow, United 
Kingdom);
Theatre ruler (Vicarey, Davidson & Company Limited, Glasgow, United 
Kingdom);
Scintillation vials (Packard Instruments Co., Downers Grove, Illinois, United 
States o f  Am erica);
Capped universal containers (Packard Instruments Co., Downers Grove, 
Illinois, United States o f  America);
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• M icrocentrifuge tubes (Packard Instruments Co., Downers Grove, Illinois, 
United States o f  America).
2.3.4 Assay kits
The following assay kits were used for the studies in this thesis:
• Bioxytech® AOP-490'^'^ assay (Oxis Research, Portland, Oregon, United 
States o f  America).
• Bioxytech® GSH/GSSG-412™  assay (Oxis Research, Portland, Oregon, 
United States o f  America).
2.3.5 Laboratory system
The following laboratory system was used for the studies in this thesis:
•  Bayer® ADVÏA 1650 chemistry system (Bayer Diagnostics, Newbury, 
Berkshire, United Kingdom).
2.4 Hum an volunteers
The University o f  Glasgow is located adjacent to the W estern Infirmary; part 
o f  the North Glasgow University Hospitals NHS Trust, which is a tertiary healthcare 
centre. Coronary artery bypass surgery is a common procedure perform ed at the 
W estern Infirmary and Glasgow Royal Infirmary, with approximately 2000 operations 
being perform ed per annum. Usually, distal segments o f  left IM A and proximal 
segments o f  LSV are surplus to requirement and are consequently discarded. This 
situation therefore presents an opportunity to obtain human blood vessels from 
patients with atherosclerotic vascular disease. All study participants underwent
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elective first tim e CAB G for isolated CAD. These patients gave consent to jo in  the 
study 5-10 days prior to the day o f  their operation.
Healthy volunteers were identified from those patients who were undergoing 
elective varicose vein surgery at Gartnavel General Hospital, w hich is part o f  the 
North Glasgow University Hospitals NHS Trust. Varicose vein surgeiy 
(saphenofemoral ligation, stripping o f  the long saphenous vein with multiple 
avulsions o f  varicosities) is a common procedure performed at the Gartnavel General 
Hospital, with approxim ately 200 operations being perform ed per annum. These 
patients gave consent to jo in  the study 5-10 days prior to the day o f  their operation. 
Clinical details were recorded from case note examination.
A history o f  current cigarette smoking, hypertension (defined as either current 
anti-hypertensive treatm ent or a blood pressure > 140/90 mmHg), diabetes mellitus 
(insulin treated or non-insulin treated), hypercholesterolaem ia (plasma cholesterol >
5.4 mmol/L), peripheral vascular disease, cerebrovascular disease, family history, 
body m ass index and left ventricular function were considered as risk factors for 
CHD. Information on current medication was also documented at this point. Blood for 
m easurem ent o f  circulating indicators o f  oxidative stress and LDL-cholesterol was 
taken from the CAB G patients one week prior to surgery.
2.5 Cardiopulm onary bypass technique
All patients underw ent elective prim aiy coronary surgery for the treatment o f 
m ultivessel coronary artery disease. Cardiopulmonary bypass with moderate 
hypotherm ia (28-30 C) and eold blood intermittent anterograde cardioplegia (4°C) 
was the technique o f  choice for myocardial protection.
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2.6 Handling o f human vessels
After sternotomy, the IM A was dissected as a pediele w ith its venae 
com m itantes from the thoracic wall by a no-touch technique, leaving the vessels in 
their anatom ic environm ent surrounded by internal thoracic fascia, using 
electrocautery and surgical clips (Deja et al. 2005) (IMA pedicle = internal thoracic 
fascia surrounding the IMA). The discarded distal end (l-2cm ) o f  the IM A was 
transferred to the laboratory as described below. Relaxation o f  IM A which have been 
harvested in this no-touch manner has been studied in our laboratories for fourteen 
years (Hamilton et al. 2002a; Hamilton et al. 2002b; Berry et al. 2000; Hamilton et al. 
2002; Hamilton et al. 1999; Hamilton et al. 1998; Hamilton et al. 1997; Thorin- 
Trescases et al. 1995; Thorin-Trescases et al. 1993) and light microscopic 
examination o f haematoxylin and eosin stained paraffin sections o f  IM A harvested by 
this no-touch technique at our unit has shown the vessels to be m uscular arteries with 
an average external diam eter o f  1.9 mm (Hamilton et al. 1999). Importantly, our unit 
has previously found that IM A harvested with this technique had intact endothelium, 
which appears to be closely applied to the luminal aspect o f  the internal elastic 
lamina, on light microscopic examination o f haematoxylin and eosin stained paraffin 
sections (Hamilton 1997) (Figure 2.1a).
LSV was obtained from veins in excess on completion o f  the last proximal 
anastomosis by traditional open or m inimally invasive techniques (M ahmood et al. 
2006). Relaxation o f  LSV harvested by the traditional open technique has been 
studied at our laboratories for fourteen years (Hamilton et al. 2002; Hamilton et al. 
1999; Berry et al. 2000; Hamilton et al. 1997; Thorin-Trescases et al. 1995; Thorin- 
Trescases et al. 1993), and histological examination has confirmed the endothelial 
integrity o f  the harvested LSV (Hamilton 1997) (Figure 2.1b).
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IM A and LSV were collected from the operating theatre and placed in ice-cold 
Krebs / Hepes buffer-solution on ice and immediately taken to the laboratory (Berry et 
al. 2000). The time delay from operating theatre to the laboratory was 0.5 - 2 h.
2,6.1 Vessel preparation
The vessels were pinned down at either end in a clear glass dissecting dish, 
where the floor was covered with a layer o f  clear silicone (Sylgard 3140RTV; Dow 
Corning, M idland, M ichigan, United States o f  America) and filled with cool Krebs / 
Hepes solution. The dish lay on a bed o f ice. The loose connective tissue was 
carefully removed under a light source using fixed position, through-the-lens surgical 
telescopes (3.5X; Designs for Vision, Ronkonkoma, New York, United States o f 
America) and fine surgical grade instruments (M ercian Basic M icro Instrum ent Set 
BMS-1; M ercian Surgical Supply Co Ltd, Birmingham, United Kingdom). At this 
point, the ring segments were transferred into cold Krebs / Hepes buffer solution in a 
capped universal container (Packard Instrum ents Co., Downers Grove, Illinois, United 
States o f  America), and m aintained in atmospheric conditions and stored in a fridge at 
4°C overnight for study the next day (Hamilton et al. 1997). Storage o f  rings o f  IMA 
and LSV in Krebs / Hepes buffer solution overnight under these conditions has been 
shown to have no effect on endothelial responses when com pared to rings studied 
immediately (Hamilton et al. 1997). The following morning, the vessel was 
straightened out by slightly stretching and pinning at either end before cutting 
transverse rings o f  length precisely known, 2 mm for IMA, and 3 mm for LSV 
(Thorin-Trescases et al. 1995; Thorin-Trescases et al. 1993), with a Swann-M orton 
surgical steel disposable scalpel (LIG Supplies Ltd., Cambridge, United Kingdom). 
Subjectively, all vessel segments appeared normal and were free o f  abnormalities.
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Figure 2.1 Photomicrographs o f  bypass conduits (a) haematoxylin and eosin stained 
section o f  150% human IMA demonstrating a normal arterial wall with a continuous 
intact endothelial layer lining the vessel lumen; (b) haematoxylin and eosin stained 
section o f  a 150% human LSV demonstrating a normal vein wall with a continuous 
intact endothelial layer lining the vessel lumen. The luminal surfaces are at the top 
with an intact endothelial lining. (From Hamilton et al. 1997; reproduced with 
perm ission from Elsevier, Amsterdam, The Netherlands).
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2.6.2 Principles o f norm alisation technique for setting resting tension
Vessels w ith circum ferentially arranged smooth muscle m ust be distended to 
bring the actin-m yosin fibres into alignment for optimal force developm ent (Angus 
and W right 2000). The preferred response when m easuring blood vessel reactivity is 
to stretch the vessel radially to its optimal length for development o f  active force and 
measure changes in isometric tension (Angus and W right 2000). The am ount o f 
passive force (stretch) applied to a segment o f  artery or vein in an organ bath should 
be relevant for the amount o f  muscle present and its geometry (Angus and Wright
2000). That is why techniques have been developed to determ ine the passive length- 
tension relationship for each vessel segment, cut to a precise length (Angus and 
W right 2000). This norm alisation procedure attempts to set the passive distension to 
correspond with that caused by transmural pressure experienced in vivo vessels 
(Angus and W right 2000).
2.6.3 Isom etric tension studies in organ baths
The 2mm long IMA and 3 mm long LSV segments (Thorin-Trescases et al. 
1995; Thorin-Trescases et al. 1993) were suspended between two L-shaped 40-|nm- 
diam eter stainless steel wires. One wire was permanently attached to a tissue bath 
hook, and the other was directly coupled to lengths o f  wire to an isom etric force- 
displacement transducer (FT03; Grass Instruments, Quincy, M assachusetts, United 
States o f America). The output from force-displacement transducers was fed to 
analogue signal ETH-400 am plifiers (CB Sciences, Dover, New Hampshire, United 
States o f  America). The voltage signals were converted to digital signals and recorded 
with M acLab 8/s (Apple Computer, Cupertino, California, United States o f  America) 
and com puter-based recorders on a Power M acintosh (7200/90, A pple Computer,
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Cupertino, California, United States o f  America). Chart recording software 
(ADInstruments, AD Instruments, M ilford, M assachusetts, United States o f  America) 
was used for data acquisition.
2.6.4 Krebs buffer-solution
Krebs buffer-solution is the standard salt solution used in our laboratories. The 
10 mL glass-jacketed organ baths were filled with K ieb 's solution, pre-heated and 
maintained at 37°C and saturated by vigorous gassing with 95% oxygen (O 2) and 5% 
carbon dioxide (CO 2).
The Krebs buffer-solution also contained the cyclo-oxygenase inhibitor 
indomethacin (0.02 mmol/L). Previous experiments performed at our laboratories 
studied relaxation to carbachol in the absence and then in the presence o f 
indomethacin (0.02 m m ol/L dissolved in DM SO) (Ham ilton et al. 1999). 
Indomethacin did not attenuate relaxation in blood vessels used for CAB G suggesting 
that prostanoids do not contribute to endothelium-dependent relaxation to carbachol 
(Hamilton et al. 1999). Indeed, there was a tendency for relaxation to improve in the 
presence o f  indomethacin and it is possible that carbachol caused contraction by the 
stimulated release o f  prostanoids such as PGH 2 (Hamilton et al. 1999). Based on the 
results from this study, indom ethacin was added to the Krebs buffer-solution to inhibit 
prostanoid synthesis (Hamilton et al. 1999).
2.6.5 Drugs and solutions used
Stock solutions o f  phenylephrine (0.01 mol/L), carbachol (0.001 mol/L), 
potassium chloride (2 mol/L), allopurinol (0.001 mol/L) and sodium nitroprusside 
(0.01 mol/L) were prepared and frozen in aliquots at -20°C. Stock solutions o f
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apocynin (1 mol/L) and calcium  ionophore A23187 (0.01 mol/L) were prepared daily 
in 0.5% dimethyl sulfoxide solution. Vehicle doses o f dimethyl sulfoxide solution at 
the concentration present in the organ bath have been previously docum ented to evoke 
no vascular effects (Luscher et al. 1988). Serial dilutions were performed with 
distilled w ater or Krebs solution.
Calcium ionophore A 23187-mediated vasorelaxations occur via an 
endothelium -dependent receptor-independent pathway and represent the final capacity 
o f the endothelium  to release NO after endothelial NO  synthase (eNOS) stimulation 
(Perrault et al. 2005; Yang et al. 2004; Deckert et al. 2002). This is in contrast to 
acetylcholine which activates endothelial NO synthase through a receptor-dependent 
mechanism (Deckert et al. 2002). Therefore, calcium ionophore was used in 
preference to acetylcholine to elicit receptor-independent and endothelium -dependent 
vasorelaxations.
2.6.6 Organ bath protocol
The conditions and norm alisation protocol in the next paragraph have been 
established in our laboratories (Hamilton et al. 2002a; Hamilton et al. 2002b; Berry et 
al. 2000; Ham ilton et al. 1997; Thorin-Trescases et al. 1995; Thorin-Trescases et al. 
1993).
Rings were allowed to equilibrate for 60 min with changes o f  buffer every 15 
min and with several adjustm ents o f  length until baseline tension stabilized at 1 g. In 
previous studies at our laboratories, it was found that 1 g o f  resting tension are 
optimal for these types o f  experiments (Thorin-Trescases et al. 1995), This tension 
has been shown to be on the optimal part o f  the tension-response curve for both 
human IM A and LSV (Thorin-Trescases et al. 1995) and our laboratories have used
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this protocol as a routine normalisation procedure for both human IMA and LSV  
(Hamilton et al. 2002a; Hamilton et al. 2002b; Berry et al. 2000; Hamilton et al. 
1997). When tension was stable, the experim ents were initiated.
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Figure 2.2 A typical concentration response curve. This original recording show s 
the response o f  a ring o f  LSV precontracted with phenylephrine (pe in figure) and 
vasorelaxed with increasing concentrations o f  calcium  ionophore A 23187 (Cal in 
figure). The x axis measures tim e in minutes and the y axis measures tension in 
grams.
2.6.7 Organ bath initial protocol
The rings were contracted with phenylephrine (3 pm ol/L). Then, 
vasorelaxation in response to carbachol (0.3 pm ol/L) was studied. N ext the organ bath 
was flushed thoroughly and the process o f  vasocontraction and vasodilation repeated. 
The organ bath was again flushed thoroughly. The rings were then exposed to a high 
(0.1 m ol/L) concentration o f  KCl until maximal contractions were achieved. After a 
plateau contraction had been attained with KCl, rings were excluded i f  contractions 
were less than 0.5 g  or show ed no relaxation to carbachol (and were therefore 
considered to have no functionally intact endothelium). The vesse ls were then 
incubated for a further 30 m inutes in Krebs solution prior to the com m encem ent o f  the 
cum ulative concentration response curves.
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2.6.8 M ain study protocol in order o f drug addition
Rings were precontracted with phenylephrine (3 pm ol/L) and vasorelaxation 
was evaluated by cum ulative addition o f  apocynin, a NAD (P)H oxidase inhibitor, 
(0.01 to 0.3 mmol/L). N ext the organ bath was flushed thoroughly and the vessels 
allowed to re-equilibrate.
Rings were precontracted with phenylephrine (3 pmol/L) and endothelium- 
dependent derived relaxation was evaluated by cumulative addition o f  calcium 
ionophore A23187 (0.01 to 10 pmol/L), N ext the organ bath was flushed thoroughly 
and the vessels allowed to re-equilibrate.
Rings were precontracted with phenylephrine (3 pmol/L) and vasorelaxation 
was evaluated by cum ulative addition o f  allopurinol, a xanthine oxidoreductase 
inhibitor, (0.01 to 0.3 mmol/L). N ext the organ bath was flushed thoroughly and the 
vessels allowed to re-equilibrate.
Rings were precontracted with phenylephrine (3 pm ol/L) and endothelium- 
independent derived relaxation was evaluated by cumulative addition o f  sodium 
nitroprusside (0.001 to 10 pmol/L).
For each dose o f  drug added, continuous tension m easurem ents were made 
over 5 minutes. The final tension measurem ent o f these continuous readings was used 
as the tension m easurem ent (g) for that drug concentration. This allowed 
concentration response curves for each vessel ring o f  each subject to be constructed. 
Relaxation to apocynin, calcium  ionophore A23187, allopurinol and sodium 
nitroprusside was expressed as a percentage o f  the contractile response to 
phenylephrine.
81
■,12.7 Lucigen in chem iium inescence and oxidative fluorescent m icrotopography
AH the lucigenin chemiiuminescence and oxidative fluorescent 
m icrotopography experim ents were performed by Dr CA H am ilton (Senior Lecturer 
in Pharmacology at University o f  Glasgow) and M rs EJ Jardine (Laboratory 
Technician at University o f  Glasgow).
Superoxide was measured using lucigenin chemiiuminescence as described by 
Berry et al. (2000). 3 x 5 mm lengths o f  vein were blotted, weighed and placed in 
scintillation vials (Packard Instrum ents Co., Downers Grove, Illinois, United States o f 
America) containing 2m 1 o f  Krebs buffer at pH 7.4 ± 0.22 and m aintained in 
atmospheric conditions at room temperature. Next, either Krebs buffer, allopurinol 
(0.1 mmol/L) or apocynin (0.1 mmol/L) were added and after 60 m inutes incubation 
at room temperature, lucigenin (0,25 mmol/L) was added and counts were recorded 
every 10 seconds for 3 m inutes in a liquid scintillation counter (Tricarb 2100TR,
Hewlett Packard; Hercules, California, United States o f  America) switched to the out- 
of-coincidence mode. Absolute counts were quantified with a xanthine /  xanthine 
oxidase calibration curve for superoxide generation and reported as nmol min'^ mg o f 
tissue. In all experiments, superoxide production was measured in paired samples with 
a matched control ftom  the same vessel in every case. |
Hydroethidine, a sodium borohydride-reduced form o f  ethidium  bromide was 
used for oxidative fluorescent microtopography. Hydroethidine, a specific and 
sensitive indicator o f  superoxide (Rothe and Valet, 1990) is freely permeable to cells 
and, in the presence o f  superoxide, is oxidized to red-fluorescent ethidium bromide, 
where it is trapped by intercalation with deoxyribonucleic acid. (Carter et al. 1994).
Ethidium brom ide is excited at 488 nm with an emission spectrum o f  610 nm. In cell-
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free assays, addition o f H 2O 2 to hydroethidine does not significantly increase ethidium 
bromide fluorescence (M iller et al. 1998; Carter et al. 1994).
For oxidative fluorescent m icrotopography with hydroethidine. Unfixed frozen 
LSV ring segments were cut into 30 pm thick sections and placed on a glass slide and 
incubated with the nuclear m arker DAPI (20 pm ol/L for 2 minutes) followed by 
hydroethidine (2 pm ol/L  for 20 minutes). The oxidative fluorescent dye hydroethidine 
was used to evaluate the in situ formation o f  superoxide as described by M ollnau et al. 
(2005), Hink et al. (2001) and M iller et al. (1998). Fluorescence was detected using a 
laser scanning confocal m icroscope (MRC 1024, Bio-Rad Laboratories; Hercules, 
California, United States o f  America) with an optical band pass filter o f  470 ±  30 nm 
for DAPI (2-photon excitation 750 nm) and a band pass o f  580 ±  16 nm for 
hydroethidine (single-photon excitation 488 nm). Vessels from CAD and control 
patients were analyzed in parallel under identical laser settings. Relative superoxide 
levels within vessel segments were quantitated by determining relative fluorescence in 
the red (hydroethidine) and blue (DAPI) channels over a defined area, using Scion 
Image version 4.0 software (Scion Corporation Inc., Frederick, M aryland, United 
States o f  America) (Cham seddine and M iller 2003).
2.8 Collection o f human blood samples
W hole blood samples were collected 5-10 days prior to CAB G surgery or 
varicose vein surgery from the chapter 5 and 6 patients. Patients were fasted overnight 
and rested in the supine position for 30 minutes prior to donating blood. W hole blood 
samples were obtained from vena cubitalis o f  the subjects; 5 to 10 ml was drawn into 
two tubes, one containing EDTA and the other containing lithium heparin and 
immediately chilled in ice.
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For the GSH sample, 50 pL o f  whole blood was added to a microcentrifuge
. . .tube (Packard Instruments Co., Downers Grove, Illinois, United States o f  America).
For the GSSG sample, 100 pL whole blood was mixed with 10 pL o f  M2 VP (1- 
M ethyl-2-vinyl-pyridium  trifluorom ethane sulfonate in hydrochloric acid (HCl), 2 
mL) to scavenge GSH in a m icrocentrifuge tube. The GSH and GSSG samples were 
then stored frozen at ~70°C. This freezing step lysed the red blood cells to maximize 
the concentration o f  GSSG in the sample.
The heparinised blood samples were centrifuged (Hettich Rotofix 32A;
Hettich-Zentrifugen GmbH & Co., Tuttlingen, Germany) at 4700 revolutions per 
minute for 10 min at 4°C and the supernatant plasm a was collected for m easurem ent 
o f total antioxidant capacity and cholesterol. All samples were frozen, and stored at - 
70°C until assay.
W ithin individuals, changes in circulating lipids and circulating indicators o f 
oxidative stress occur in response to a variety o f  factors (Dikalov et al. 2007; Seifried 
et al. 2007; Choi et al. 2006; Kamuren et al. 2006; Kato et al. 2006; Bairaktari et al.
2005; Cole et al. 2005; W atson et al. 2005; Nedeljkovic et al. 2005; Redon et al. 2003;
Anderson et al. 2001; Bae et al. 2001; Nourooz-Zedeh et al. 2001). Several steps 
within the m ethodology help reduce this variability;
m aintenance o f  a quiet environment at a fixed temperature;
all subjects were studied in the m orning after an overnight fast o f  at least 12
hours; j
subjects were asked to avoid caffeine, alcohol and smoking tobacco for at least
24 hours prior to the study and were rested supine for 30 m inutes prior to
taking blood.
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2.9 M easurem ent o f circulating ind icators of oxidative stress in human blood
No single com ponent o f  the antioxidant complex exists that fully reflects the 
protective capacity o f  whole blood. Thus, we assessed two different circulating 
indicators o f antioxidant capacity: total antioxidant capacity (TAG) was assessed in 
plasma, and GSH and GSSG content in whole blood.
2.10 Total Antioxidant Capacity
Individual antioxidant moieties play specific roles in com bating oxidative 
stress and m easurem ent o f  single antioxidants may be beneficial to some studies 
(Kaur et al. 2006; Scheibmeir et al. 2005; M aritim  et al, 2003; Polidori et al. 2001; 
Sies 1997). However, individual results may not be indicative o f  the overall effect o f 
multiple antioxidants working in concert with one another (Kaur et al. 2006; 
Scheibmeir et al. 2005; M aritim  et al. 2003; Polidori et al. 2001; Sies 1997). 
Therefore, an important index in oxidative stress studies may be m easurem ent o f  the 
total antioxidant capacity o f  the biological system (Kaur et al. 2006; Polidori et al. 
2001; Sies 1997). Copper (Cu) has advantages over iron for total antioxidant assays in 
that all classes o f  antioxidants, including thiols, are detected with little interference 
from reactive radicals and the copper reaction kinetics are faster than iron (Prior et al. 
2005).
Total antioxidant capacity was evaluated by the established Bioxytech® AOP- 
490™  assay kit (OxisResearch™ , Portland, Oregon, United States o f  America) 
(Huffman et al. 2006a; H uffm an et al. 2006b; Vitalini et al. 2006; Cole et al. 2005; 
Prior et al, 2005; Roberts et al. 2005; Hermo et al. 2005; Chyu et al. 2004; Zeidler et 
al. 2004a; Zeidler et al. 2004b; Zeidler et al. 2003; Calo et al. 2003; Caruso et al. 
2001; Visioli et al. 2001). The Bioxytech® AOP-490™  product insert stated that this
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assay has a coefficient o f  variation o f  2.2 % for intra-assay and 4.2 % for inter-assay 
(OxisResearch 2002). Oxis International Inc. correspondence states that they do not 
release formulation inform ation about their kits (appended in appendix 9.2). Therefore 
concentrations o f chemicals in their kits are not available.
2.10.1 Principles o f the total antioxidant capacity assay
The Bioxytech® AOP-490™  assay is based upon the reduction o f  Cu "^  ^ to Cu^ 
by the com bined action o f  all antioxidants present in the plasm a sample 
(OxisResearch 2002; Y am ashita et al. 1998). A chromogenic reagent, bathocuproine 
(2,9-dim ethyI-4,7-diphenyl-l,10-phenanthroline), selectively forms a stable 2:1 
com plex with Cu^ which has a maximum absorbance at 490 nm (Huffm an et al, 2006; 
Vitalini et al. 2006; Cole et al. 2005; Prior et al. 2005; Roberts et al. 2005; Hermo et 
al, 2005). The rate o f  this reaction is followed by the bathocuproine complexation o f 
the Cu"  ^ produced (Calo et al. 2003). The results are compared w ith a standard 
calibration curve obtained from samples o f  known concentration o f  uric acid (a water 
soluble antioxidant), used as a reductant (Bellomo et al. 1998). This dilution curve 
generated by uric acid standards is used to convert sample absorbance to uric acid 
equivalents. The results o f  the assay may be expressed either as these “mol/L uric acid 
equivalents” or as “m ol/L copper reducing equivalents.” The conversion between the 
two units is based upon the reduction o f  2189 mmol/L Cu "^  ^ to Cu^ by 1 mmol uric 
acid.
2.10.2 Total antioxidant capacity assay standard preparation
The uric acid standard was dissolved in 1,0 mL o f  10 % sodium hydroxide 
solution and 2 m L o f  deionized w ater was added. The pH value was adjusted to 7.4 by
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adding concentrated HCl dropwise. Next, deionized water was added to m ake a total 
volume o f  100 ml to m ake a 2 mmol/L uric acid. The uric acid standard was diluted 
with deionized water to obtain 6 concentrations o f  uric acid: 0.063, 0.125, 0.25, 0.5,
1.0 and 2.0 mmol/L.
2.10,3 Total antioxidant capacity assay
Samples and standards were then diluted in 1/40 with R1 buffer, mixed, and 
200 pL laced into wells, on a 96 well plate. 50 pL o f  R2 solution was added to each 
well, mixed, and incubated for three minutes at room temperature. 50 pL o f stop 
solution was then added to each well and mixed. The plate was then read on a 
SPECTRAmax Plus 384 microplate reader (M olecular Devices Corporation; 
Sunnyvale, California, United States o f  America) set at 490nm. A  R1 buffer blank and 
set o f  standards was run on each plate and a standard curve was constructed. The uric 
acid equivalent concentration o f  each sample was determined using the standard 
curve.
2.11 M easurem ent o f reduced/oxidised glutathione (GSH/GSSG) ratio in 
whole blood
The GSH/GSSG m olar ratio was determined by using the established 
Bioxytech® GSH/GSSG-412™ assay (Oxis International Inc., Portland, Oregon, USA) 
(Griguer et al. 2006; Kamuren et al. 2006; Liang et al. 2006; Ber son et al. 2006; 
Sandstrom et al. 2006; Shao et al. 2006; Berson et al. 2006; A ndziak et al. 2006; Lin 
et al. 2006; Liang et al. 2006; W aypa et al. 2006; M artirosyan et al. 2006; Franco et 
al. 2006; Choi et al. 2006; Nedeljkovic et al. 2005; Hsu et al. 2005; Blanchi et ai. 
2005; W atson et al. 2005; Hochscheid et al. 2005; van Rensburg et al. 2005; Sanz-
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aRosa et al. 2005; Hino et al. 2005; Robin et al. 2005; de M offarts et al. 2004; Felix et 
al. 2004; Bowler et al. 2003; Yamamoto et al. 2003; Belinky et al. 2003).
This was m easured in whole blood by a colorimetric reaction using Ellman's 
reagent. E llm an’s reagent (5,5'-dithiobis-2-nitrobenzoic acid in sodium phosphate 
(NaP0 4 ) with EDTA, with ethanol, 40 mL) reacts with GSH to form a 
spectrophotom etrically detectable product w ith an absorption m axim um  at 412 nm. 
GSSG was determined using glutathione reductase and NAD(P)H to reduce GSSG to 
GSH, followed by reaction with Ellman's reagent. The concentration o f  GSH can then 
be calculated from a calibration curve (0 to 3 pmol/L GSH). The Bioxytech® 
GSH/GSSG-412™ product insert stated that this assay has a coefficient o f  variation o f
3.0 % for intra-assay and 3.9 % for inter-assay (OxisResearch 2001). As stated 
previously, Oxis International Inc. do not release formulation information about their 
assay kits, so the concentrations o f  chemicals in this kit was not available.
The accurate m easurem ent o f  GSSG levels has proved very difficult due to the 
low am ount o f GSSG in tissues and because o f  the absence o f  effective methods to 
prevent oxidation o f  GSH to GSSG during sample preparation. To m easure GSSG in 
tissues, Guntherberg and Rost (1966) first introduced N -ethylm aleim ide (NEM) to 
eliminate the GSH. Although NEM  can react with GSH to form a stable com plex and 
prevent the participation o f  the reduced form in the enzymatic assay, NEM  also 
inhibits GR. For this reason, Griffith (1980) first introduced 2-vinylpyridine (2-VP), 
which does not inhibit GR significantly, to derivatize GSH, However, the 2-VP 
reaction is relatively slow and the reagent has little solubility in an aqueous medium. 
2-VP at 10 mmol/L, usually takes 60 minutes to remove 70 % o f the GSH in the 
sample during w hich time oxidation o f GSH may occur, resulting in significant 
overestim ation o f  the GSSG concentration. The Bioxytech® GSH/GSSG-412™ assay
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uses the thiol-scavenging reagent, M2 VP at a level that rapidly scavenges GSH but 
does not interfere w ith the GR assay (OxisResearch 2001). Using M 2 VP, complete 
scavenging o f  GSH is accom plished in less than one minute (OxisResearch 2001).
2,11.1 GSH /G SSG  ratio assay
W hen assessm ent was performed, the samples were thaw ed and immediately 
mixed and incubated at room tem perature for 2-10 minutes. Both samples were 
prepared in 5% metaphosphoric acid (MPA) to remove proteins.
350 pL o f  5% M PA was mixed with the GSH sample and 290 o f  5% MPA 
wase mixed with the GSSG samples. A  GSSG blank was prepared by mixing 50 pL 
M PA with to 700 pL GSSG buffer.
For m easurem ent o f  GSH and GSSG, 50 pi M PA supernatant was mixed with 
3 ml assay buffer (assay buffer: N aP 0 4  with EDTA), and for GSSG estimation, 50 pi 
o f  the M PA supernatant with M2 VP was m ixed with 700 pi GSSG assay buffer. For 
both assays, the samples were mixed with 200 pi o f  chromagen, glutathione reductase 
and 3.8 pmol NAD(P)H, and 4.5 min later the absorbance (reduction o f  dithiobis-2- 
nitrobenzoic acid at 412 nm) was m easured in a spectrophotom eter (Pye Unicorn 
SP8-500 UV/VIS; Spectronic Unicam, Cambridge, Cam bridgeshire, United 
Kingdom). The spectrophotom etric detection was recorded at 412 nm every 10 s for 3 
min. Reduced glutathione at concentrations from 0 to 3 pm ol/L was used as the 
standard to calibrate the curves. The GSH/GSSG ratio was calculated as follows: 
GSH/GSSG = [GSH - (2 GSSG)]/GSSG.
89
2.12 M easurem ent o f  cholesterol in human blood
2.12.1 Background
The association between cholesterol and the risk o f  atherosclerotic disease is 
well established by many studies (Larosa et al. 2005; Nissen et al. 2005; Cannon et al. 
2004; Castelli et al. 1986). LDL particles are the main carriers o f  the circulating 
cholesterol and they play a key role in cholesterol transfer and metabolism  (Bairaktari 
et al. 2005). Increased superoxide production has been reported in 
hypercholesterolem ia and it is well established that free radical damage contributes to 
the aetiology o f  CVD (Collin et al. 2007; Ohara et al. 1993). Free radicals can cause 
oxidation o f  LDL and oxidised LDL has been demonstrated to accelerate endothelial 
damage, macrophage recruitm ent and increased uptake o f LDL-cholesterol by foam 
cells, which gradually develops into fatty streaks (Collin et al. 2006; Ohara et al. 
1993). The executive summary o f  the National Cholesterol Education Program 
identifies LDL-cholesterol as the primary target o f  cholesterol-lowering therapy 
(National Cholesterol Education Program 2001) and recent clinical trials show that 
LDL-lowering therapy reduces the risk for CAD (Larosa et al. 2005; N issen et al. 
2005; Cannon et al. 2004).
2.12.2 Friedewald equation
M ost clinical laboratories and clinical trials use the Friedewald equation for 
the calculation o f  LDL-cholesterol levels (Bairaktari et al. 2005; Sniderman 2003; 
Bairaktari et al. 2001; Yu et al. 1997; Friedewald et al. 1972). The Friedewald et al. 
(1972) article has more than 3,000 citations (Bruns 1998; Gotto and Cooper 1998).
The principle o f  the Friedewald equation is based on the assum ptions that: (1) 
total cholesterol is distributed among the three m ajor lipoprotein classes [high-density
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lipoprotein (HDL), LDL and very low-density lipoprotein (VLDL)], and (2) VLDL 
carries m ost o f  the circulating triglycerides and therefore VLDL-cholesterol can be 
estimated reasonably w ell from m easured total triglycerides (triglycerides / 2.2 for 
mmol/L units). LDL-cholesterol is then calculated as (Friedewald et al. 1972): 
LDL-cholesterol = Total cholesterol -  HDL-cholesterol -  Triglycerides / 2.2
The advantages o f  the Friedewald calculation are that there is extensive 
experience o f its use in m any clinical studies (Bairaktari et al. 2005; N auck et al. 
2002; Bairaktari et al. 2001), it has well established clinical significance (Bairaktari et 
al. 2005) and is convenient and inexpensive when total cholesterol, triglycerides and 
HDL-cholesterol are m easured (Bairaktari et al. 2005).
The w ell-know n limitations o f  the calculation concern mainly three 
circumstances in which the equation cannot be used:
1. In the presence o f  chylomicrons, which contain proportionately less cholesterol 
relative to triglycerides than VLDL and therefore leads to overestim ation o f  VLDL- 
cholesterol and underestim ation o f  LDL-cholesterol. As postprandial specim ens often 
contain traces o f  chylom icrons, a fasting specimen (8-12 hours) is required (Nauck et 
al. 2002);
2. In patients w ith Type III hyperlipoproteinim ia or dysbetalipoproteinemia, 
characterized by the accum ulation o f  remnant lipoproteins w ith an increased 
proportion o f cholesterol relative to triglycerides, leading to underestim ation o f 
VLDL-cholesterol and overestim ation o f  LDL-cholesterol (W arnick et al. 1990);
3. In increased triglyceride concentration when the proportion o f  cholesterol to 
triglycerides in VLDL decreases, giving rise to errors (Bairaktari et al. 2005; N auck et 
al. 2002).
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For this reason, calculation was recommended only for specimens with 
triglyceride levels o f  less than 4.5 mmol/L. However, its reliability is considerably 
decreased even at triglyceride concentrations o f  2.25 to 4.5 mmol/L. Specimens with 
triglyceride concentrations below 2.25 m m ol/L give the best agreem ent with 13- 
quantification (86% -92%  o f  the samples show deviations o f  less than 10%), whereas 
in specimens with triglyceride concentrations o f  2.25 to 3.37 mmol/L and 3.37 to 4.5 
mmol/L, only 75% and 61%  o f  the samples show deviations o f  less than 10%, 
respectively (W arnick et al. 1990; M cNam ara et al. 1990). M any studies have focused 
on determining alternative triglyceride multipliers to improve the reliability o f  the 
Friedewald equation (Fujimoto 1988; Hata and Nakajim a et al. 1986; Lippi et al. 
1986; W ilson et al. 1985; W ilson et al. 1981; Castelli et al. 1977; Tyroler et al. 1975) 
but (1) the use o f  alternative triglyceride multipliers gives only m arginally better 
LDL-cholesterol values and may not apply equally to all populations anyway, and (2) 
the Friedewald equation triglyceride multiplier seems to distribute the error about 
equally on both sides o f  zero and thus, it is concluded that there is little advantage in 
using a m odified Friedew ald equation (Rifai et al. 1992).
The application o f  the Friedewald formula was also investigated in patients 
with secondary hyperlipidem ia, such as diabetes mellitus, renal disease, hepatic 
failure, and hormone replacem ent therapy (Bairaktari et al. 2001; Legault et al. 1999; 
Branchi A et al. 1998; Johnson et al. 1997; Rubies-Prat et al. 1997; W hiting et al. 
1997; Nauck et al. 1996; Hirany et al. 1996; M atas et al. 1994; W inocour et al. 1989). 
As these conditions are characterised predominantly not only by increased triglyceride 
levels but also by lipoprotein alterations, the acceptable reliability o f  the calculation at 
triglyceride concentrations o f  2.25 to 4.5 mmol/L needs special concern in patients 
with secondary hyperlipidemia. The m ost recent executive sum m ary o f  the National
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Cholesterol Education Program  did pragmatically acknowledge continued use o f  the 
Friedewald calculation, despite these known concerns, until well validated methods 
become available (Expert Panel on Detection, Evaluation, and Treatm ent o f High 
Blood Cholesterol in A dults 2001). M ost clinical laboratories and clinical trials 
continue to use the Friedewald equation for the calculation o f  LDL-cholesterol levels 
(Bairaktari et al. 2005).
2.12.3 AD VIA 1650 chem istry analyser for measurem ent o f  cholesterol in
plasm a
Venous blood (10 ml) was collected into serum specimen tubes and 
centrifuged at 4700 revolutions per minute (Hettich Rotofix 32A; Hettich-Zentrifugen 
GmbH & Co., Tuttlingen, Germany) for 10 min. A  1.0 ml aliquot o f  the supernatant 
plasm a was withdrawn, and total cholesterol, HDL-cholesterol, and triglyceride levels 
were measured by enzymatic methods on a Bayer® ADVIA 1650 chem istry analyser 
with standard reagents (Bayer Diagnostics, Newbury, Berkshire, United Kingdom).
The Bayer® ADVIA 1650 chemistry analyser (Bayer Diagnostics, Newbury, 
Berkshire, United Kingdom) is the routine method to measure total cholesterol, HDL- 
cholesterol and triglycerides at the North Glasgow University H ospitals NHS Trust. 
Dr Ian Louden (Biomedical Scientist, North Glasgow University Hospitals NHS 
Trust) and the Departm ent o f  Biochem istry staff at Gartnavel General Hospital (North 
Glasgow University Hospitals NHS Trust) carried out all the cholesterol 
measurements.
The ADVIA 1650 method has been certified to measure total cholesterol, 
HDL cholesterol, LDL-cholesterol and triglyceride levels by the NHS Purchasing and 
Supply A gency Centre in the United Kingdom and total cholesterol, HDL cholesterol
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and LDL-cholesterol levels by the Cholesterol Reference M ethod Laboratory 
N etwork on behalf o f  the Centers for Disease Control and Prevention in the United 
States o f Am erica (NHS Purchasing and Supply Agency 2005; Centers for Disease 
Control and Prevention 2007a; Centers for Disease Control and Prevention 2007b; 
Centers for Disease Control and Prevention 2007c).
For the total cholesterol method (Bayer Diagnostics, Newbury, Berkshire, 
United Kingdom), the cholesterol esters were hydrolysed by the enzyme cholesterol 
esterase to yield free cholesterol and fatty acids. The free cholesterol was then 
oxidised to cholestene-3-one and H 2O2 by another enzyme, cholesterol oxidase. 
Peroxidase then catalysed the reaction o f  H2O2 w ith 4-aminoantipyrine and phenol to 
produce a coloured quinoneim ine dye (Trinder's reaction) (Trinder 1969). The 
absorbance o f  the coloured dye was measured spectrophotom etrically as an endpoint 
reaction at 505nm.
The direct HDL Cholesterol method (Bayer Diagnostics, Newbury, Berkshire, 
United Kingdom) m easures HDL cholesterol without prior separation, based on 
procedures developed by Izawa et al. (1997). A synthetic polym er w ith a polyanion 
selectively blocked the non-HDL fractions by forming complexes with LDL, VLDL 
particles and chylom icrons which were then eliminated. The cholesterol in HDL 
particles was then released by detergent and measured by Trinder’s reaction (Trinder 
1969) in a sim ilar m anner to the total cholesterol method.
The triglycerides method (Bayer Diagnostics, Newbury, Berkshire, United 
Kingdom) was based on the Fossati three-step enzymatic reaction (Fossati and 
Prencipe 1982) with a Trinder endpoint (Trinder 1969). The triglycerides were 
converted to glycerol and free fatty acids by lipoprotein lipase. The glycerol was then 
converted to glycerol-3-phosphate by glycerol kinase in the presence o f  glycerol-3-
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phosphate-oxidase to form H 2O2 . Next, a red quinoeimine dye was formed from H 2O2, 
4-aminophenazone and 4-chlorophenol under the catalytic influence o f  peroxidase. 
The absorbance o f  the com plex was measured as an endpoint reaction at 505 nm.
M easurem ent o f  the total cholesterol, HDL cholesterol and triglyceride levels 
from the patients in chapters 5 and 6 permitted the estimation o f  LDL-cholesterol 
concentrations, based upon the Friedwald formula (Friedwald et al. 1972). For 
chapters 3 and 4, total cholesterol level was obtained from reviewing the medical 
record o f  each patient, for the m ost recent result, as described by Raggi et al. (2004).
2.13 Statistical analysis
All o f  the statistical analyses within this thesis were perform ed using Minitab 
version 13.1 software package (Minitab for W indows 13.1, M initab Inc., State 
College, Pennsylvania, United States o f  America). Dr Niall Anderson (Senior 
Lecturer in Statistical Genetics, University o f  Edinburgh) perform ed the statistical 
analyses for chapters 3 and 4, Dr Ian Ford (Senior Lecturer in Biostatistics, University 
o f  Glasgow) and Dr John M cClure (Lecturer in Biostatistics, University o f  Glasgow) 
performed the statistical analyses for chapters 5 and 6.
All o f  the com parisons o f  vasorelaxant responses in blood vessels, circulating 
indicators o f  oxidative stress and superoxide production between CAD and control 
patients were made in age- and sex-matched samples. Age matching was performed 
using subjects at m ost two years apart from each other (Goodman et al. 2000; Terân- 
Santos et al. 1999; Cassidy et al. 1999; Strom et al. 1998; Duggan et al. 1998; Jick et 
al. 1998). This was done to create similar age/sex profiles for the 2 groups, because 
CAD patients tended to be older and have a higher male/female ratio than patients 
undergoing varicose vein surgery.
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Relaxation to apocynin, calcium ionophore A23187, allopurinol and sodium 
nitroprusside was expressed as a percentage o f  the contractile response to 
phenylephrine. For each group, concentration response curves were constructed with 
mean ± standard error o f  the mean (SEM ) values, allowing easy visual comparisons. 
Where appropriate, unpaired Student t tests were used for the comparisons o f  
relaxation at different concentrations to calcium ionophore A23187, sodium 
nitroprusside, apocynin, and allopurinol between the 2 groups. Statistical analyses o f 
vascular superoxide concentrations were undertaken by use o f the unpaired Student t 
test. Norm al distribution o f  this data was examined by the Kolm ogorov-Sm irnov test 
and the M ann-W hitney U test was used for comparison o f non-normally distributed 
data between the groups (TAC, GSH, GSSG, GSH:GSSG ratio).
To investigate w hich risk factors were independently related to vasorelaxation, 
multiple linear regression analysis was performed using data from the 264 CABG 
patients in chapter 4 and 188 CAD patients in chapter 6, and estim ated effects, 95% 
confidence intervals, and p values were tabulated. M ultiple correlation coefficients 
were calculated as an overall measure o f  the relationship between risk factors and 
vasorelaxation. Data not following normal distributions (TAC and GSH/GSSG ratio) 
were log transform ed for this analysis. P coefficients and their confidence intervals for 
these 2 analyses were back transform ed from the log scale, and they indicate the 
estimated proportional increase in the response associated with a unit increase in the 
predictor. W here appropriate, Pearson correlation coefficients are displayed.
Unless otherwise indicated, results are shown as m ean ±  standard error o f  the 
mean (mean ± SEM), including 95% CIs where appropriate, and p < 0.05 was 
considered significant.
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Chapter 3
Comparison of calcium ionophore A23187 mediated 
relaxation of LSV harvested by traditional open vein 
harvesting and minimally invasive vein harvesting
techniques
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3.1 INTRO DUCTIO N
The traditional open vein harvesting (TOVH) m ethod o f  the LSV for CABG 
requires an extended longitudinal lower extremity incision from the ankle to the groin 
(Dashwood et al. 2007). This long incision is associated with significant intra­
operative and postoperative complications in up to 25% o f  patients (infection, 
cellulitis, drainage, dehiscence, delayed healing, lymphangitis, sepsis, and limb 
amputation), creating an im portant clinical and economic burden (Aziz et al. 2006; 
Cheng et al. 2005; Cheng et al. 2005; Nickum  2005; Bonde et al. 2004; Bitondo et al. 
2002; Bitondo et al. 2002).
As an alternative, minim ally invasive vein harvesting (M IVH) has been 
reported to reduce leg wound complications and improve patient satisfaction (Aziz et 
al. 2006; Bonde et al. 2005; Aziz et al. 2005; Cheng et al. 2005; Cheng et al. 2005; 
N ickum 2005; Furnary 2005; Yun et al. 2005; Cook et al. 2004; B itondo et al. 2002). 
Recent data show that M IVH is perform ed in the 65% o f  CABG cases in the United 
States o f  Am erica (Burris et al. 2006), The rapid adoption and acceptance o f  this 
technology is the consequence o f  a dramatic reduction in leg wound complications 
(Bonde et al. 2004; Schurr et al. 2002). Several teehniques are available for minimal 
invasive vein harvesting (MIVH), but all necessitate traction on the LSV to maximize 
surgical visibility and enable side branch ligation (Aziz et al. 2006; Aziz et al. 2005; 
Nickum  2005; Yun et al. 2005; Cook et al. 2004; Bitondo et al. 2002; Carpino et al. 
2002; Kiaii et al, 2002; Griffith et al. 2000; M eyer et al. 2000). Excessive surgical 
manipulation o f  saphenous vein impairs endothelial cell function and reduces the 
bioavailability o f  N O  (Lawrie et al. 1990; Angelini et al. 1989; Bush et al. 1986). 
Light m icroscopy and scanning and transm ission electron m icroscopy have been used 
to compare the histological quality o f the LSV conduit w ith M IVH versus TOVH and
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found no significant difference between veins harvested using the two techniques 
(Bonde et al. 2004; Bonde et al. 2002; Lamm et al. 2002; Kiaii B, et al. 2002; Alrawi 
et al. 2001; Fabricius et al. 2000; Griffith et al. 2000; M eyer et ai. 2000; Fabricius et 
al. 2000; Lancey et al. 2001). However, concerns remain, that m inim ally invasive 
m anipulation o f the LSV graft could traum atise the functional integrity o f  the 
harvested and prepared LSV and compromise immediate and long-term graft patency 
(Cook et al. 2004; B lack et al. 2001).
3.1.1 Hypothesis
LSV harvested from patients undergoing CABG by TO V H  have better 
calcium ionophore A23187 mediated relaxation than LSV harvested by M IVH.
3.1.2 Aim
To com pare calcium ionophore A23187 m ediated relaxation in LSV harvested 
by TOVH and M IV H techniques.
3.1.3 Experim ental Approach
Endothelium -dependent relaxation to calcium ionophore A23187 and 
endothelium -independent relaxation to sodium nitroprusside will be determined in 
organ baths in rings o f  LSV from patients undergoing CABG by TOVH and MIVH 
techniques.
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3.2 M ETHODS
3.2.1 Patient selection and characteristics
Thirty-one consecutive patients scheduled for elective first tim e CABG at the 
Departm ent o f  Cardiothoracic Surgery, Glasgow Royal Infirmary w ere recruited into 
the study. Study participants had isolated CAD that required at least part o f  their 
revascularisation to be done using the LSV. Exclusion criteria included patients 
undergoing emergency CABG (M IVH equipm ent was electively ordered) and those 
with severe varicose veins. The consultant cardiac surgeons (Udim N kere and Andrew 
M urday) would choose radial artery in preference to severe varicose veins as the 
mismatch in diam eter between the coronary artery recipient (1-3 mm) and varicose 
veins (~1 cm) would give a poor anastomosis. The study was approved by the Local 
Research and Ethics Board at Glasgow Royal Infirmary. Before enrolm ent and 
randomisation each participant provided written informed consent.
3.2.2 Power calculations
Pilot data from 19 patients undergoing CABG with TOVH at the Glasgow 
Royal Infirmary (Age 59-72) demonstrated that after precontraction o f  LSV rings with 
phenylephrine (3 pm ol/l), calcium ionophore A23187 (10 pm ol/L) mediated 
vasorelaxation was 20.9%  ± 3 . 1  % (mean ±  standard deviation). Based on a study 
with 90% power at a level o f  significance o f  p < 0.01, it is estimated that to identity a 
difference o f  1.5 standard deviations from the mean in M IVH patients by a 2-sample 
t-test 15 TOVH patients and 15 M IVH patients would be required. To detect the same 
difference in vasorelaxation with 80% power, 12 patients would be required and 
hence we would conservatively aim to recruit 15 TOVH patients and 15 MIVH 
patients.
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Table 3.1 Power calculations. This table illustrates the power calculations used 
and from it 15 individuals per group would give us at least 90%  power at a level o f 
significance o f  p < 0.01 to detect differences as small as 1.5 standard deviations. We 
thus would seek to recruit between 15 and 20 TOVH and M IVH patients to ensure 
that the study is adequately powered.
Difference in multiples o f  
standard deviations
Num ber o f  Patients Required 
Per Group for Power
Pow er
1.0 25 80%
1.0 29 85%
1.0 34 90%
1.5 12 80%
1.5 13 85%
1.5 15 90%
2.0 7 80%
2.0 8 85%
2.0 9 90%
2.5 5 80%
2.5 5 85%
2.5 6 90%
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In the only study to show a difference in vasodilation in M IVH patients and 
TOVH patients, there was no net relaxation in LSV rings from M IVH group after 
exposure to 10 pniol/L acetylcholine (Cook et al. 2004). In contrast, rings from the 
TOVH group dem onstrated relaxation o f  -0.32 ±  0.09 g after exposure to 10 pmol/L 
acetylcholine (Cook et al. 2004). Hence our aim to detect a difference o f  1.5 standard 
deviations in vasodilation is an appropriate one.
3.2.3 Surgical techniques
Two consultant cardiac surgeons (Udim Nkere and Andrew  M urday) carried 
out all o f  the operative procedures reported in this study.
3.2.3.1 Trad itional open technique for LSV harvest
The incision was com m enced ju st above the medial malleolus. The vein was 
identified and cleared o f  all adventitia and connective tissue using sharp and blunt 
dissection. The skin was incised over the whole length o f  the vein to the required 
length and careful dissection was used to isolate the vein in situ, w ith attention given 
to avoid unnecessary traum a to the vein or its tributaries. Side branches were ligated 
with 4/0 ethibond ligatures on the vein side and metal clips on the patient side. The 
leg wound was closed in layers and a full length pressure dressing was applied.
3.2.3.2 M in im al invasive technique for LSV harvest
A 2 cm longitudinal incision was made above the medial m alleolus. The LSV 
was identified and cleared o f  all adventitial and connective tissue using sharp 
dissection. The distal end o f  vein was tied. The proximal part was also tied and about 
6-8  cm o f thread was left with that end. The vein was then divided between the two
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tied ends. The end w ith a thread was passed through the ring in the M ayo vein stripper 
and forward pressure was applied to the vein stripper in the direction o f  usual vein 
anatomy while applying traction on the vein through the length o f  thread. W henever 
resistance was felt on the vein stripper, a small incision (2 to 3 cm) at the area where 
resistance was felt was made. W ith a combination o f  sharp and blunt dissection any 
branch o f the LSV at that site was isolated and ligated using a 4/0 ethibond ligature on 
the vein side and a metal clip on the patient side. The same process was repeated with 
multiple short incisions until the required length o f  vein was obtained. The skin 
incisions were closed with skin staples and full length pressure dressing applied.
In com m on to both techniques o f  harvest, the vein was inflated with 
heparinised blood to check for any unidentified side branches or tears in the vein. 
Any that were identified were either ligated with a 4-0 ethibond suture or closed with 
a 6-0 prolene suture.
3.2.4 M in im isation
Random isation is the most effective and efficient method to remove selection 
bias between two groups o f  patients (Pocock 1983). The prim ary objective o f 
randomisation is to ensure that all other factors that might influence the outcome will 
be equally represented in the two groups, leaving the treatment under test as the only 
dissimilarity (Pocock 1983).
Supposing one group has more elderly wom en with diabetes and symptoms o f 
heart failure. It would then be impossible to attribute a better outcom e in the other 
group to the beneficial effects o f  treatm ent since poor left ventricular function and age 
at outset are m ajor determ inants o f  survival in any longitudinal study o f  heart disease,
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and wom en with diabetes, as a group, are likely to do worse. A t this point the primai-y 
objective o f  randomisation, exclusion o f  confounding factors, has failed.
The w ay to avoid this is by minimisation. It was first described by Taves 
(1974) and shortly after by Pocock and Simon (1975) and Freedman and White 
(1976). W ith this method the group allocation does not rely solely on chance but is 
designed to reduce any difference in the distribution o f  known or suspected 
determ inants o f  outcome, so that any effect can be attributed to the treatm ent under 
test (Treasure and M acRae). The trialists determine at the outset which factors they 
would like to see equally represented in the two groups (Treasure and M acRae).
At the point w hen it is decided that a patient is definitely to enter a trial, these 
factors are listed. The treatm ent allocation is then made, not purely by chance, but by 
determining in which group inclusion o f  the patient would minim ise any differences in 
these factors. Thus, if  group A  has a higher average age and a disproportionate 
number o f  females, other things being equal, the next elderly female is likely to be 
allocated to group B. The allocation may rely on m inimisation alone, or still involve 
chance but "with the dice loaded" in favour o f  the allocation which minimises the 
differences. The theoretical validity o f  the method o f  m inim isation was shown by 
Smith (1984). Recent examples o f the use o f minimisation are found in Cape 11 et al. 
(2007), Houslay et al. (2006), Struijs et al. (2006) and Robinson et al. (2006).
In this study the following patient characteristics were employed for 
minimization: age, gender, diabetes m ellitus and peripheral vascular disease.
3.2.5 Vascular reactivity o f veins
LSV segm ents that were surplus to CABG requirem ents were collected from 
the operating theatre and placed in ice-cold Krebs /  HEPES buffer-solution on ice and
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immediately taken to the laboratory. All rings were stored in Krebs-Hepes solution 
overnight at 4°C for study the next day, 3 mm long rings o f vein were studied in organ 
chambers according to m ethods described in Chapter 2. Vessels were constricted with 
phenylephrine (3 pmol/l), a relative ai-selective adrenoreceptor agonist which has (3- 
adrenergic effects at high doses. Endothelium -dependent relaxation was evaluated by 
cumulative addition o f  calcium ionophore A23187 (0.1 - 10 pmol/L) and endothelial- 
independent relaxation was evaluated by cumulative addition o f  sodium nitroprusside 
(0.001 - 0.1 pmol/L). The LSV taken and prepared traditionally, served as a control 
group. No patient from M IVH group was converted to the traditional open technique. 
Relaxation was expressed as a % o f  the constriction to phenylephrine.
3.2.6 Statistical analyses
W hen the com parison was made between M IVH veins and TOVH veins, 
statistical analysis o f  maxim al vasorelaxation was undertaken using unpaired 
Student's t test. A  probability value o f  less than 0.05 was considered statistically 
significant. Results are shown as means ± SEM.
3.3 RESULTS
3.3.1 Patient characteristics
The study population consisted o f  31 consecutive patients w ith CAD who 
underwent elective CABG at the Glasgow Royal Infirmaiy from Septem ber 2002 until 
M arch 2003. Two patients who died within the first 48 hours were excluded from 
further analysis on the instructions o f  the consultant cardiac surgeons. Clinical 
variables known to be im portant in vascular function were recorded. D ata on age, sex, 
risk factors, and drug therapy are given in Table 3.2. Patient age ranged from 53 to 79
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years. 100 % o f  patients had > I risk factor for CAD, and 100 % o f  patients were on > 
1 types o f  anti-anginal therapy. The TOVH and M IVH groups were closely matched 
in demographics (Table 3.2). There were no statistical significant differences between 
the patient characteristics.
3.3.2 Iiitra-operative F indings
The total operative time taken to harvest vein was divided into 3 parts; stage 1: 
start o f  skin incision to removal o f  vein, stage 2: incision closure and stage 3: vein 
preparation. Adding the 3 gives the total vein operation time (Table 3.3).
Table 3.3 dem onstrates that M IVH was significantly quicker than TOVH, 
whilst requiring no increase in the time required to prepare the vein. Time was saved 
both during removal o f  the vein and during skin closure. There was no statistically 
significant difference in length o f  vein harvested but as expected total wound length 
and num ber o f  incisions were significantly reduced in M IVH (Table 3.3).
3.3.3 Endothelial-dependent relaxations to calcium ionophore A23187
A fter contraction induced by phenylephrine (3 pmol/L), the NO-dependent 
endothelial vasodilator calcium ionophore A 23I87  (0.1 -  10 pm ol/L) caused similar 
endothelial-dependent relaxations in TOVH (n = 14) and M IVH groups (n = 15) 
(calcium ionophore A23187, 10 pmol/L; 18.4 ± 1.9 % versus 17.6 ±  1.9 % 
respectively; p = 0.446, C l -5.4 % - 2.4 %) (Figure 3.1).
3.3.4 Endothelial-independent relaxations to sodium n itroprusside
A fter contraction induced by phenylephrine (3 pmol/L), the N O  donor sodium 
nitroprusside (0.001 - O .lpm ol/L) caused sim ilar endothelial-independent relaxations
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in relaxations in TOVH (n = 14) and M IVH groups (n = 15) (sodium nitroprusside, 
O.I pmol/L; 37.6 ±  3.2 % versus 40.1 ± 3.4 % respectively; p = 0.647, C l -7.4 % - 1.4 
%) (Figure 3.2).
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Table 3,2 General characteristics o f the TOVH and MIVH study groups.
Variables TOVH M IVH
Num ber 14 15
Age, y 62 ± 6 61 3=4
Gender (M/F) 9 / 5 1 0 / 5
Body M ass Index 31±7 303=6
Systolic B lood Pressure, mmHg 1363=4 1373=4
Diastolic Blood Pressure, m m Hg 863=4 853=4
Total cholesterol, mmoI/L 5.7 3=0.7 5.9 3= 1.2
Diabetes mellitus, % 14 13
Smokers % (active / stopped /  none) 8 / 3 / 3 8 / 4 / 3
Peripheral vascular disease % 14 13
ACE inhibitor/ARB medication, % 29 20
New York Health Association class (I / II /  III / IV) 0 / 2 / 4 / 8 0 / 2 / 6 / 7
Aspirin % 100 100
Beta Blockers % 57 67
Calcium Channel Antagonists % 57 60
Insulin (%) 7 7
Oral hypoglycaem ics (%) 7 7
Nitrate % 57 60
Statin medication, % 50 47
Results are shown as mean ±  SEM  or %.
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Table 3.3 Intra-operative data on the TOVH and MIVH study groups.
T O V H
11 = 14
M IV H  
n = 15
P
Cardiopulm onary bypass time (min: mean ± SEM) 85 ± 2 .9 78 ± 1.9 0.471
Theatre time (min: mean ± SEM) 200 ± 4 .0 192 ± 3 .0 0.722
Vein harvest site:
C alf only 35 35
C alf and thigh 3 4
Total no o f  grafts (mean + SEM) 3.3 ± 0 .2 3.2 ± 0 .1 0.342
No o f  vein grafts (mean ± SEM) 1.9 ± 0 .2 ) 1 .6 ± 0 .1 0.302
Length o f  vein harvested (cm: mean ± SEM) 31 ±3.5 25 ± 2 .3 0.018
Length o f  wound (cm: mean ± SEM) 35 ±3.5 16 ± 1.5 <0.001
Num ber o f  incisions (mean ± SEM) 1.2 ±0.1 6.9 ± 0 .7 <0.001
Vein harvest time
(min; median + interquartile range)
Stage I 1 6 ±  10 11 ± 14 O.OI
Stage 2 9 ± 6 2 ±  1 <0.001
Stage 3 2 ± 2 2 ± 4 0.513
Total 2 6 ±  16 15 ± 2 2 0.002
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F igure 3.1 Vasorelaxation to calcium ionophore A23187 in rings o f  LSV from 
TOVH (n = 14) and M IVH (n = 15) patients. The x-axis is on a 
logarithmic scale. O  TOVH #  M IVH
Results are shown as mean ± SEM.
There was no significant difference in relaxation mediated by calcium 
ionophore A23187 between TOVH and MIVH groups were noted using 
unpaired t-tests.
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Figure 3.2 Vasorelaxation to sodium nitroprusside in rings o f  LSV from TOVH (n = 
14) and M IVH (n = 15) patients. The x-axis is on a logarithmic scale. 
O T O V H  #  MIVH 
Results are shown as mean ± SEM.
There was no significant difference in relaxation mediated by sodium 
nitroprusside between TOVH and MIVH groups were noted using unpaired 
t-tests.
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3.4 DISCUSSION
The study dem onstrates sim ilar endothelial-dependent and -independent 
relaxation o f  LSV harvested by minim ally invasive and traditional open techniques 
and proposes that concerns over surgical traum a may be exaggerated. There was no 
difference in vascular function between these two groups o f  segments. W ithin the 
limitations o f  our experim ental set-up, the results were surprising, as the mechanical 
force applied to veins prepared by M IVH seemed to be higher than in the TOVH 
group.
The data from this study are concordant w ith the observations o f five studies 
who found no significant differences in the vascular reactivity o f  LSV harvested by 
traditional open or minim ally invasive techniques (Black et al. 2001; Fabricius et al. 
2000a; Rinia-Feenstra et al. 2000; O 'R egan et al. 1997). In contrast, Cook et al. 
(2004) found significantly impaired acetylcholine-mediated endothelium-dependent 
relaxation in LSV segm ents isolated using a minim ally invasive technique compared 
to traditional open technique.
A functional method was used to evaluate and compare the viability o f  the 
LSV used in CABG operations harvested by m eans o f M IVH and TOVH because the 
presence o f an intact wall, as obtained by means o f  m orphologic studies, does not 
necessarily imply norm al function o f  the tissue. As loss o f  endothelial function is a 
highly sensitive indicator o f  vascular injury, this study sought to evaluate responses in 
LSV rings to endothelial-dependent relaxation.
These results dem onstrate no evidence that the m anipulation o f  the LSV, 
consequent upon using the M ayo stripper, affected functional traum a to both 
endothelial-dependent and -independent function any more than the traditional open 
harvest method. In order to eliminate the effect o f  surgical expertise, the study used 2
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very experienced surgeons who were equally comfortable with either technique to 
carry out all o f the vein harvesting. However, there is no reason why the less invasive 
technique cannot be taught to surgical trainees and surgical assistants, or why they 
should not be able to carry it out to an equally high standard. These data indicate that 
M IVH veins should perform as well as TOVH veins.
In this random ised study it was found that compared to the traditional open 
method o f  harvesting LSV, a less invasive technique em ploying a M ayo vein stripper 
was quicker. There are other instruments available but the M ayo stripper has the 
advantage o f  being reusable and is therefore less expensive than disposable devices.
As the surgeons’ practice is to use the left IM A and usually a radial artery as 
the conduits o f  choice, the num ber o f  vein grafts per patient in this study is an average 
o f 1.7 per patient. This m eans that the m ajority o f  patients only have vein harvested 
from the calf rather than the thigh. The practice o f these two surgeons is to 
commence vein harvesting at the ankle whereas others commence at the groin. This 
study cannot necessarily extrapolate its findings to those who choose such a practice.
This study has several noteworthy limitations that m ight influence 
interpretation o f  results. The num ber o f  patients and therefore the num ber o f LSV 
samples is relatively small and statistical power is thereby limited. Although a type II 
error may be present w ith the small sample size in the present study, the similarity in 
the two groups suggests a larger sample size would, at most, only detect a small 
difference that, although interesting, would not likely be clinically relevant. Also, 
sampling only two rings from harvested veins may miss areas o f  injury at other sites 
within the vein. Finally, although significant functional differences were not seen, 
more studies evaluating clinical outcomes are necessary to further evaluate the 
importance o f preservation o f  endothelial function and to determ ine whether MIVH
113
has an effect on patency rates o f LSV grafts used in CABG surgery, For long-term 
quality control, post-operative assessment o f  graft patency by angiography m ay give 
further insight into possible differences between conventional and minim ally invasive 
harvesting techniques.
Extrapolations from the results o f  this study to the in vivo situation must be 
made with caution, as additional factors may cause endothelial injury o f  vein grafts, 
aside from harvest trauma. These factors include high-pressure distention, 
nonphysiologic pH  o f  the preservation solution, and transient loss o f  luminal flow 
with resultant ischemia (Dashwood and Loesch 2007; Dashwood et al. 2007; Souza et 
al. 2006; Dashwood et al. 2005; Perrault et al. 2005; A lam anni et al. 2002; Lin et al. 
2001; Sessa et al. 2001; O ’Regan et al. 1997; Soyombo et al. 1993; Dilley et al. 1988; 
Angelini et al. 1987b; Unni et al. 1974). The present study did not examine all o f 
these variables as the purpose was limited to comparison o f  injury to endothelium- 
dependent function.
In this study, the cardiac surgeons at Glasgow Royal Infirm aiy inflated the 
LSV to check for any unidentified side branches or tears in the vein. Manual 
distension o f  the LSV changes its biomechanical properties (Zhao et al. 2006); it can 
structurally and functionally damage the endothelium (Chello et al. 2003; Johnson et 
al. 2001; Thatte and Khuri 2001; M ills and Everson 1995; Chester et al. 1998; Sayers 
et al. 1992; Dhein et al. 1991; Angelini et al. 1989; Angelini et al. 1987a; Angelini et 
al. 1987b; Angelini et al. 1987c; Svendsen et al. 1986; Hasse et al. 1981; Bonchek et 
al. 1980), smooth muscle (Cornelissen et al. 2004; O ’Brien et al. 1998; Angelini et al. 
1987b; Angelini et al. 1987c; George et al. 1997; Angelini et al. 1985), and 
interstitium (Kennedy et al. 1989a and Kennedy et al. 1989b). The patients in chapters 
4, 5 and 6, had operations by a different set o f  cardiac surgeons at a different hospital,
114
the W estern Infirm ary Glasgow, from the patients in this chapter. Importantly, the 
LSV studied in chapters 5 and 6 was not distended prior to study. Therefore the 
patients in this chapter were not included in further studies.
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Chapter 4
Effect of IMA pedicle width harvested by monopolar 
electrocautery on calcium ionophore A23187 mediated 
relaxation of IMA obtained from CABG patients
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4.1 INTRODUCTION
During CABG, the IM A is traditionally harvested as a pedicle together with 
concomitant veins, lymphatics, sympathetic plexus and internal thoracic fascia (De)a 
et al. 2005). In contem porary cardiac surgical practice, however, certain surgeons 
practice the IM A skeletonisation technique. (Deja et al. 2005; Raja and Dreyfus 
2005). Skeletonisation involves harvest o f  only the IMA without adventitia or any 
other surrounding tissue (Deja et al. 2005; Raja and Dreyfus 2005).
Skeletonisation o f  the IMA has been proposed as a solution to many o f  the 
problems associated with IM A harvesting (Deja et al. 2005; Raja and Dreyfus 2005; 
Athanasiou et al. 2004). The skeletonisation technique allows for longer availability 
o f the graft (Deja et al. 1999), hence opportunity for more distal coronary artery 
anastomoses and easier sequential grafting (Raja and Dreyfus 2005). The increased 
early blood flow through the skeletonised IM A (Takami et al. 2002) has been implied 
as a factor to decrease the risk o f  hypoperfusion syndrome (Takami and Ina 2002). 
Also, chest wall injury is minimized, sternal blood supply is preserved, the sternal 
infection rate is decreased (De Paulis et al. 2005; Cohen et al. 1999), pain is reduced 
and there is better postoperative respiratory function (Boodhwani et al. 2006; Peterson 
et al. 2003; M atsum oto et al. 1997).
Despite these advantages, skeletonisation is time consuming, technically more 
dem anding and may theoretically induce mechanical and physical dam age to the 
vessel wall (Deja et al. 2005; Raja and Dreyfus 2005; Athanasiou et al. 2004; Ueda et 
al. 2003). This may result in detrimental effects on the functional integrity o f  the IMA 
(Deja et al. 2005; Raja and Dreyfus 2005; Athanasiou et al. 2004; Ueda et al, 2003).
Skeletonisation and narrow pedicles may injure IMA, precluding good results 
o f  surgery and Cunningham  (1996) and Yacoub (1996) suggested that avoiding the
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use o f electrocautery near the IM A can prevent or minimize endothelial dysfunction. 
Although a w ider pedicle m ay minimise the damage done to the endothelium, 
physiological studies to verify this are lacking (M atsumoto et al. 2006).
4.1.1 H ypothesis
The width o f pedicles harvested by m onopolar electrocautery influences 
calcium ionophore A23187 mediated relaxation o f IM A harvested from patients 
undergoing CABG.
4.1.2 Aim
To determ ine the effect o f  pedicle width on calcium ionophore A23187 
m ediated relaxation o f  IM A harvested by m onopolar electrocautery from patients 
undergoing CABG.
4.1.3 Experim ental approach
1 ) IM A pedicle w idth and IM A diam eter will be determined post harvest.
2) Relaxation to calcium ionophore A23187 (endothelium -dependent
vasodilatator) and sodium nitroprusside (endothelium -independent 
vasodilatator) will be determined in IM A from patients undergoing CABG.
3) Cardiovascular risk factors (age, sex, body m ass index, current active
smoking, diabetes m ellitus status, diastolic blood pressure, total cholesterol) 
and current drug therapy will be recorded.
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4.2 METHODS
4.2.1 Study population
Between April 2001 and Januaty 2004, 264 patients undergoing elective 
CABG were prospectively recruited from the W estern Infirmary Glasgow. At 
admission a careful clinical history was taken. Total cholesterol level was obtained 
from reviewing the medical record o f each patient for the m ost recent result, as 
described by Raggi et al. (2004). The general characteristics o f  the study population 
are summarised in Table 4.1.
4.2.2 Surgical technique
At the W estern Infirmaiy Glasgow, the IMA is harvested as a pedicle with its 
venae com m itantes from the thoracic wall by a no-touch technique, leaving the 
vessels in their anatom ic environm ent surrounded by internal thoracic fascia. The 
internal thoracic fascia is incised with conventional m onopolar high frequency 
electrocautery along both sides o f the IM A approximately 0.5 -1.0 cm aw ay from the 
concomitant veins. The flap o f  fascia, muscle, and fat tissue containing the IM A with 
concomitant veins is dissected with electrocautery, working from its distal to proximal 
end. The m ajor IM A branches are ligated with metal clips and the m inor branches are 
electrocoagulated w ith electrocautery.
The discarded distal end ( 1 - 2  cm) o f  the IM A was carefully removed and 
placed in ice-cold Krebs/HEPES buffer-solution on ice, and immediately taken to the 
laboratory. Since the use o f the vessels was at the discretion o f  the cardiothoracic 
surgeon, it was not possible to select patients in advance. There were, therefore, no 
specific exclusion criteria.
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4.2.3 Laboratory methods
The width o f  the pedicle was measured perpendicular to the course o f  the IMA 
using a theatre ruler (Vicarey, Davidson & Company Limited, Glasgow, United 
Kingdom). The loose connective tissue was carefully removed under a light source 
using fixed position, through-the-lens surgical telescopes (3.5x; Designs for Vision, 
Ronkonkoma, N ew  York, U nited States o f  America) and fine surgical grade 
instruments (M ercian Basic M icro Instrum ent Set B M S-I; M ercian Surgical Supply 
Co Ltd, Birmingham, United Kingdom) leaving the adventitia in situ. The vessel was 
straightened out by slightly stretching and pinning at either end before cutting 2 mm 
long rings o f IM A with a Sw ann-M oiton surgical steel disposable scalpel (LIG 
Supplies Ltd., Cambridge, United Kingdom). All rings were stored in Kiebs-Hepes 
solution overnight at 4°C for study the next day. The next day the diam eter o f the 
IMA rings was recorded using a caliper ruler (Vicarey, Davidson & Company 
Limited, Glasgow, United Kingdom).
4.2.4 Vascular reactivity o f IM A
2 mm long rings o f  IM A were studied in organ chambers according to 
methods described in Chapter 2, Vessels were constricted with phenylephrine (3 
pmol/L) and relaxations to calcium ionophore A23187 (0.01 - 10 pm ol/L) and sodium 
nitroprusside (0.01-10 pm m ol/L) examined. Relaxation was expressed as a % o f the 
constriction to phenylephrine.
4.2.5 Statistical Analysis
To investigate which risk factors were related to vasorelaxation m ultiple linear 
regression analysis was perform ed using data from the 264 CABG patients and
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estimated effects, 95% confidence intervals (Cl), and p values were tabulated. 
M ultiple correlation coefficients were calculated as an overall m easure o f  the 
relationship between risk factors and the dependent parameter - vasorelaxation to 
calcium ionophore A23187 (10 pmol/L). The m ultiple linear regression analysis 
included the following risk variables in the model: age in years; sex (0 = female, 1 = 
male); diastolic blood pressure (mmHg); tobacco smoking status (0 = non-smokers 
and ex-smokers o f  more than 30 days, 1 = current smoker); diabetes mellitus (0 = 
non-diabetes mellitus, 1 = on antidiabetic medication); body m ass index (kg/m^); 
blood levels o f  total cholesterol (mmol/L); statin therapy (0 = no therapy, 1 = on 
therapy) and ACE inhibitor / ARB therapy (0 = no therapy, 1 = on therapy). When 
risk factors were known to be interdependent, such as systolic and diastolic blood 
pressure, only one risk factor was included in the analysis. Note that quantitative 
variables, for example smoking status, were included as factors in the analysis. Linear 
relationships have been assumed between all continuous variables and outcomes. 
Normal distribution o f  data was examined by the Kolm ogorov-Sm irnov test. 
Coefficients and their confidence intervals indicate the estim ated proportional 
increase in vasorelaxation to calcium ionophore A23187 (10 pm ol/L) (the dependent 
parameter in the multivariate linear regression analysis) associated with a unit 
increase in the predictor. Where appropriate, Pearson correlation coefficients 
coefficients are displayed. Statistical analysis was perform ed using the statistical 
package M INITAB, version 13.1 (M initab Inc, State College, Pennsylvania, United 
States o f  America). Results are shown as mean ± SEM (standard error o f  the mean) 
and p < 0.05 was considered statistically significant.
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4.3 RESULTS
4.3.1 Patient characteristics
Demographics and clinical characteristics o f the patients are shown in Table 
4.1. The age range was 38 - 87 years. The high male to female ratio in Table 4.1 is a 
combined result o f local referral patterns and insufficient vascular tissue left after 
CABG in women.
4.3.2 Vascular reactivity
For the rings used in the study, maximal calcium ionophore A23187 mediated 
relaxation (10 pm ol/L) was 62.2 ±  1.1 % (mean ±  SEM) (Figure 4.1) and maximal 
endothelium -independent relaxation to sodium nitroprusside (10 pm ol/L) was 76.5 ±
1.2 % (mean ±  SEM) (Figure 4.2).
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Table 4.1 General demographics of the study population.
Variables CABO
N 264
Age (y) 63 ± 2
Gender (M / F) 1 5 5 /5 6
Body M ass Index 28.0 ± 0 .3
Blood pressure, mmHg 135.1 ± 1 .2 /8 7  ± 0 .5
Total cholesterol, mmol/L 5.7 ± 0 .7
Fam ily history CAD (%) 43.6
Peripheral vascular disease (%) 12.2
Cerebrovascular disease (%) 6.1
Diabetes mellitus (%) 13.6
Currently smoke (%) 52.7
ACE inhibitor / ARB m edication (%) 40.5
Statin medication (%) 68.5
Values shown are means ±  SEM or %.
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F igure 4.1 Vasorelaxation to calcium ionophore in rings o f  IM A from patients 
undergoing CA BG (n = 264). The x-axis is on a logarithmic scale. 
Results are shown as mean ± SEM.
M axim al calcium  ionophore A23187 mediated relaxation (10 pmol/L) 
was 62.2 ± 1.1 % (mean ± SEM).
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F igure 4.2 Vasorelaxation to sodium nitroprusside in rings o f  IM A from patients 
undergoing CABG (n = 264). The x-axis is on a logarithmic scale. 
Results are shown as mean ±  SEM.
M axim al sodium nitroprusside m ediated relaxation (10 pmol/L) was
76.5 ±  1.2 % (mean ±  SEM).
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4.3.3 R isk factor analysis
M ultiple regression analysis using IM A pedicle width and cardiovascular risk 
factors that could be related to endothelial dysfunction was conducted on the CABG 
population studied (n = 264).
The analysis identified IM A pedicle width as a highly significant predictor o f  
calcium ionophore A23187 mediated relaxation in the CABG patients (|3 coefficient,
0.79 per mm; p < 0.001). Total cholesterol level was also a significant determinant o f 
calcium ionophore A 23187 mediated relaxation in the CABG patients (P coefficient - 
2.90 per mmol/L; p = 0.035). There was no evidence that age, sex, body mass index, 
blood pressure, diabetes status, statin, and angiotensin-converting enzyme inhibitor 
therapy contributed to calcium ionophore A23187 mediated relaxation (Table 4.2). 
Tendencies to relationships between age and calcium ionophore A23187 mediated 
relaxation (p = 0.07) and statin therapy and calcium ionophore A 23187 mediated 
relaxation (p = 0.092) were observed although these were not statistically significant 
(Table 4.2). Overall the model was able to account for 13.4 % o f the variation in 
calcium ionophore A23187 mediated relaxation in the CABG patients (coefficient o f 
determination) (Table 4.2).
Thus, a significant positive correlation between IM A pedicle width and a 
marker o f  endothelial function was observed (Table 4.2; Figure 4.3) and IM A pedicle 
width correlated directly to calcium  ionophore A23187 mediated relaxation (IMA 
pedicle width versus calcium ionophore A23187 mediated relaxation: p = < 0.001) 
(Figure 4.3). Also, a negative correlation between total cholesterol and calcium 
ionophore A23187 m ediated relaxation was observed (Table 4.2; Figure 4.4). 
However total cholesterol did not significantly correlate directly to calcium  ionophore
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A23187 mediated relaxation (total cholesterol versus calcium ionophore A23187 
m ediated relaxation: p = 0.077) (Figure 4.4).
There was no significant relationship between IM A pedicle width and 
endothelium -independent relaxation to sodium nitroprusside (10 pm ol/L) (n = 264, p 
= 0.440) (Figure 4.5). There was no significant relationship between calcium 
ionophore A23187 m ediated relaxation and IMA diameter (n = 264, p = 0.743) 
(Figure 4.6).
At follow up after a m edian o f 32 months (range 1 9 - 5 1  months), none o f 
these patients showed evidence o f mediastiiiitis, deep sternal infection or sternal 
wound dehiscence.
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Table 4.2 Analysis o f variance p-values for the null hypothesis of no 
relationship between risk factors and calcium ionophore A23187 
(10 pmoI/L) mediated relaxation o f IM A in CABG patients.
Variable Calcium
P
ionophore (n=264) 
p coefficient
(95% confidence intervals)
Age (10 years) 0.073 -0.17 ( -0 .3 6 -0 .0 1 )
Sex (0=F, 1=M) 0.210 2.94 (-1 .6 4 -7 .5 3 )
Body M ass Index (kg/m^) 0.325 0.29 (-0.29 -  0.87)
IM A pedicle width (mm) <0.001 0.79 (0 .4 0 -  1.19)
Current Active Smoking (0=no, l=yes) 0.851 -0.40 (-4 .5 3 -3 .7 3 )
Diabetes M ellitus (0=no, l=yes) 0.657 1.38 (-04.71 -7 .4 8 )
Diastolic Blood Pressure (lOmmM g) 0.641 0.06 ( -0 .1 8 -0 .3 0 )
Total Cholesterol (mmol/L) 0.035 -2.90 (-5.57 - -0.22)
Angiotensin Converting Enzyme Inhibitor (0=no, l=yes) 0.342 2.01 ( -2 .1 2 -6 .1 3 )
Statin (0=no, M yes) 0.092 3.87 ( -0 .6 2 -8 .7 3 )
This analysis identified pedicle width (p coefficient 0.79 per mm, p < 0.001) and total 
cholesterol (P coefficient -2.90 per mmol/L; p = 0.035) as significant predictors o f  
calcium ionophore A23187 m ediated relaxation o f  IM A from CABG patients. There 
was no evidence that age, sex, body mass index, current active smoking, diabetes 
mellitus status, diastolic blood pressure, angiotensin-converting enzyme inhibitor 
therapy or statin therapy contributed to ealcium ionophore A23187 mediated 
relaxation. Overall the m odel was only able to account for 13.4% o f  the variation in 
relaxation (coefficient o f  determination).
The P coefficients indicate the estimated proportional increase in calcium ionophore 
A23187 mediated relaxation with a unit increase in the predictor.
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Figure 4.3 Scatter plots o f  IMA pedicle width (mm) and calcium ionophore 
A23187 (10 jimol/L) mediated relaxation o f IMA (n = 264).
Pearson correlation coefficient (r) and p-value are shown in the figure. 
This scatter plot shows a significant correlation between pedicle width 
(mm) and calcium ionophore A23187 (10 pmol/L) mediated relaxation 
o f IMA (p < 0.001, r = 0.281).
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Figure 4.4 Scatter plots o f  total cholesterol concentration and calcium ionophore 
A23187 (10 pmol/L) mediated relaxation o f IMA (n = 264).
Pearson correlation coefficient (r) and p-value are shown in the figure. 
This scatter plot shows no significant correlation between total- 
cholesterol and calcium ionophore A23187 (10 pmol/L) mediated 
relaxation o f IMA (p = 0.077, r = -0.109).
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F igure 4.5 Scatter plots o f  IMA pedicle width (mm) and sodium nitroprusside (10 
pmol/L) mediated relaxation o f IMA (n = 264).
Pearson correlation coefficient (r) and p-value are shown in the figure. 
This scatter plot shows no significant correlation between pedicle 
width and sodium nitroprusside (10 pmol/L) mediated relaxation o f  
IMA (p = 0.077, r = -0.287).
131
N00
CO
9
2O
Q .
ED"u(DüO
C0
1  (0
(Dû:
90
80
70
60
50
40
30
20
10
1.5
I i
2.0 2.5 
[IMA diameter] (mm)
I
##
#
i
#
# i
r = -0.037 
p = 0.544
3.0
Figure 4.6 Scatter plots o f  IMA diameter (mm) and calcium ionophore A 23187 
(10 pmol/L) mediated relaxation o f  IMA (n = 264).
Pearson correlation coefficient (r) and p-value are shown in the figure. 
This scatter plot shows no significant correlation between IMA 
diameter and calcium ionophore A 23I87 (10 pmoI/L) mediated 
relaxation o f IMA (p = 0.544, r = -0.037).
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4.4 DISCUSSION
4.4.1 Pedicle width and endothelium -dependent fnnction
This study has dem onstrated the predominant role o f  IM A pedicle width in 
determining calcium ionophore A23187 mediated relaxation o f  IM A in patients 
undergoing CABG. This study also showed a significant positive correlation between 
IMA pedicle width and calcium  ionophore A23187 mediated relaxation o f IMA 
m aintained across the whole range o f  IM A pedicle widths.
This is the first study investigating IM A endothelial function demonstrating 
that a w ider pedicle harvested with monopolar electrocauteiy preserves NO-dependent 
endothelial function. N O  synthesised by healthy intact endothelium has a plethora o f 
roles in m aintaining vessel patency (Simionescu 2007; Y etik-Anacak and Catravas 
2006; Félétou and Vanhoutte 2006; M oncada and Higgs 2006; Herm an and M oncada 
2005). Dissection o f  the IM A with a narrower pedicle may theoretically induce 
mechanical and physical dam age to the vessel wall and result in detrimental effects on 
the functional integrity o f  the IM A (Ueda et al. 2003; Cunningham 1996).
Electrocautery means heating through radiofrequency electric current; heat is 
generated by passing this current through the tissues (Morris and M alt 1994). With 
m onopolar electrocautery the current is passed through a large volum e o f  tissue from 
an “ indifferent” electrode o f  comparatively large surface area w hich is in good 
electrical contact with a large area o f the body and the current then passes through an 
active electrode o f  very small contact surface, which is under control o f  the surgeon 
(Morris and M alt 1994). A very low current density is therefore passed through most 
o f  the body, but at the point o f  contact between the electrode and the tissues the 
current density is very high, and therefore has a large heating effect (Patricelli et ai. 
2001; M orris and M alt 1994). Tissue temperatures in o f  up to 129.5 °C  have been
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measured 5 mm from monopolar electrode placem ent (Patricelli et al. 2001) and tissue 
charring and vaporisation have been associated with tissue tem peratures exceeding 
100 °C (Panescu et al. 1995).
Light and scanning electron m icroscopy have shown com plete loss o f 
endothelium with electrocautery in blood vessels associated with mural thrombus 
formation (Gaudino et al. 2000; Acedia et al. 1995; Yoshida et al. 1995; Sparmann et 
al. 1992; N oera et al. 1993; W aieczek et al. 1993; Lehtola et al. 1989) and 70% o f 
early graft occlusions in CABG are caused by thrombi overlying areas o f endothelial 
loss (Alrawi 2001). In an animal model, skeletonised IM A harvested using 
electrocautery, showed a higher incidence o f  thrombosis, intimai thickening, and 
medial injury that pedicled grafts (Daly et al. 1988). The demand for a safe distance 
from vital structures when using electrocautery has also been dem onstrated (W aieczek 
et al. 1993; Sparmann 1992). These histological studies corroborate this study’s 
functional findings.
Although the m ain focus o f  this study was into the effect o f  pedicle width on 
NO -dependent endothelial-function, there are other potential sources o f  NO  that are 
m aintained with IM A pedicles (Gao et al. 2005). A  recent study described the release 
o f  a transferable relaxing factor from the perivascular adipose tissue surrounding the 
human IMA and suggested that its retention when harvesting the IMA may play an 
important role in the superior patency rate o f  the IMA (Gao et al. 2005).
To prove that IM A harvested with a w ider pedicle am eliorates survival, will be 
difficult because o f  the low sensitivity o f  clinical endpoints and the good results that 
are available with the use o f  norm al harvested IMAs (Rosamund et al. 2007; Cho et 
al. 2006; Eagle et al. 2004; Sergeant et al. 1998). The W estern Infirmary Glasgow on 
behalf o f  the National Adult Cardiac Surgical Database prospectively follows up their
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CABG patients and five year freedom-from-reintervention and m ortality data will be 
available to further investigate the influence o f  pedicle w idth on freedom-from- 
reintervention and survival.
This study has dem onstrated the predominant role o f  IM A pedicle width in 
determining calcium ionophore A 23187 mediated relaxation o f  IM A harvested with 
m onopolar electrocautery. This study proposes that by reducing vascular injury to the 
IMA, using the less traum atic surgical technique (Ueda et al. 2003; Cunningham
1996) o f  a wider pedicle, N O-dependent endothelial function is m aintained and this 
will result in improved graft performance (Luscher et al. 1988).
4.4.2 Total cholesterol and endothelium -dependent function
In this study, total cholesterol level was also a significant determ inant o f  
calcium ionophore A23187 mediated relaxation and a negative correlation between 
total cholesterol and a calcium ionophore A23187 mediated relaxation was observed. 
However total cholesterol did not correlate directly to calcium ionophore A23187 
m ediated relaxation. A tendency to a relationship between statin therapy and calcium 
ionophore A23187 m ediated relaxation was observed although these were not 
statistically significant. Lipid-lowering therapy with statins has been demonstrated to 
improve endothelial function (Fichtlscherer et al. 2006; Tsunekawa et al. 2001; 
Anderson et al. 1995; John et al. 2001; John et al. 1998; O ’Driscoll et al. 1997b) and 
reduce the occurrence o f m ajor cardiovascular events (Larosa et al. 2005; N issen et al. 
2005; Cannon et al, 2004). Apart from lipid-lowering therapy (Jerem y et al. 2007), no 
intervention has hitherto proved clinically effective in preventing late graft failure 
(Dataiii et al. 2000; Campeau et al. 2000; The Post Coronary Artery Bypass Graft 
Trial Investigators 1997). This study adds support to lipid-lowering in CABG patients
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(Campeau et al. 2000; The Post Coronary Artery Bypass Graft Trial Investigators
1997). A  recent study dem onstrated that simvastatin treatm ent significantly reduced 
endothelial CD40-sCD40L, a culprit link between local inflam m ation and the 
coagulation cascade, in both venous and arterial grafts, and speculated that this effect 
o f statins, in addition to enhancem ent o f  eNOS (Lefer et al. 2001; M iller et al. 2001), 
may help prevent vein graft throm bosis and graft failure (Chello et al. 2006).
The focus o f  this study was into the effect o f  pedicle width on NO-dependent 
endothelial-function. This study was not intended to examine the relationship between 
endothelial dysfunction and CVD. Given the important prognostic significance o f 
endothelial dysfunction (Endemann and Schiffrin 2004; W idlansky et al. 2003; Gokce 
et al. 2002; Heitzer et al. 2001; Al Suwaidi et al. 2000; Schachinger et al. 2000), 
further studies were undertaken in the subsequent chapters to address the relationship 
between endothelial function and cardiovascular risk factors.
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Chapter 5
Comparison of vasorelaxation and superoxide production in 
LSV from patients undergoing CABG and patients 
undergoing surgery for removal of varicose veins:
1) Effect of calcium ionophore A23187, allopurinol, 
apocynin, and sodium nitroprusside on relaxation of LSV
2) Measurement of superoxide production in LSV
3) Measurement of circulating indicators of oxidative stress
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5.1 INTRODUCTION
Chapter 1 outlined that endothelial dysfunction occurs in conjunction with 
CAD and it is observed both in the coronaiy and peripheral vasculature (Félétou and 
Vanhoutte 2006). M oreover, risk factors for CAD have been alm ost universally 
associated with a degree o f  endothelial dysfunction in hum ans (Landm esser et al. 
2004). Increased production o f ROS, in particular, superoxide-and radicals derived 
from superoxide, has been associated with endothelial dysfunction in animal models 
o f  disease, and there is increasing evidence o f  a link between oxidative stress and 
endothelial dysfunction in humans (Touyz and Schiffrin 2004; Taniyam a and 
Griendling 2003; Harrison and Griendling 2003; Hamilton et al. 2002; A lexander and 
Dzau 2000). However these studies have been limited by the absence o f  control 
vascular tissue from subjects without clinical m anifestation o f  coronary artery disease 
(CAD). The accepted m eans o f  comparison in this instance had been to compare 
arteries to veins (Berry et al. 2000) or to stratify subjects according to risk factors or 
disease severity (Simic et al. 2006; Redon et al. 2003; Guzik et al. 2000a). However, 
comparative data on endothelial function, direct measures o f  superoxide in human 
vessels, and circulating indicators o f  oxidative stress are not available in patients with 
CAD nor in control subjects with no documented CVD.
5.1.1 Non-varicose LSV from patients undergoing surgery for rem oval o f varicose 
veins: A reasonable control model?
M ashiah et al. (1991) found no changes in the intima or adventitia o f  non- 
varicosed segments o f varicose LSV with a scanning electron microscope. The 
abnormalities that were found coincided with areas o f  varicose dilatation that were 
between areas that retained their normal configuration (M ashiah et al. 1991). Khan et
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al. (2000) studied the tunica intima o f  varicose veins with light and electron 
m icroscopy and found that the endothelial lining was intact in varicose sections and 
was not significantly different from those seen in control vein samples. A  recent 
review article by Somers and Knaapen (2006) called “The Histopathology o f  Varicose 
Vein Disease” em phasised that intimai thickening found in varicose veins can be 
ascribed to phlebosclerosis due to ageing (M ilroy et al. 1989) and is therefore not 
attributable to changes o f  the vein wall as observed in varicose vein disease (Somers 
and Knaapen 2006). M acFarlane et al. (1985) documented that LSV segments below 
the knee do not become varicose even in patients with extensive below-knee 
varicosities. Therefore LSV segments, particularly below knee non-varicosed LSV 
segments, from patients who are undergoing surgery for removal o f  varicose veins, 
who have no conventional risk factors for CVD, no documented CVD and a normal 
electrocardiogram  (ECG) are proposed as a reasonable control model system to 
compare to LSV from subjects undergoing CABG.
5.1.2 H ypothesis
Patients w ith severe CAD have endothelial dysfunction and increased levels o f 
oxidative stress com pared to healthy control subjects with no docum ented CVD.
5.1.3 Aim s
1. To study endothelium -dependent and -independent relaxation o f  LSV in a 
group o f  patients with severe CAD com pared to controls.
2. To study superoxide production levels in blood vessels in a group o f  patients 
w ith severe CAD com pared to controls.
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3. To study circulating indicators o f  oxidative stress in a group o f  patients with
severe CAD com pared to controls.
5.1.4 Experim ental Approach
1. Relaxation to calcium  ionophore A23187 (endothelium  dependent
vasodilatator), sodium nitroprusside (endothelium independent vasodilatator), 
allopurinol (inhibitor o f  xanthine oxidase) and apocynin (reduced NAD(P)H 
oxidase inhibitor) will be determined in LSV from patients undergoing CABG 
and age- and sex-matched control patients with no docum ented CVD who 
were undergoing surgery for removal o f  varicose veins.
2. To evaluate circulating oxidative stress indicators. The GSH/GSSG ratio and
the TAC will be determined in blood from patients undergoing CABG and
age- and sex-m atched control patients with no documented CVD who were
undergoing surgery for removal o f  varicose veins.
3. To measure superoxide production using lucigenin chemilum inescence and 
oxidative fluorescent m icrotopography with hydroethidine from patients 
undergoing CABG and age- and sex-matched control patients with no 
docum ented CVD who were undergoing surgery for rem oval o f  varicose 
veins.
5.2 M ETHODS
5.2.1 Study population
51 subjects undergoing elective CABG and 51 subjects undergoing elective
varicose vein surgery were recruited as controls. All were outpatients recruited at the
Cardiothoracic U nit at the W estern Infirmary Glasgow or the V ascular Unit at
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Gartnavel General Hospital. Patients undergoing CABG surgery had obstructive CAD 
dem onstrated by coronary angiography (CAD subjects). The control subjects had no 
history o f  CVD (angina, coronary artery disease or peripheral vascular disease), no 
conventional risk factors for CVD and a normal ECG. These control subjects 
underwent general health screening test, including a physical examination and ECG 
and they were enrolled if  they had neither a history nor clinical evidence o f 
atherosclerosis. In addition, any control subject taking any pharm acological therapy 
was not included in the study. The study was approved by the local ethics committee 
and all subjects gave informed written consent. Beiow-knee, non-varicose LSV were 
collected at the time o f surgery. In addition, blood samples were collected 5-10 days 
prior to CABG surgery or within 1 month o f varicose vein surgery. Subjects were 
fasted overnight and rested supine for 30 min prior to donating blood.
5.2.2 Vascular reactivity o f veins
3 mm long rings o f  undistended LSV were studied in organ chambers 
according to methods described in Chapter 2. Only non-varicosed portions o f  vein 
were studied. Vessels were constricted with phenylephrine (3 pm ol/L) and relaxations 
to calcium ionophore A23187 (0.01 - 10 pmol/L), sodium nitroprusside (0.01 - 10 
pmol/L), apocynin (0.01 - 0.3 mmol/L) or allopurinol (0.01 - 0.3 m mol/L) examined. 
Relaxation was expressed as a % o f  the constriction to phenylephrine.
5.2.3 C irculating ind icators o f oxidative stress
Blood samples were collected from control and CAD subjects for 
determ ination o f  TAC, GSH, GSSG, GSH/GSSG molar ratio and LDL-cholesterol 
according to m ethods described in Chapter 2.
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TAC was m easured in plasma using a commercially available kit (AOP-490; 
Oxis International Inc., Portland, Oregon, United States o f  Am erica) based upon the
reduction o f  Cu^^ to Cu^.
The GSH/GSSG ratio was m easured in w hole blood using a commercially 
available kit (GSH/GSSG-412, Oxis International Inc., Portland, Oregon, United 
States o f America). GSH reacts with Ellman's reagent to form a 
spectrophotom etrically detectable product at 412 mm. In a separate reaction GSSG is 
reduced to GSH w hich is then determ ined in the same manner.
5.2.4 LDL-cholesterol
The Bayer® ADVIA 1650 chemistry system with standard reagents (Bayer 
Diagnostics, Newbury, Berkshire, United Kingdom) was used to determ ine measure 
total cholesterol, HDL-cholesterol and triglycerides in plasma. The plasm a total 
cholesterol concentration was m easured by cholesterol esterase and cholesterol 
oxidase conversion, plasm a triglyceride concentration by lipoprotein lipase/glycerol 
kinase enzymatic determ ination and HDL cholesterol m easured cholesterol by 
polyethylene glycol-linked cholesterol esterase and oxidase after serum incubation 
with sulphated cyclodextrin buffer. M easurem ent o f  the total cholesterol, HDL 
cholesterol and triglyceride levels permitted the estim ation o f  LDL-cholesterol 
concentrations, based upon the Friedwald formula (Friedwald et al. 1972).
5.2.5 Superoxide production in blood vessels
All experim ents to investigate superoxide production in LSV w ere performed 
by Dr CA Ham ilton (Senior Lecturer in Pharmacology at University o f  Glasgow) and
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Mrs EJ Jardine (Laboratory Technician at University o f  Glasgow). Superoxide levels 
were m easured in LSV from CAD (n = 15) and age- and sex-matched control patients 
(n = 15). Superoxide was m easured using lucigenin chemilum inescence as described 
by Berry et al. (2000). 3 x 5 mm lengths o f  vein were blotted, weighed and placed in 
2m 1 o f  Krebs buffer at pH 7.4 ± 2 and maintained in atmospheric conditions at room 
temperature. Next, either Krebs buffer, allopurinol (0.1 mmol/L) or apocynin (0.1 
mmol/L) w ere added and after 60 minutes incubation at room temperature, lucigenin 
(0.25 m mol/L) was added and counts were recorded every 10 seconds for 3 minutes in 
a liquid scintillation counter (Tricarb 2100TR, Hewlett Packard; Hercules, California, 
United States o f  Am erica) switched to the out-of-coincidence mode. Absolute counts 
were quantified with a xanthine /  xanthine oxidase calibration curve for superoxide 
generation and reported as nmol min ' mg tissue. In all experiments, superoxide 
production was m easured in paired samples with a m atched control from the same 
vessel in eveiy case.
For oxidative fluorescent m icrotopography with hydroethidine, frozen sections 
were prepared and incubated with the nuclear m arker 4 ’,6-diamidino-2-phenylindoIe 
(DAPI; 0.5 pg/m L for 2 minutes) followed by hydroethidine (2 pm ol/L for 20 
minutes). The oxidative fluorescent dye hydroethidine was used to evaluate the in situ 
formation o f  superoxide as described by M ollnau et al. (2005), Hink et al. (2001) and 
M iller et al. (1998). Fluorescence was detected using a laser scanning confocal 
m icroscope (M RC 1024, Bio-Rad Laboratories; Hercules, California, United States o f 
America) w ith an optical band pass filter o f  470 ± 3 0  nm for DAPI (2-photon 
excitation 750 nm) and a band pass o f 580 ±  16 nm for hydroethidine (single-photon 
excitation 488 nm). Vessels from CAD and control patients were analyzed in parallel 
under identical imaging parameters. Relative superoxide levels within vessel
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segments were quantitated by determ ining relative fluorescence in the red 
(hydroethidine) and blue (DAPI) channels over a defined area, using Scion Image 
version 4.0 software (Scion Corporation Inc., Frederick, M aryland, United States o f 
America) (Cham seddine and M iller 2003).
5.2.6 Statistical analysis
All com parisons between responses in CAD and control vessels, superoxide 
production and circulating indicators o f  oxidative stress were made in age and sex 
matched samples. Age m atching was perform ed using subjects at most two years apart 
from each other (Goodman et al. 2000; Terân-Santos et al. 1999; Cassidy et al. 1999; 
Strom et al. 1998; D uggan et al. 1998; Jick et al. 1998). Norm al distribution o f  data 
was examined by the Kolm ogorov-Sm irnov test. W here appropriate, unpaired Student 
t tests were used for the com parisons o f relaxation at different concentrations to 
calcium ionophore, sodium nitroprusside, apocynin, and allopurinol between the 2 
groups. Plots o f  m ean vessel responses together with their SEM are shown, with 
asterisks indicating when there was significant evidence o f a difference between CAD 
and control subjects’ response curves (p < 0.05). Statistical analyses o f  vascular 
superoxide concentrations were undertaken by use o f  the unpaired Student t test. The 
M ann-W hitney U test was used for comparison o f  non-normally distributed data 
between the groups (total antioxidant capacity and reduced/oxidized glutathione ratio). 
Unless otherwise indicated, results are shown as m ean ± SEM, including 95 % CIs 
where appropriate, and p < 0.05 was considered significant.
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5.3 RESULTS
5,3.1 Subject Characteristics
Demographics characteristics o f  the 2 subject groups are shown in Table 5.1. 
Vessels and blood from all subjects was available for study o f  circulating indicators o f 
oxidative stress. The average age o f  the CAD subjects was lower and the proportion 
o f females higher than that o f  a typical CABG population (see chapters 3 and 4). This 
was due to subject selection to match w ith control subjects who underwent varicose 
vein surgery, who tended to be younger women. This may also account for the high 
prevalence o f risk factors present in the CAD group o f subjects,
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Table 5,1 CAD and control patient demographics.
Variables CAD Controls
Num ber 51 51
Age, (y) 5 5 ±  11 5 5 ±  11
Gender, (M/F) 2 2 /2 9 2 2 /2 9
Body M ass Index 30 ± 6 2 7 ± 4  *
Systolic Blood Pressure, (mm Hg) 140 ±  14 1 2 0 ± 11 *
Diastolic B lood Pressure, (mm Hg) 83 ± 9 71 ±  10 *
Total cholesterol, (mmol/L) 4.7 ± 0 .7 3.7 ± 0 .7
LDL-cholesterol, (mmol/L) 2.9 ± 0 .6 1.8 ± 0 .4  *
Triglycerides, (mmol/L) 1.0 ± 0 .6 1.4± 1.3 *
Diabetes mellitus, (%) 31 0
Smokers (%) (active / stopped / none) 35 /3 5  /3 0 53 / 2 0 / 2 7
New York Heart Association heart failure score (%) 4/40/48/8 n/a
(I/II/III/IV)
Canadian Cardiovascular Society angina score (%) 10/29/49/12 n/a
(I/II/III/IV)
ACE inhibitor / ARB medication (%) 47 0
Antiarrhythm ic (Amiodarone or Digoxin) (%) 4 0
Aspirin (%) 75 0
Beta Blockers (%) 58 0
Calcium Channel Antagonists (%) 45 0
Clopidogrel (%) 6 0
Diuretic (%) 29 0
Nicorandil (%) 32 0
Nitrate (%) 20 0
Statin m edication (%) 86 0
Results are shown as mean ±  standard deviation.
*p<0.001 between age and sex matched CAD and control patients
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5.3.2 Vascular reactivity
Endothelium -dependent relaxations to calcium ionophore A23187 were 
attenuated in vessels from CAD subjects compared to control subjects across the full 
concentration response curve (Figure 5.1) maximal relaxation (calcium ionophore 
A23187 lOjuimol/L) being 26 d= 2 % and 60 ± 1 % respectively in CAD and control 
subjects (p < 0.001 95 %, C l 29 % to 39 %). In contrast, endothelium -independent 
relaxation to sodium nitroprusside was not attenuated in the CAD patients; in fact, at 
the highest dose (10 pmol/L), relaxation was greater in CAD than in control patients 
[77 ± 3 % and 64 ±  2 % respectively (p < 0.01 95 %, C l 21 % to 29 %)] (Figure 5.2). 
At the highest concentrations examined both the xanthine oxidase inhibitor, 
allopurinol, and the NAD(P)H oxidase inhibitor, apocynin, caused greater relaxations 
in vessels from CAD subjects compared to control subjects (Figure 5.3; Figure 5.4). 
In the presence o f  allopurinol, 0.3 mmol/L, relaxations were 25 ±  2 % and 16 ±  1% (p 
< 0.001 95 %, Cl -14% to -4%), while in the presence o f apocynin, 0.3 mmol/L, 
relaxations were 23 ±  2% and 10 ±  1% (p < 0.001 95 %, Cl -18 % to -8 %) in CAD 
and control tissues respectively.
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F ig u re  5.1 Vasorelaxation to calcium ionophore A23187 in rings o f  LSV from age 
and sex m atched CAD (n = 51) and control (n = 51) patients. The x-axis 
is on a logarithmic scale. O  Control # C A D
Results are shown as mean ± SEM. Differences in relaxation between 
CAD and control patients were examined using unpaired t-tests.
* p < 0.01, ** p < 0.001.
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F igure 5.2 Vasorelaxation to sodium nitroprusside in rings o f  LSV from age and 
sex m atched CAD (n = 51) and control (n = 51) patients. The x-axis is 
on a logarithmic scale. O  Control # C A D
Results are shown as mean ± SEM. Differences in relaxation between 
CAD and control patients were examined using unpaired t-tests.
* p < 0 .0 1 .
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F ig u re  5.3 Vasorelaxation to allopurinoi in rings o f  LSV from age and sex 
m atched CAD (n = 51) and control (n = 51) patients. The x-axis is on a 
logarithmic scale. O  Control # C A D
Results are shown as m ean ±  SEM. Differences in relaxation between 
CAD and control patients were examined using unpaired t-tests.
* p <0.001.
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F ig u re  5.4 Vasorelaxation to apocynin in rings o f  LSV from age and sex matched 
CAD (n = 51) and control (n = 51) patients. The x-axis is on a 
logarithmic scale. O  Control # C A D
Results are shown as mean ±  SEM. n=51 for all groups. Differences in 
relaxation between CAD and control patients were examined using 
unpaired t-tests. * p < 0.01, * * p <  0.001.
151
5,3.3 D irect m easu rem en t o f  v a scu la r  su peroxide
L ucigen in  chem ilum inescence m easurem ents o f  superoxide w ere sign ifican tly  greater in 
blood vessels from  C A D  th an  from  contro l patien ts  (0.89 ±  0.10 versus 0.55 ±  0.06 
nm ol/m g/m in; p ^  0 .008; 95%  C l, 10.1 to  59.5 nm ol/m g/m in ; F igure 5.5) w h en  com pared  by 
unpaired  S tuden t t  test. A pocyn in  (p =  0 .021) an d  allopurino i (p =  0 .038) reduced  superoxide 
p roduction  sign ifican tly  by  0.12 ±  0.05 nm ol/m g/m in  (95%  C l, 0.02 to 0.21 nm ol/m g/m in) and 
0.22 ± 0 . 1 0  m no l/m g/m in  (95%  C l, 0 .14 to  0.43 nm ol/m g/m in) w hen  com pared  w ith  baseline 
values in patien ts w ith  C A D  (F igure 5.6). T he h igher levels o f  superox ide p roduc tion  in patients 
w ith  C A D  w ere confirm ed  using  hydroeth id ine  (F igure 5.8; F igure 5.9; F igure 5.11; F igure 5.12) 
and w ere observed  th roughou t the vessel w all. In  con trast to hydroe th id ine the in tensity  o f  D A PI 
stain ing w as sim ilar in vesse l sections from  C A D  and  contro l p atien ts  (F igure 5.7 and Figure 
5.10).
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F igure 5.5 *02* levels in LSV  from  age- and  sex-m atched  C A D  (n =  15) and  control (n = 15)
patien ts. Sam ples w ere incubated  w ith  D A PI 0.5 p g  / m L  fo r 2 m inutes follow ed 
by hydroeth id ine  2 pm ol /  L for 20 m inutes. Superox ide levels m easured  by 
lucigen in  chem ilum inescence.
•  C A D  O  C ontrol
* p < 0 .0 1 w hen  superox ide p roduction  in  vessels from  C A D  and control patients 
com pared  by unpaired  S tudent t test.
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F ig u re  5.6 S uperoxide levels in  LSV  from  the age- and  sex-m atched  C A D  (n = 15) subgroup 
a t baseline and  afte r incubation  (60 m inutes) w ith  a llopurino i (0.1 m m ol / L) and 
apocyn in  (0.1 m m ol /  L). Sam ples w ere incubated w ith  D A PI 0.5 p g  /  m L for 2 
m inu tes fo llow ed  by hydroeth id ine  2 pm ol / L for 20 m inutes. Superoxide levels 
m easured  by lucigen in  chem ilum inescence.
•  B aseline C A D  #  A llopurino i O  A pocynin
* p < 0.05 w hen  superox ide p roduction  after incubation  w ith  allopurinoi or 
apocynin  is com pared  w ith  baseline C A D  values by unpaired  S tudent t tests.
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Figure 5.7 Figure 5.8 Figure 5.9
Figure 5.10 Figure 5.11 Figure 5.12
Figure 5.7 DAPI staining in a vein from a C A D  patient; Figure 5.8 Hydroethidine 
fluorescence in the same vein; Figure 5.9 Merged im ages o f  Figure 5.7 and Figure 5.8; Figure
5.10 DAPI staining in a vein from a control patient; Figure 5.11 Hydroethidine fluorescence in 
the same vein; Figure 5.12 Merged im ages o f  Figure 5.10 and Figure 5.11.
Bar in Figure 5.9 represents 100 pm. E indicates endothelium.
Numbers in the right bottom com er o f  the vessels in Figure 5.7, Figure 5.8, Figure 5.9, and 
Figure 5.10 represent average fluorescence on a scale o f  0 to 256 over the area o f  the vessel 
whereas the numbers in Figure 5.9 and Figure 5.12 show the ratio o f  DAPl/hydroethidine 
fluorescence. The higher levels o f  superoxide production in patients with C A D  are demonstrated 
using hydroethidine (Figure 5.8; Figure 5.9; Figure 5.11; Figure 5.12) and were observed 
throughout the vessel wall. In contrast to hydroethidine the intensity o f  DAPI staining was 
similar in vessel sections from C A D  and control patients (Figure 5.7 and Figure 5.10).
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throughout the vessel wall. In contrast to hydroethidine the intensity o f  DAPI staining was 
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5.3.4 C irculating ind icators of oxidative stress
T he levels o f  G SSG  w ere  sign ifican tly  h ig h er in  b lood  from  C A D  com pared  w ith  control 
patien ts (18 ±  3 versus 4 ±  1 pm ol/L ; P <  0 .001) (T ab le 5.13 A ), and  the ra tio  o f  G SH /G SSG  w as 
low er (129 ±  31 versus 641 ±  115; p  <  0.001) (T able 5.13 C). In  con trast, levels o f  G SH  did  not 
d iffer betw een  C A D  and con tro l p atien ts  (1127 ±  81 versus 1113 ±  49 pm ol/L ; p =  0 .556) (Table 
5.13 B). C onsisten t w ith  these find ings, the TA C  w as sign ificantly  red u ced  in  p lasm a from  the 
sam e group o f  C A D  p atien ts  (1703 ±  57 versus 2012 ±  67 Cu^^-reducing equ ivalen ts; p < 0.001) 
(Table 5.14).
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Figure 5.14 TAC measured as Cu^^ reducing equivalents in plasm a from age and 
sex matched CAD and control patients (n=51 for both patient groups).
I  I  Control patients 
0 0  CAD patients 
Results shown as mean ± SEM.
*p<0.001 when examined by unpaired t-tests.
158
5.4 DISCUSSION
This study dem onstrated contrasting levels o f  oxidative stress and endothelial 
function between patients w ith severe CAD and age- and sex-matched individuals 
with no documented CVD. This is the first study to assess endothelial function, 
superoxide production, and oxidative stress, not only in vessels used for 
revascularization in coronary arteiy bypass graft surgery, but also in the equivalent 
vessels from healthy control subjects.
The organ bath studies dem onstrated that CAD subjects had significantly 
attenuated vasorelaxation to the NO-dependent endothelial vasodilator calcium 
ionophore A23187 that maxim ally stimulates endothelial NO synthase independent o f 
any receptor-mediated pathway. In contrast, similar relaxations to the endothelial- 
independent NO donor sodium nitroprusside were observed when compared to the 
individuals with no docum ented CVD, suggesting a specific endothelial dysfunction 
in CAD subjects.
The studies perform ed do not allow an adequate explanation o f  the mechanism 
underlying endothelial dysfunction in CAD subjects. Endothelial dysfunction could be 
the result o f either a dim inished endothelial capacity to synthesize and release NO or 
an increased inactivation o f  NO after its synthesis. However, inhibition o f  superoxide 
production with allopurinoi (xanthine oxidase inhibitor) and apocynin (NAD(P)H 
oxidase inhibitor) enhanced vasorelaxation in vessels from CAD subjects but had 
minimal effects in vessels from individuals with no docum ented CVD. This suggests 
that both xanthine oxidase and N AD (P)H  oxidase contribute to excess superoxide 
production in CAD subjects. This excess superoxide may interact w ith N O  reducing 
NO bioavailability and thus endothelial function.
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Consistent w ith these observations, increased xanthine oxidase activity has 
been suggested in subjects with CAD (Harrison et al. 2003). In addition, allopurinoi 
treatm ent has been reported to improve endothelial function in subjects with type 2 
diabetes mellitus (Butler et ai. 2000) and oxypurinol to improve forearm blood flow in 
hypercholesterolaem ic subjects (Cardillo et al. 1997). No specific N AD (P)H  oxidase 
inhibitors are licensed for use in man. However angiotensin II is known to upregulate 
NAD (P)H  oxidase and increase superoxide production in blood vessels from animals 
and man (Touyz et al. 2005; Cruzado et al. 2005; Gao et al. 2005; Zuo et al. 2005; 
Erdos et al. 2005; Touyz et al. 2002; Berry et al. 2000; Rajagopalaii et al. 1996a) and 
inhibition o f the renin-angiotensin system by ACE inhibition and angiotensin receptor 
blockade has been shown to reduce superoxide production in blood vessels from CAD 
subjects (Berry et al. 2001).
This study is consistent with studies that demonstrated increased NAD(P)H 
oxidase activity is closely associated w ith the presence o f cardiovascular risk factors 
and impaired endothelium -dependent vasodilatation in human arteries (Guzik et al. 
2000a). In the latter study, diabetes mellitus and hypercholesterolaem ia were 
independently associated with N AD(P)H-dependent superoxide production. In vessels 
from the animals w ith atherosclerotic disease up regulation o f NAD (P)H  oxidase in 
endothelial cells can occur (Zalba et al. 2001).
O f note, quantitative analyses o f  the contribution o f  N A D (P)H  oxidase and 
xanthine oxidase to superoxide production are not possible from these experiments. 
Apocynin acts by blocking the assembly o f  the NAD(P)H oxidase com plex (Ximenes 
et al. 2007; Barbieri et al. 2004). N 0 X 4  has been shown to be the predominant 
homologue in vascular smooth muscle from conduit vessels (Lambeth 2004) NOX4 is 
constitutively active (Clem pus and Griendling 2006; Cheng et al. 2006); thus,
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apocynin may have low potency in the LSV and only inhibit a proportion o f 
NAD(P)H oxidase activity.
Free radical generation and oxidative stress have been proposed as putative 
m echanisms o f  endothelial dysfunction. Healthy people are protected against free 
radicals by several defence mechanisms. Reduced GSH is the m ost important 
intracellular scavengers o f  free radicals (Kir et al. 2006). GSH serves as a reductant in 
oxidation reactions resulting in the formation o f  GSSG. Thereby decreased GSH 
levels and increased GSSG levels may reflect depletion o f the antioxidant reserve 
(Halliwell and Gutteridge 1999). In particular, oxidative damage occurs when the 
delicate balance betw een pro- and anti oxidants is alterated. In the body exist various 
antioxidant m olecules to be used against free radicals injury. Am ong them, GSH and 
the enzyme and glutathione peroxidase are critical for maintaining the redox balance 
o f  the cell (Penckofer et al. 2002; Yu 1994). However, this balance may be destroyed 
by certain vascular features, such as by certain risk factors for atherosclerosis 
including hypertension, hyperlipidaemia, diabetes mellitus and cigarette smoking 
(Rojas et al. 2006; W assm ann et al. 2006; Yung et al. 2006; M aytin et al. 1999). Once 
oxidant stress is evoked, characteristic adverse pathological conditions, namely 
reduced vessel reactivity is established (Rojas et al. 2006; W assmann et al. 2006; 
Yung et al. 2006).
The balance between pro-oxidants and antioxidants m ay depend on the 
oxidative stress evoked as well as the anti oxidant defence system (Rojas et al. 2006; 
W assmann et al. 2006; Yung et al. 2006). The simultaneous evaluation o f  the TAC 
together w ith GSH/GSSG ratio as undertaken here may represent the optimum 
approach for the evaluation o f  circulating indicators o f  oxidative stress in the field o f 
CVD and may be useful when evaluating therapeutic interventions directed against
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pathologie processes related to atherosclerosis. In the present study, CAD subjects 
showed not only enhanced GSSG concentration and a decrease in the GSH/GSSG 
ratio, but also significantly reduced TAC. This study is consistent w ith studies that 
revealed increased oxidative stress in hypertensive subjects (Simic et al. 2006; Redon 
et al. 2003).
The present findings dem onstrate marked differences in vascular function and 
oxidative stress between the two discrete populations and defines for the first time 
endothelial function in conduit veins from a ‘low risk’ population. This study was not 
designed to examine in detail the relationship between oxidative stress and risk factors 
including pharmacological regim es but to compare levels o f  endothelial function and 
oxidative stress in a CAD population with those found in a ‘norm al’ low risk 
population. The CAD and the varicose vein individuals w ith no documented CVD 
present two distinct populations. Each population is homogenous but they are discrete 
populations. There are extrem ely marked differences between the two groups; 
atherosclerotic disease is severe in the CAD subjects and is associated with many 
cardiovascular risk factors and atherosclerotic disease is minimal in the varicose vein 
individuals with no docum ented CVD who have no cardiovascular risk factors. 
Therefore detailed analysis o f  risk factors was not performed in this unsuitable group 
o f  subjects. In the next chapter detailed analysis o f  risk factors is performed in a 
homogenous group o f  188 subjects undergoing CAB G surgery.
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Chapter 6
Relationship of LDL-cholesterol and circulating indicators 
of oxidative stress to calcium ionophore A23187, apocynin 
and allopurinoi mediated relaxation of LSV obtained from
CABG patients
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6.1 IN T R O D U C T IO N
The w ork in chapter 5 dem onstrated marked endothelium  dysfunction and 
increased oxidative stress in CAD patients compared to varicose vein patients with no 
docum ented CVD matched for age and sex. This raised a num ber o f  questions:
1) W hat causes the deterioration in A23187 mediated relaxation o f  LSV from the 
CAD patients compared to the varicose vein patients with no documented CVD?
2) Is this m arked deterioration in A23187 mediated relaxation o f  LSV due to 
increased oxidative stress?
3) W hat are the risk factors that contribute to this increased oxidative stress? 
Circulating indicators o f  oxidative stress have been investigated in human
patients with essential hypertension and in control subjects (Simic et al. 2006; Redon 
et al, 2003), but the relationship between these circulating indicators o f  oxidative 
stress and endothelial function was not examined. In addition, although the degree o f 
endothelial function has been consistently linked to the num ber o f  risk factors present 
in patients with CAD, the relative importance o f  individual risk factors in determining 
levels o f  oxidative stress and endothelial function remains uncertain (Guzik et al. 
2000; Huraux et al. 1999).
6.1.1 H ypothesis
Cardiovascular risk factors modify endothelial function.
6.1.2 Aim
To determ ine which study cardiovascular risk factors influence A23187 
mediated relaxation o f  LSV in patients undergoing CABG.
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6.1.3 E x p erim en ta l A p p ro ach
1) Relaxation to calcium ionophore A23187 (endothelium  dependent
vasodilatator), sodium nitroprusside (endothelium independent vasodilatator), 
allopurinoi (inhibitor o f  xanthine oxidase) and apocynin (reduced
nicotinam ide-adenine dinucleotide phosphate (NAD(P)H) oxidase inhibitor) 
will be determ ined in LSV from patients undergoing CABG.
2) To evaluate circulating oxidative stress indicators: the GSH/GSSG ratio and
the TAC will be determined in blood from patients undergoing CABG and 
age- and sex-m atched control patients w ith no docum ented CVD who were 
undergoing surgery for removal o f  varicose veins.
3) Cardiovascular risk factors (age, sex, body mass index, current active 
smoking, diabetes mellitus status, diastolic blood pressure, LDL-cholesterol) 
and current drug therapy will be recorded.
6.2 M E T H O D S
6.2.1 S ubjects
188 subjects undergoing elective CABG surgery were studied. A  subset o f 51 
o f  these subjects were involved studied in chapter 5. All were outpatients recruited at 
the Cardiothoracic U nit at the W estern Infirmary Glasgow. Patients undergoing 
CABG surgery had obstructive CAD demonstrated by coronary angiography. The 
study was approved by the local ethics committee and all patients gave informed 
written consent. Vein samples were collected at the time o f surgery, stored in Krebs- 
HEPES buffer overnight and assayed the following day. Blood samples were 
collected 5-10 days prior to CABG surgery. Patients were fasted and rested supine for
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30 min prior to donating blood. At the time o f the blood sampling, all subjects gave a 
complete history w hich included cardiovascular risk factors such as smoking habits, 
hypertension, diabetes mellitus and dyslipidaemia. No patients were receiving 
antioxidant therapy and none had acute or chronic inflam m atory diseases. 
Immunological diseases and history or presence o f neoplastic disease.
6.2.2 Vascular reactivity o f veins
3 mm long rings o f  undistended LSV were studied in organ chambers, 
according to m ethods described in Chapter 2. Vessels were constricted with 
phenylephrine (3 pmol/L) and relaxations to calcium ionophore A23187 (0.01 - 10 
pmol/L; endothelium  dependent vasodilatator), sodium nitroprusside (0.01 - 10 
pmol/L; endothelium  independent vasodilatator), allopurinoi (0.01 - 0.3 mmoI/L; 
inhibitor o f xanthine oxidase) or apocynin (0.01 - 0.3 mmol/L; NAD(P)H oxidase 
inhibitor) were examined. Relaxation was expressed as a percentage o f the 
constriction to phenylephrine.
6.2.3 C irculating ind icators of oxidative stress
Blood samples were collected from control and CAD subjects for 
determination o f  TAC, GSH, GSSG, GSH/GSSG m olar ratio and cholesterol.
TAC was m easured in plasm a using a commercially available kit (AOP-490; 
Oxis International Inc.; Portland, Oregon, United States o f America) based upon the 
reduction o f  Cu^^ to Cu^ as described in chapter 2.
The GSH/GSSG ratio was m easured in whole blood using a commercially 
available kit (GSH/GSSG-412, Oxis International Inc.; Portland, Oregon, United 
States o f  Am erica) as described in chapter 2. GSH reacts w ith Ellm an's reagent to
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form a spectrophotom etrically detectable product at 412 mm. In a separate reaction 
GSSG is reduced to GSH w hich is then determined in the same manner.
6.2.4 LDL-cholesterol
The Bayer® AD VIA 1650 chemistry system with standard reagents (Bayer 
Diagnostics, Newbury, Berkshire, United Kingdom) was used to determ ine measure 
total cholesterol, HDL-cholesterol and triglycerides in plasma. The plasma total 
cholesterol concentration was measured by cholesterol esterase and cholesterol 
oxidase conversion, plasm a triglyceride concentration by lipoprotein lipase/glycerol 
kinase enzymatic determ ination and HDL cholesterol m easured cholesterol by 
polyethylene glycol-linked cholesterol esterase and oxidase after serum incubation 
with sulphated cyclodextrin buffer. M easurem ent o f the total cholesterol, HDL 
cholesterol and triglyceride levels permitted the estimation o f  LDL-cholesterol 
concentrations, based upon the Friedwald formula (Friedwald et al. 1972).
6.2.4 Statistical analysis
To investigate which risk factors were related to vasorelaxation m ultiple linear 
regression analysis was perform ed using data from the 188 CAD patients and 
estimated effects, 95% confidence intervals (Cl), and p values were tabulated. 
M ultiple correlation coefficients were calculated as an overall m easure o f the 
relationship between risk factors and vasorelaxation. The varicose vein patients with 
no documented CVD had been selected in the previous study chapter to have 
contrasting clinical characteristics to the CAD patients and were therefore not 
included in the regression analysis. The multiple linear regression analysis included 
the following risk variables in the model: age in years; sex (0 = female, 1 = male);
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diastolic blood pressure (mmHg); tobacco smoking status (0 = non-sm okers and ex­
smokers o f  more than 30 days, 1 = current smoker); diabetes mellitus (0 = non­
diabetes mellitus, 1 = on antidiabetic medication); body mass index (kg/m^); serum 
levels o f  LDL-cholesterol (mmol/L); statin therapy (0 = no therapy, 1 = on therapy) 
and ACE inhibitor / ARB therapy (0 = no therapy, 1 = on therapy). W hen risk factors 
were known to be interdependent, such as systolic and diastolic blood pressure or total 
cholesterol and LDL-cholesterol, only one risk factor was included in the analysis. 
Note that quantitative variables, for example smoking status, were included as factors 
in the analysis. Linear relationships have been assumed between all continuous 
variables and outcomes. Data not following normal distributions (TAC and 
GSH/GSSG ratio) were logarithmically transform ed for this analysis. Coefficients and 
their confidence intervals for these 2 analyses are given in Tables 6,6 to 6.7 have been 
back transform ed from the log scale, and they indicate the estim ated proportional 
increase in the response associated with a unit increase in the predictor. The 
dependent param eter in the five multivariate linear regression analyses were 
vasorelaxation to 10 pm ol/L  calcium ionophore A23187, vasorelaxation to 0.3 
mmol/L apocynin, vasorelaxation to 0.3 m m ol/L allopurinoi, GSH/GSSG ratio and 
TAC. W here appropriate, Pearson correlation coefficients and Spearman correlation 
coefficients are displayed. Statistical analysis was performed using the statistical 
package M INITAB, version 13.1 (M initab Inc, State College, PA, United States of 
America). Results are shown as mean ± SEM and p < 0.05 was considered statistically 
significant.
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6,3 RESULTS
6.3.1 Patient characteristics
Demographics and clinical characteristics o f  the patients are shown in Table 
6.1. Vessels and blood from all subjects was available for study o f circulating 
indicators o f oxidative stress. This larger group o f  CAD patients showed a similar 
degree o f  oxidative stress and endothelial dysfunction to the sub-group matched to 
control patients (Table 6.2). The total CAD population contained a significantly 
higher proportion o f  males (p < 0.001) than the population selected for comparison 
with the patients undergoing varicose vein surgery in Chapter 5, but was comparable 
in all other respects.
6.3.2 Endothelium -dependent vasorelaxation to calcium ionophore A23187
The m ultivariate linear regression analysis identified LDL-cholesterol to be 
the only independent factor associated with A23187 m ediated vasorelaxation to 10 
pm ol/L calcium ionophore A23187 in the CAD patients (F=10.93, p=0.001) (Table 
6.3). There was an inverse relationship found between LDL-cholesterol and 
endothelium -dependent vasorelaxation to calcium ionophore A23187 (r = -0.287, p = 
0.001) (Figure 6.1).
Age, sex, BMI, diastolic blood pressure, diabetic status, ACE inhibitor and 
statin therapy did not contribute to endothelium -dependent relaxation (Table 6.3). 
Overall the model was only able to account for 12.1% o f  the variation in relaxation 
(coefficient o f  determ ination) (Table 6.3), The Joint British Societies' Guidelines 2 
recommend that LDL-cholesterol should be below 2.0mmol/L. (British Cardiac 
Society et al. 2005). The LDL-cholesterol is substantially elevated (m ean 3.0 mmol/L
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± SEM 0.1) in m any o f  the CAD patients studied in this chapter despite 76% o f  them 
being on lipid lowering therapy with statins.
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Table 6.1 General characteristics of the study population
Total CAD
Number 188
Age (years) 5 8 ±  12
Sex M/F 135/ 53
Systolic Blood Pressure mmHg 139± 1.0
Diastolic Blood Pressure mmHg 83 ± 0.8
Total cholesterol (mmol/L) 4.8 ± 0.1
LDL-cholesterol (mmol/L) 3.0 ±0.1
Triglycerides (mmol/L) 1.3 ±0.1
Body Mass Index (kg/m^) 29 ±0 . 4
Diabetes Mellitus % 24
Smokers % (active / stopped / none) 3 8 / 3 8 / 2 4
NYHA heart failure score % (I / II / III / IV) 9 / 3 7 / 4 7 / 7
CCS angina score % (I/II/III/IV) 1 3 / 2 7 / 5 1 / 9
Prior MI % (no prior MI / 1 to 90 days from prior MI / > 90 days from 
prior Ml)
5 6 / 1 0 / 3 4
ACE Inhibitors and/or ARBs % 46
Antiarrhythmic (Amiodarone or Digoxin) % 4
Aspirin % 80
Beta Blockers % 58
Calcium Channel Antagonists % 42
Clopidogrel % 10
Diuretic % 25
Nicorandil % 32
Nitrate % 30
Statins % 76
Results expressed as mean ± SEM.
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Table 6.2 Com parison o f vasorelaxation and circulating ind icators of 
oxidative stress in full CAD group com pared to CAD subgroup  
which was age and sex matched to the varicose vein group with no 
docum ented CVD in chapter 5.
Total CAD Group CAD subgroup P
Num ber o f patients 188 51
% Relaxation ealcium ionophore 26.3 ±  1.0 26.2 ±  1.9 0.980
A 23187(10 lamol/L)
% Relaxation to sodium nitroprusside 73.5 ± 1.8 76.8 ± 3 .2 0.414
(10 pmol/L)
% Relaxation apocynin 23.4 ± 1.2 23 ± 2 .3 0.978
(0.3 mmol/L)
% Relaxation allopurinol 25 ±  1.4 24 ±  1.8 0.816
(0.3 mmol/L)
TAC 1625 (1575; 1677) 1662 0.521
(1575;1774)
GSH/GSSG ratio 91 83 0.587
(77; 108) (63; 109)
Student's t-test was used to compare between the groups. TAC and GSH/GSSG were 
log transform ed before Student's t-test was applied. Note the absence o f any 
significant difference between the groups.
Data following normal distribution are expressed as mean ± SEM, otherwise 
geometric mean (95% Cl o f  geometric mean) is given.
In this table it can been seen that the larger group o f 188 CAD patients investigated 
this chapter showed a sim ilar degree o f oxidative stress and endothelial dysfunction to 
the 51 CAD patient sub-group matched to the varicose vein group with no 
documented CVD in chapter 5.
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Table 6.3 Analysis of variance p-valnes for the null hypothesis of no
relationship between risk factors and calcium ionophore A23187
mediated relaxation of LSV in CAD patients.
Variable Calcium ionophore A23187 (11=134)
P
P coefficient
(Confidence Intervals)
Age (10 years) 0.807 -0.26 (-2.4, 1.9)
Sex(0=F, 1=M) 0.876 -0.38 (-5.1, 4.4)
Body M ass Index (kg/m^) 0.427 -0.19 (-0.66, 0.28)
Current Active Smoking (0=no, l==yes) 0.789 0.68 (-4.3, 5.7)
Diabetes M ellitus (0=no, l=yes) 0.436 -2.2 (-7.7, 3.3)
Diastolie Blood Pressure (lOmmMg) 0.188 -1.3 (-3 .3 ,0 .65)
LDL Cholesterol (mmol/L) 0.001 -4.7 (-7 .6 ,-1 .9)
ACE inhibitor /  ARB (0=no, l=yes) 0.401 -1.9 (-6.3, 2.5)
Statin (0=no, l=yes) 0.937 -0.21 (-5.6, 5.1)
This analysis identified LDL cholesterol as a significant predictor o f  calcium 
ionophore A23187 mediated relaxation o f LSV in the CAD patients ((3 coefficient, - 
4.7 per mmol/L; P=0.001). There was no evidence that age, sex, body m ass index, 
current active smoking, diabetes m ellitus status, diastolic blood pressure, ACE 
inhibitor /  ARE therapy or statin therapy contributed to calcium ionophore A23187 
mediated relaxation. Overall the m odel was only able to account for 12.1% o f the 
variation in relaxation (coefficient o f  determination).
The p coefficients indicate the estimated proportional increase in calcium  ionophore 
A23187 m ediated relaxation with a unit increase in the predictor.
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Table 6.4 Analysis of variance p-values for the null hypothesis of no
relationship between risk factors and apocynin mediated
relaxation of LSV in CAD patients.
Variable Apocynin (n=142) 
p coefficient
p (Confidence Intervals)
Age (10 years) 0.751 -0.43 (-3.2, 2.3)
Sex(0=F , 1=M) 0.461 2.3 (-3.8, 8.4)
Body M ass Index (kg/m^) 0.234 0.35 (-0.24, 0.94)
Current Active Smoking (0=no, l=yes) 0.357 -3 (-9.3, 3.3)
Diabetes M ellitus (0=no, l=yes) 0.377 3.2 (-4.1, 11)
Diastolic Blood Pressure (lOmmMg) 0.546 -0.77 (-3.3, 1.7)
LDL Cholesterol (mmol/L) 0.019 4.4 (0.64, 8.2)
ACE inhibitor / ARB (0=no, l=yes) 0.433 2.2 (-3.3, 7.7)
Statin (0=no, l=yes) 0.321 3.5 (-3.4, 10)
This analysis identified LDL cholesterol as a significant predictor o f  apocynin 
mediated relaxation o f  LSV in CAD patients (P coefficient, 4.4 per mmol/L; 
P=0.019). There was no evidence that age, sex, body mass index, current active 
smoking, diabetes m ellitus status, diastolic blood pressure, ACE inhibitor / ARB 
therapy or statin therapy contributed to apocynin mediated relaxation. Overall the 
model was only able to account for 8.0% o f  the variation in relaxation (coefficient o f 
determination).
The p coefficients indicate the estimated proportional increase in apocynin mediated 
relaxation with a unit increase in the predictor.
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Table 6.5 Analysis of variance p-valnes for
relationship between risk factors
relaxation of LSV in CAD patients.
the null hypothesis of no 
and allopurinol mediated
Variable Allopurinol (n=142)
P coefficient
P (Confidence
Intervals)
Age (10 years) 0.386 -0.94 (-3.1, 1.2)
Sex (0=F, 1=M) 0.190 3.2 (-1.7, 8.1)
Body M ass Index (kg/m^) 0.186 -0.31 (-0.77, 0.15)
Current Active Smoking (0=no, l=yes) 0.356 2.4 (-2.7, 7.5)
Diabetes M ellitus (0=no, l=yes) <0.0005 1 7 (1 1 ,2 3 )
Diastolic Blood Pressure (lOmmM g) 0.947 -0.07 (-2, 1.9)
LDL Cholesterol (mmol/L) 0.326 -1.5 (-4.5, 1.5)
ACE inhibitor /  ARB (0=no, l=yes) 0.020 5.3 (0.55, 10)
Statin (0=no, l=yes) 0.374 -2.5 (-8, 3)
This analysis identified diabetes mellitus (p coefficient, 17 per mmol/L; T<0.0005) 
and ACE inhibitor / ARB therapy (p coefficient, 5.3 per mmol/L; f =0.020) as 
significant predictors o f  allopurinol m ediated relaxation o f  LSV in CAD patients. 
There was no evidence that age, sex, body mass index, current active smoking, 
diastolic blood pressure, LDL cholesterol or statin therapy contributed to allopurinol 
mediated relaxation. Overall the model was only able to account for 27.6% o f  the 
variation in relaxation (coefficient o f  determination).
The p coefficients indicate the estimated proportional inerease in allopurinol mediated 
relaxation with a unit increase in the predictor.
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Table 6.6 Analysis of variance p-values for the null hypothesis of no
relationship between risk factors and GSH/GSSG ratio in CAD
patients.
Variable GSH/GSSG ratio (n= 108)
P coefficient
p (Confidence Intervals)
Age (10 years) 0.043 17.35 (0.12, 37.54)
Sex (0=F, 1=M) 0.576 10.52 (-22.68, 57.97)
Body M ass Index (kg/m^) 0.864 0.3 (-3.03, 3.74)
Current Active Smoking (0=no, 1 =yes) 0.021 55.27 (6.5, 126.38)
Diabetes M ellitus (0=no, l=yes) 0.437 17.35 (-22.64, 78.02)
Diastolic Blood Pressure (lOmmM g) 0.005 24.61 (7.38, 44.6)
LDL Cholesterol (mmol/L) <0.0005 -53.14 (-63.07, -40.54)
ACE inhibitor / ARB (0=no, l=yes) 0.891 2.02 (-25.73,40.15)
Statin (0=110, l=yes) 0.871 -2.96 (-34.75, 44.32)
This analysis identified age (P coefficient, 17.35; P=0.043), current active smoking (p 
coefficient, 55.27; P=0.021), diastolic blood pressure (p coefficient, 24.61; f= 0 .005) 
and LDL cholesterol (P coefficient, -53.14; P<0.0005) as significant predictors o f 
GSH/GSSG ratio in CAD patients. There was no evidence that sex, body m ass index, 
diabetes mellitus or ACE inhibitor /  ARB therapy contributed to GSH/GSSG ratio. 
Overall the model was only able to account for 36.0% o f  the variation in relaxation 
(coefficient o f  determination).
The p coefficients indicate the estimated proportional increase in GSH/GSSG ratio 
with a unit increase in the predictor.
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Table 6.7 Analysis of variance p-values for the null hypothesis of no
relationship between risk factors and TAC in CAD patients.
Variable TAC (n = 
P
142)
P coefficient 
(Confidence Intervals)
Age (10 years) 0.097 -2.37 (-5.23, 0.57)
Sex (0=F, 1=M) 0.447 -2.47 (-8.63,4.11)
Body M ass Index (kg/m^) 0.039 -0.66 (-1.28, -0.03)
Current Active Smoking (0=no, l=yes) 0.052 -6.57 (-12.65,-0.07)
Diabetes M ellitus (0=no, l=yes) 0.142 -5.64 (-12.64, 1.93)
Diastolic Blood Pressure (lOmmM g) 0.006 -3.73 (-6.43, -0.95)
LDL Cholesterol (mmol/L) <0.0005 -12.28 (-15.68, -8.74)
ACE inhibitor / ARB (0=no, l=yes) 0.174 4.19 (-1.82, 10.56)
Statin (0=no, l=yes) 0.301 3.98 (-3.36, 11.87)
This analysis identified body m ass index (p coefficient, -0.66; R=0.039), diastolic 
blood pressure (p coefficient, -3.73; f= 0 .006), and LDL cholesterol (p coefficient, - 
12.28; jP<0.0005) as significant predictors o f  TAC in CAD patients. There was no 
evidence that age, sex, current active smoking, diabetes mellitus, ACE inhibitor / 
ARB therapy or statin therapy contributed to TAC. Overall the m odel was only able to 
account for 36.6% o f  the variation in relaxation (coefficient o f determination).
The p coefficients indicate the estimated proportional increase in TAC with a unit 
increase in the predictor.
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Figure 6.1 Scatter plots o f  LDL-cholesteroi concentration and calcium ionophore 
A23187 mediated relaxation o f  LSV (n = 134). Pearson correlation 
coefficient and p value are shown in the figure. This scatter plot shows 
a significant correlation between LDL-cholesterol and calcium 
ionophore A23187 mediated relaxation o f LSV (p = 0.001, r = -0.287)
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6.3,3 Circulating indicators of oxidative stress
6.3.3.1 G S H /G S S G  ratio
In a second model o f  multivariate linear regression analysis, in which log 
GSH/GSSG ratio represented the dependent parameter, LDL cholesterol again 
showed a strong association with log GSH/GSSG (Table 6.6). Log GSH/GSSG 
showed a highly significant independent inverse relationship with LDL-cholesterol (r 
= -0.490, p < 0.0005) (Figure 6.2). In addition the potential cardiovascular risk 
factors, age (p = 0.043), tobacco smoking (p = 0,021) and m ore strongly diastolic 
blood pressure (p=0.005) were related to log GSH/GSSG (Table 6.6). Overall the 
model was able to account for 36.0 % o f  the variation in relaxation (coefficient o f 
determination) (Table 6.6).
6.3.3.2 TAC
In a third m odel o f  m ultivariate linear regression analysis, in which log TAC 
represented the dependent parameter, log TAC showed a strong association with 
LDL-cholesterol and showed a highly significant inverse relationship with LDL- 
cholesterol (r = -0.514, p < 0.0005) (Table 6.7; Figure 6.4). In addition the potential 
cardiovascular risk factors, body mass index (p = 0.039) and once again diastolic 
blood pressure (p = 0.006) represented risk factors for log TAC (Table 6.7; Figure 
6.5). Tendencies to relationships between log TAC and age (p = 0.097) and log TAC 
and tobacco sm oking (p=0.052) were observed although these were not statistically 
significant (Table 6.7). This model was able to account for 36.6 % o f  the variation in 
relaxation (coefficient o f  determ ination) (Table 6.7).
Although the m ultivariate analysis showed that both TAC and GSH/GSSG 
were strongly associated with diastolic blood pressure when direct correlations
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between diastolic blood pressure and both log TAC and log GSH/GSSG ratio were 
performed neither log TAC nor log GSH/GSSG ratio showed a significant correlation 
with the potential cardiovascular risk factor diastolic blood pressure (Figure 6.6; 
Figure 6.7). Both circulating indicators o f  oxidative stress showed a strong association 
with diastolic blood pressure.
Linear regression analysis had shown LDL-cholesterol was the most important 
determ inant followed by diastolic blood pressure for both circulating indicators o f 
oxidative stress, however when direct correlations between the circulating indicators 
o f  oxidative stress were performed both log TAC and log GSH/GSSG ratio (p = 
0.163) and TAC and GSH/GSSG (p = 0.725) failed to dem onstrate a significant 
correlation (Figure 6.6; Figure 6.7).
M oreover although correlations between LDL-cholesterol and markers o f 
endothelial function and oxidative stress were observed (Figure 6.1), the circulating 
indicators o f  oxidative stress did not correlate directly with endothelium -dependent 
relaxation to calcium  ionophore A23187 (log TAC vs calcium ionophore A23187 
p=0.072; log GSH/GSSG vs calcium ionophore A23187 p=0.651).
6.3.4 Endothelium -independent vasorelaxation to superoxide inhibitors
LDL cholesterol was also a significant predictor o f  relaxation to the NADPH 
oxidase inhibitor apocynin (p coefficient, -4 .4 2  per mmol/L, p=0.019), although this 
was weaker than for other relationships (Table 6.4). No association between ACE 
inhibitor /  ARB treatm ent and response to apocynin was demonstrated. No other 
factors included in the analysis had any effect on relaxation to apocynin.
In contrast to the other phenotypes examined, relaxation to the xanthine 
oxidase inhibitor allopurinol was not determined by LDL cholesterol but was very
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significantly associated with the presence o f diabetes mellitus (p coefficient, -1 7  with 
the presence o f  diabetes m ellitus, p < 0.0005) (Table 6,5). Figure 6.8 demonstrates 
that in diabetic subjects, xanthine oxidase inhibition with allopurinol had a greater 
effect on the percentage o f  vasorelaxation than in nondiabetic subjects (35 ± 3 versus 
21 ± 1 %; p < 0.001; 95 % Cl, -2 0  % to - 7  %). ACE inhibitor /  ARB therapy was the 
only other variable that was related to the xanthine oxidase inhibitor allopurinol (p = 
0.020) (Table 6.5).
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F ig u re  6.2 Scatter plots o f  LDL-cholesterol concentration and log GSH/GSSG 
ratio, (n = 108). Pearson correlation coefficient and p value are shown 
in the figure. This scatter plot shows a significant correlation between 
LD L-cholesterol and log GSH/GSSG ratio o f  LSV (p < 0.001, r = - 
0.490).
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Scatter plots o f log GSH/GSSH and diastolic blood pressure (mmHg) 
in the CAD patients (n = 108). Pearson correlation coefficient and p 
value are shown in the figure. This scatter plot shows no significant 
correlation between log GSH/GSSG ratio and diastolic blood pressure 
(p = 0.178, r = 0.121).
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F ig u re  6.4 Scatter plots o f  LDL-cholesterol concentration and lo g  TAC (Cn^^ 
reducing equivalents) (n = 142). Pearson correlation coefficient and p 
value are shown in the figure. This scatter plot shows a significant 
correlation betw een LDL-cholesterol concentration and lo g  TAC (p < 
0.001, r = -0.490).
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F igure 6.5 Scatter plots o f  TAC and diastolic blood pressure (mmHg) in the CAD 
patients (n = 142). Pearson correlation coefficient and p value are 
shown in the figure. This scatter plot shows a significant correlation 
between log  TAC coneentration and diastolic blood pressure (p = 
0.006, r = -0.205).
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Figure 6.6 Scatter plots o f  TAC and GSH/GSSG ratio in the CAD patients (n = 
108). Pearson correlation coefficient and p value are shown in the 
figure. This scatter plot shows no significant correlation between TAC 
and GSH/GSSG ratio (p = 0.725, r = 0.032).
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F igure 6.7 Scatter plots o f log TAC and log GSH/GSSG ratio in the CAD 
patients, (n = 108). Pearson correlation coefficient and p value are 
shown in the figure. This scatter plot shows no significant correlation 
between log TAC and log GSH/GSSG ratio (p = 0.163, r = -0.101).
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F ig u re  6.8 V asorelaxation to allopurinol in rings o f  LSV from CAD patients with 
diabetes mellitus (n=45) and non-diabetic CAD patients (n=143). The 
x-axis is on a logarithmic scale. O  Non-diabetic #  Diabetes mellitus 
Results are shown as mean ± SEM. Differences in relaxation between 
CAD and control patients were examined using unpaired t-tests.
* p < 0 . 0 1 , * * p  < 0 .001.
In diabetic subjects, xanthine oxidase inhibition with allopurinol had a 
greater effect on the percentage o f vasorelaxation than in nondiabetic 
subjects (35 ±  3 versus 21 ±  1 %; p < 0.001; 95 % Cl, -2 0  % to -7  %).
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16.4 DISCUSSION
Data provided in this study showed that severity o f  LDL-cholesterol levels J
represents an independent factor for both endothelium -dependent vasorelaxation and 
circulating indicators o f  oxidative stress in patients with CAD. The 'oxidative 
modification hypothesis' o f  lipids is now supported by many lines o f  evidence, and it 
is well known that oxidized low density proteins (LDL) may contribute to the onset 
and progression o f  atherosclerotic lesions by numerous mechanisms, including its 
pro inflammatory, im munogenic and cytotoxic actions (Steinberg and W itztum 2002).
The role o f  lipoprotein oxidation in atherosclerosis is well established. A  decreased 
resistance to oxidation o f  LDL (shortened lag phase) indicates an atherogenic nature 
o f LDL (Holvoet et al. 2000; A hotupa and Vasankari 1999) and is associated with an 
increased risk o f atherom atosis (Regnstrom et al. 1992). Hypercholesterolem ia has 
been shown to attenuate endothelial dependent vasorelaxation in num erous vascular 
beds including human coronary arteries (Quyyaimi et al. 1997) and forearm resistance 
vessels (Chowienczyk et al. 1992). In animal models o f  hypercholesterolaemia, 
attenuated endothelial function associated with increased superoxide production is 
observed (Mügge et al. 1994). Both native and oxidised LDL-cholesterol may cause 
uncoupling o f  eNOS and superoxide production in cultured endothelial cells (Vergani 
et al. 2000). In addition, components o f oxLDL have been reported to stimulate 
superoxide production via NAD(P)H oxidase (Rueckschloss et al. 2001).
Investigators dem onstrated in a small series o f  hypercholesterolemic patients that 
lipid-lowering therapy reverses disturbed endothelium -dependent vasorelaxation in 
peripheral arteries and that endothelial dysfunction returns rapidly when 
hypercholesterolem ia is restored (Stroes et al. 1995).
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The Joint British Societies' guidelines on prevention o f  CVD in clinical 
practice recom m end that the target for LDL-cholesterol should be under 2.0 mmol/L 
for patients with clinically established CVD and those considered at risk o f 
developing the disease, including those with diabetes mellitus (British Cardiac Society 
et al. 2005). Only 4% (7/188) o f  CAD patients included in this study had a 
cholesterol in this recommended target range despite 76% o f them being on statin 
therapy.
Although LDL-cholesterol showed significant association with both 
circulating indicators o f  oxidative stress and endothelial function there was no 
obvious relationship between either o f the indicators o f  oxidative stress examined and 
endothelial function. O ther factors including surgical preparation o f  vessels 
(Dashwood et al. 2007; Souza et al. 2006; Dashwood et al. 2005) and levels o f  oxygen 
radical degrading enzymes such as ecSOD and catalase within the vessel wall 
(Landmesser et al. 2004, Bream an et al. 2002) will have a major im pact on endothelial 
function.
Both circulating indicators o f  oxidative stress also showed an association with 
blood pressure w hich was not observed for endothelial function. The reason for this is 
not clear. Guidelines produced by the Joint National Com mittee on Prevention, 
Detection, Evaluation, and Treatm ent o f High Blood Pressure recommend that the 
target for diastolic blood pressure should be under 75 mmHg for individuals. The 
guidelines also state that patients w ith a high cardiovascular risk profile can benefit 
from reducing blood pressure below the goal o f  diastolic blood pressure < 7 5  mmHg 
(Chobanian et al. 2003). Y et 80.3 % o f  these CAD patients have a diastolic blood 
pressure above this recom m ended target range despite 93.6 % o f  these CAD patients 
taking anti-hypertensive therapy.
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LDL-cholesterol also influenced superoxide production via NAD (P)H oxidase 
as measured by relaxation to apocynin, although the significanee o f  the association in 
this case was relatively low. NAD(P)H oxidase is the predominant source o f 
superoxide in the human vasculature. Smoking, hypertension, hypercholesterolemia 
and diabetes mellitus have all been reported to upregulate this enzyme (Grindling et 
al. 2000) but showed no association in this study.
Tobacco sm oking was only classified as yes or no; to control for smoking, 
total pack-years o f  smoking is a more accurate measure to incorporate all past 
smoking experience. One cigarette pack-year is equivalent to having smoked one 
pack or 20 cigarettes per day for an entire year. A  dose related relationship between 
total amount (often expressed as "cigarette pack years") o f  cigarettes smoked and 
relaxation to apocynin would have been a better study and m ight have revealed an 
association with endothelial function and / or NAD(P)H oxidase derived superoxide.
Sim ilarly as the CAD patients were on polypharm acy (Table 6.1) for diabetes 
mellitus and hypertension, this makes interpretation o f  the data in subjects with these 
disorders more difficult.
In contrast to the other analyses, LDL-cholesterol had no significant influence 
on superoxide production via xanthine oxidase as measured by relaxation to 
allopurinol, but activity o f  this enzyme was enhanced in diabetic subjects consistent 
with the positive effect o f  allopurinol on endothelial function in diabetics (Butler et al.
2000). Xanthine oxidase inhibition has also been suggested to have therapeutic 
potential in patients with heart failure (Berry and Hare 2004). A CE inhibitor therapy 
was the only other variable that was weakly associated with relaxation to the xanthine 
oxidase inhibitor allopurinol. There is evidence in the literature for interactions 
between xanthine oxidase, angiotensin converting enzyme and NAD (P)H oxidase
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(Berry and Hare 2004; Usui et al. 1999). Allopurinol has been shown to prevent 
increases in ACE activity (Usui et al. 1999). Additionally, it has been stated that 
xanthine oxidase can generate superoxide via NAD(P)H oxidase activity and can 
produce N O  via nitrate and nitrite reductase activities (Berry and Hare 2004).
There has been m uch interest recently in inhibition o f  vascular NAD(P)H 
oxidase as a m eans to reduce oxidative stress and progression o f  CVD (Cai et al. 
2003, Jacobson et al. 2003). This data would indicate further research into the benefit 
o f xanthine oxidase inhibition in diabetic subjects but m ost importantly this study 
highlights the role o f  LDL-cholesterol in m odulating endothelial function and levels 
o f  oxidative stress and supports the mandatory use o f cholesterol lowering drugs in 
patients w ith CAD. It was noted in the previous chapter that the CAD patients have 
higher cholesterol levels than the control patients. This may suggest that more 
vigorous treatm ent w ith cholesterol lowering therapy may be beneficial despite over 
three quarters o f  CAD patients already being on statin therapy.
Neither o f  the circulating indicators o f  oxidative stress were directly related to 
endothelial function but the simultaneous evaluation o f  the two circulating indicators 
o f  oxidative stress, TAC together and GSH/GSSG, may represent fundamental 
indicators for the evaluation o f  oxidative stress levels in the field o f  CVD and also 
constitute a potential tool to m onitor therapeutic interventions and disease progression 
directed against pathologic processes related to atherosclerosis.
In conclusion, the m ost important finding in this study was the principal role 
o f  LDL-cholesterol in determ ining oxidative stress and endothelial dysfunction in 
CAD patients. This study supports vigorous intervention and therapy to reduce the 
severity o f  risk factors and oxidative stress both before and after CAD surgery.
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Chapter 7
Discussion
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Endothelial dysfunction is a common pathophysiological feature which 
develops in the evolution o f  CVD (Simonescu 2007). Strategies to m aintain a healthy 
endothelium or to reverse endothelial dysfunction are crucial for the norm al function 
o f  the cardiovascular system and the maintenance o f cardiovascular health 
(Simonescu 2007). Endothelial dysfunction is observed both in the coronary and 
peripheral vasculature (Drexler 1997).
The main objective o f  this thesis was to study the effect o f  harvesting 
techniques and cardiovascular risk factors on endothelial function o f hum an coronary 
artery bypass grafts.
The chapter 3 study found no significant difference in calcium ionophore 
A23187 mediated vasorelaxation or sodium nitroprusside m ediated vasorelaxation in 
LSV harvested by traditional vein open harvesting and minimally invasive techniques. 
These results dem onstrate no evidence that the increased m anipulation o f the LSV, 
consequent upon using the M ayo stripper, affected endothelial function any more than 
the traditional open harvest method. In order to eliminate the effect o f  surgical 
expertise, the study used 2 very experienced surgeons who were equally comfortable 
with either technique to carry out all o f  the vein harvesting. This study supports the 
notion that harvesting vein through multiple incisions using the M ayo vein stripper is 
quicker, results in better wound healing and has no more deleterious effect on 
endothelial function than the open technique.
This study has several noteworthy limitations that m ight influence 
interpretation o f  results. The num ber o f  patients, and therefore the num ber o f  LSV 
samples, is relatively small, and statistical power is thereby limited. Although a type 
II error may be present with the small sample size in the present study, the similarity 
in the two groups suggests a larger sample size would, at most, only detect a small
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difference that, although interesting, may not be clinically relevant. Also, sampling 
only two rings from harvested veins may miss areas o f injury at other sites within the 
vein. For long-term quality control, post-operative assessm ent o f  graft patency by 
angiography may give further insight into possible differences between traditional 
open and minim ally invasive harvesting techniques.
Although the main focus o f  the chapter 3 study was into the effect o f 
harvesting techniques on N O-dependent endothelial function, there are other 
considerations to the study that should be addressed. As the M ayo vein stripper 
requires dissection intimate to the adventitial layer to visualize the side branches, the 
adventitia and the surrounding tissue was removed. The adventitia is also removed 
during TOVH (Dashwood and Loesch 2007). This measure m ay play an important 
part in the subsequent processes involved in endothelial dysfunction and graft 
occlusion, because the adventitia does not merely provide structural support for the 
media, but contains the vasa vasorum, a microvascular network responsible for the 
exchange o f gases and supply o f  nutrients to the vein wall (Dashwood et al. 2007). 
The preservation o f the perivascular tissue around the LSV m ight be im portant as a 
natural external support (Souza et al. 2006), thereby protecting the vein against the 
effects o f  aortic shear stress (Vijayan et al. 2004; Tsui and Dashwood 2002), and has 
been associated with improved graft patency (Souza et al. 2006). It has been proposed 
that by reducing vascular injury using atraumatic surgical techniques, NO-dependent 
endothelial function is maintained and that this will result in improved graft 
performance (Dashwood et al. 2007; Dashwood et al. 2005; Tsui et al. 2002). 
Preservation o f  endothelial function o f  LSV grafts used in CAB G surgery is an 
important determ inant o f  patency up to 18 months postoperatively (Cook et al. 2004). 
It would be interesting to repeat this study incorporating the “Souza no-touch
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technique” (Souza et ai. 2006) to compare calcium ionophore A23187 mediated 
relaxation in LSV harvested with perivascular tissue by traditional open and 
minimally invasive techniques.
The aim o f the chapter 4 was to determine the effect o f  IM A pedicle width on 
endothelium -dependent vasorelaxation o f  IM A harvested by m onopolar electrocautery 
from patients undergoing CABG. This study demonstrated the predom inant role o f 
IM A pedicle width in determ ining calcium ionophore A23187 m ediated relaxation o f 
IM A harvested by m onopolar electrocautery from patients undergoing CABG. This 
study dem onstrated that a w ider IM A pedicle harvested w ith m onopolar 
electrocautei7  better preserves the NO-dependent endothelial function o f  the IMA. 
Although the main focus o f  this study was into the effect o f  pedicle width on NO- 
dependent endothelial-function, there are other potential sources o f  NO that are 
m aintained with IM A pedicles (Gao et al. 2005). A recent study described the release 
o f  a transferable relaxing factor from the perivascular adipose tissue surrounding the 
human IMA and suggested that its retention when harvesting the IM A may play an 
important role in the superior patency rate o f  the IM A (Gao et al. 2005). To prove that 
IM A harvested w ith a wider pedicle ameliorates survival, will be difficult because o f 
the low sensitivity o f  clinical endpoints and the good results that are available with the 
use o f normal harvested IM A (Rosamund et al. 2007; Cho et al. 2006; Eagle et al.
2004). Long-term follow-up including angiographic assessment o f  the patients may 
add valuable data regarding outcom e with regard to this harvesting technique. The 
Western Infirmary Glasgow on behalf o f  the National A dult Cardiac Surgical 
Database prospectively follows up their CABG patients and five year freedom-from- 
reintervention and mortality data will be available to further investigate the influence 
o f  pedicle width on freedom -from -reintervention and survival.
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Damage to segments o f the LSV and IM A during harvesting as a graft has 
been described as inevitable (Dashwood and Loesch 2007; Gaudino et al. 2003) and a 
recent publication stated ‘‘...as  basic research scientists, we are surprised by the 
degree o f dam age inflicted on the saphenous vein during conventional bypass 
surgery ...It seems, when harvesting this vessel as a graft, many surgeons are in effect 
preparing a “tube” or “pipe” (common definitions o f  conduit) with no regard to its 
many vital vascular structu res...” (Dashwood and Loesch 2007).
M aintaining structural and functional integrity o f  the endothelium  o f  the graft 
is an important feature o f  any procurem ent technique (Dashwood and Loesch 2007; 
Dashwood et al. 2007; Dashwood et al. 2005; Ueda et al. 2003; Thatte and Khuri
2001). There are many factors that contribute to endothelial dysfunction in grafts for 
CAB G (Hinokiyam a et al. 2006; Barker et al. 1994; Lawrie et al. 1990; Angelini et al. 
1989). Such factors may be categorized as unavoidable and avoidable. Unavoidable 
factors include the exposure o f  the vein to arterial pressure. However, some factors 
such as high-pressure distention, stripping the adventitia (Dashwood et al 2007; Souza 
et al. 2006) and the use o f  scissors to avoid electrocautery heat injury (Deja et al.
2005) are avoidable. Relatively simple technical changes aim ed at preserving the 
integrity o f  endothelial function and preventing endothelial dysfunction may have 
considerable impact on graft patency (Dashwood and Loesch 2007; H inokiyam a et al. 
2006; Ueda et al. 2003; Cunningham 1996).
The Chapter 5 studies dem onstrated contrasting levels o f  oxidative stress and 
endothelial function between patients w ith severe CAD and age- and sex-matched 
individuals with no docum ented CVD. This is the first study to assess endothelial 
function, superoxide production, and oxidative stress, not only in vessels used for 
revascularisation in CAB G surgery, but also in the equivalent vessels from healthy
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control subjects. M oreover, the predom inant role o f  LDL cholesterol in determining 
oxidative stress and endothelial dysfunction in CAD patients has been demonstrated
The studies showed severe depression o f relaxation to calcium ionophore 
A23187 in veins from CAD patients despite normal responses to sodium 
nitroprusside, consistent w ith a specific defect in endothelium -dependent nitric oxide 
pathways. Superoxide levels, measured directly within the vessel wall using 2 
methods, were elevated in blood vessels from CAD compared with control patients. In 
addition, in the organ bath studies, inhibition o f  xanthine oxidase and NADPH 
oxidase with allopurinol and apocynin, respectively, caused significantly greater 
relaxation in vessels from CAD compared with control patients. These findings 
indicate excess superoxide production as an important cause o f  the attenuation o f 
endothelium -dependent relaxations in CAD patients and suggest that both xanthine 
oxidase and NA D PH oxidase contribute to superoxide production in these patients. 
Consistent with these observations, increased NADPH oxidase and xanthine oxidase 
activity has been suggested in patients with CAD (Landmesser et al. 2007; Guzik et 
al. 2006; Simic et al. 2006; Redon et al. 2003; Spiekermann et al. 2003), and 
inhibitors o f  these enzymes have been shown to inhibit superoxide production in LSV 
from CAD patients (Berry et al. 2000). O f note, quantitative analyses o f the 
contribution o f  nicotinam ide-adenine dinucleotide phosphate oxidase and xanthine 
oxidase to superoxide production are not possible from these experiments. Apocynin 
acts by blocking the assem bly o f  the NADPH oxidase complex (Bedard and Krause 
2007). N 0 X 4  has been shown to be the predominant homologue in vascular smooth 
muscle from conduit vessels (Lambeth et al. 2004). N 0 X 4  is constitutively active 
(Bedard and Krause 2007); thus, apocynin may have low potency in the LSV and only 
inhibit a proportion o f  NAD(P)H oxidase activity.
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The degree o f  endothelial dysfunction has been reported to be related to the 
num ber o f  risk factors present in CAD patients (Guzik et ah 2000; Huraux et ah
1999). However, Huraux et ah (1999) failed to show any relationship between 
superoxide levels and endothelial dysfunction in IM A from a group o f  97 CAD 
patients, whereas Redon et ah (2003) reported that no relationship was observed 
between 24-hour mean blood pressure and reduced/oxidized glutathione ratio in 
hypertensive subjects.
The findings in chapter 6 show a significant relationship between LDL 
cholesterol levels and both endothelium -dependent vasorelaxation and markers o f 
oxidative stress in patients w ith CAD. Hypercholesterolem ia has been shown to 
attenuate endothelium -dependent vasorelaxation in numerous vascular beds, including 
human coronary arteries (Quyyuni et ah 1997) and forearm resistance vessels 
(Chowienczyk et ah 1992). In animal models o f hypercholesterolemia, attenuated 
endothelial function associated with increased superoxide production is observed 
(Mugge et ah 1994). The studies performed in this thesis do not provide a mechanistic 
explanation for the relationship between LDL cholesterol and superoxide generation.
However, LDL cholesterol and oxidized LDL cholesterol have been shown to affect 
the trafficking o f  eNOS to caveolae (Shaul 2002). Both native and oxidized LDL %
cholesterol may cause an uncoupling o f  eNOS, resulting in superoxide production in j
endothelial cells (Vergnani et ah 2000). In addition, components o f  oxidized LDL 
have been reported to stimulate superoxide production via N AD PH oxidase 
(Rueckschloss et ah 2001). Lipid-lowering therapy with statins has been demonstrated 
to improve endothelial function (Fichtlscherer et ah 2006; John et ah 1998).
In the chapter 6, the relationship between LDL cholesterol and endothelial 
dysfunction and oxidative stress was m aintained across the whole range o f  LDL
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cholesterol concentrations. These results are consistent w ith those from recently 
published studies, which showed that intensive lipid-lowering therapy in patients with 
stable CAD reduced the occurrence o f  major cardiovascular events (Larosa et al. 
2005; N issen et al. 2005; Cannon et al. 2004) and reduced the progression o f 
atherosclerosis (Nissen et al. 2004). Significantly fewer events have been observed in 
patients in whom LDL cholesterol levels were 2.0 mmol/L compared with those with 
a mean LDL cholesterol o f  2.6 mmol/L (Larosa et al. 2005).
Although LDL cholesterol was a significant predictor o f  both markers o f 
oxidative stress and endothelial function in our study, there was no obvious 
relationship between either o f  the circulating markers o f  oxidative stress examined 
and endothelial function. Other factors, including surgical preparation o f  vessels 
(Dashwood et al. 2007; Dashwood and Loesch. 2007; Hinokiyam a et al. 2006; Souza 
et al. 2006; D ashw ood et al. 2005) and levels o f  oxygen radical degrading enzymes, 
such as extracellular superoxide dismutase and catalase within the vessel wall, will 
have a m ajor impact on endothelial function (Landmesser et al. 2004; Brennan et al.
2002). In addition, C-reactive protein has been reported to influence endothelial 
function (Clapp et al. 2005; Fichtlscherer et al. 2000). CRP renders oxidized LDL 
more susceptible to uptake by macrophages, induces the expression o f  vascular-cell 
adhesion molecules, stimulates the production o f  tissue factor, and impairs the 
production o f  nitric oxide (Verm a et al. 2002; Torzewski et al. 2000; Cermak et al. 
1993; Zouki et al. 1997). W e cannot rule out a contribution o f  C-reactive protein to 
endothelial function in addition to that o f LDL cholesterol. Interestingly, both the 
reduced/oxidized glutathione ratio and total antioxidant capacity showed an 
association with blood pressure that was not observed for endothelial function.
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LDL cholesterol was also related to superoxide production via NADPH 
oxidase as m easured by relaxation to apocynin, although at a lower level o f 
significance. NADPH oxidase is the predominant source o f  superoxide in the human 
vasculature. (M iller et al. 2005; Griendling 2004; Touyz et al. 2004; Bengtsson et al. 
2003; Cai et al. 2003) Smoking, hypertension, hypercholesterolemia, and diabetes 
have all been reported to upregulate this enzyme (Griendling 2004; Griendling et al.
2000). In contrast, LDL cholesterol had no influence on the production o f  superoxide 
from xanthine oxidase, but superoxide production via this enzyme was significantly 
enhanced in diabetic subjects, consistent w ith the positive effect o f  allopurinol on 
endothelial function in patients with diabetes (Butler et al. 2000). ACE inhibitor / 
ARB therapy was related to superoxide production via xanthine oxidase as measured 
by relaxation to allopurinol. A recent study demonstrated that angiotensin II -  
dependent stimulation o f  endothelial xanthine oxidase activity plays a m ajor role for 
increased endothelium bound xanthine oxidase activity in patients with CAD 
(Landmesser et al. 2007). Xanthine oxidase inhibition has been suggested to have 
therapeutic potential in patients w ith heart failure (Berry and Hare 2004).
There has been much interest recently in the inhibition o f  vascular NADPH 
oxidase as a means to reduce oxidative stress and progression o f  CVD (Guzik and 
Harrison 2006; M iller et al. 2005; Calo et al. 2005). Our data indicate that there is a 
significant relationship between LDL cholesterol and vascular oxidative stress across 
the entire range o f  LDL cholesterol concentrations. This provides a m echanistic 
explanation in support o f  intensive LDL cholesterol-lowering therapy as suggested by 
recent clinical trials.
In conclusion, this thesis proposes that a m ultifactorial strategy aimed at 
prevention o f  endothelial dysfunction, should include improved surgical techniques
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and the use o f specific pharmacologic agents, including LDL cholesterol-lowering 
therapies, as a form o f intervention. The successful application o f  this strategy, and 
the developm ent o f  newer strategies, including the use o f  new pharmacological agents 
(Lorusso et al 2006), gene therapy (George et al. 2006; Baker et al. 2006) and the use 
o f  m echanical devices (Jeremy et al. 2007), may impact on long-term graft patency.
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